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Chapter 1
General introduction
Partly based on: 
Elasmoid scales of fishes as model in biomedical bone research 
Juriaan R. Metz1, Erik de Vrieze1, Erik-Jan Lock2, Ines E. Schulten1 and Gert Flik1
1 Department of Organismal Animal Physiology, Institute for Water and Wetland 
Research, Faculty of Science, Radboud University Nijmegen, Heyendaalseweg 135, 6525AJ, 
Nijmegen, The Netherlands
2 National Institute of Nutrition and Seafood Research (NIFES), Bergen, Norway
Journal of Applied Ichthyology, 2012; 28 (3): 382-387
© 2012 John Wiley & Sons. Reprinted with permission
bone research
A plethora of different cell culture assays and animal models is available to design 
and test pharmaceuticals to treat osteoporosis and other bone diseases. Most 
commonly used for in vivo experiments is the ovariectomized (OVX) rat model, 
which is included in the guidelines for drug testing (Kalu et al., 1991; Rissanen and 
Halleen 2010). Other options include the so-called disuse-model, where a limb 
is immobilized, and glucocorticoid treatment (e.g. prednisolone), which are both 
known to induce osteoporosis in rats (Fleisch et al., 1969; Yao et al., 2008). Often 
used alternatives for whole animal models generally consist of cultured bone cells 
or tissues, either in primary culture, or differentiated from cell lines of osteoblast or 
osteoclast precursors (Kadis et al., 1980; Sudo et al., 1983; Sorensen et al., 2007). 
To fully mimic interactions between osteoblasts and osteoclasts as occur in bone 
in vivo, co-culture models of these cell types have been introduced (Teti et al., 
1991). Such co-cultures are, however, difficult to perform as osteoclasts and osteo- 
blasts require radically different culture conditions, which compromise the specific 
cell activities mutually. The best viable options are 3D-cultures with isolated cell 
phases or cultures of one cell type with culture medium conditioned by the other 
(Rissanen and Halleen, 2010).
Zebrafish models
In the last decade, teleost fish1, in particular zebrafish (Danio rerio), have become 
widely recognized as a valuable model in the search for bone therapeutics and 
drug discovery (Renn et al., 2006; Lieschke and Currie, 2007; Brittijn et al., 2009). 
Based on exterior localization (easy experimental access) and their function in cal-
cium and phosphorus physiology, fish scales2 recently gained special attention in 
biomedical research (Yoshikubo et al., 2005; Suzuki et al., 2011a; Pasqualetti et al., 
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1 Teleost fish (infraclass Teleostei; Dutch: beenvissen) form a taxonomic subgroup within the superclass 
of bony fish (Osteichthyes; Dutch: beenvisachtigen). The majority of species within this superclass (ap-
proximately 27.000), belong to the infraclass Teleostei. Zebrafish, medaka, carp, goldfish, tilapia, salm-
on and seabream, the species most studied in skeletal biology, all belong to the infraclass Teleostei.
2 The term “scale” is a generally used term for any hard plate-like structure that grows out of the skin 
of different groups of vertebrates. Reptilian scales mainly consist of keratin and form in the epidermis, 
while scales of bony fish are dermally derived. In this thesis (unless specified otherwise), one particular 
type of scale is studied: the elasmoid scale, typically found in teleost fish and characterized by the 
presence of elasmodin.
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2012a). The most commonly found type of scales in fish, including zebrafish, is the 
scale of the so-called elasmoid type. This type is characterized by the presence of 
flexible elasmodin; layers of collagen organized in a plywood-like pattern (Sire and 
Huysseune, 2003). Elasmoid scales form within the dermis via direct ossification 
(i.e. without a cartilaginous precursor phase). Scales are aligned in partly overlap-
ping rows to protect the fish body. Although scales, from an evolutionary point of 
view, are closer related to odontodal than to skeletal tissues (Sire and Akimenko, 
2004) it has become increasingly clear in recent years that elasmoid scales can be 
useful models in bone research (Suzuki and Hattori, 2003; Yoshikubo et al., 2005): 
they not only have many structural and physiological characteristics in common 
with mammalian bone (cells), the use of scales offers also many advantages over 
the use of mammalian bone samples and cell lines of osteoblasts or osteoclasts. 
Especially the possibility to culture both osteoblasts and osteoclasts together, on 
their original matrix, is a unique addition to existing models. In this respect it is 
noteworthy that the increasing incidence of joint and bone diseases in the human 
population (U.S. Department of Health and Human Services, 2004), such as osteo-
porosis, warrants development and validation of new models to reduce costs and 
speed up preclinical and phase-I research (Brittijn et al., 2009). This thesis aims to 
provide knowledge on structure, development and physiology of elasmoid scales 
of teleost fish, mainly from studies on zebrafish and to design and validate a unique 
and valuable new model in bone research.
TeleosT bone
Compared to mammals, bony fish (Osteichthyes) are early vertebrates and repre-
sent a clade in which many specialized skeletal tissues have originated (Sire and 
Huysseune, 2003). Most successful is the acellular bone, which is found through-
out the teleost lineage, whereas in humans it is normally regarded as pathological 
(Hall, 2005). In advanced teleosts, such as medaka (Oryzias latipes), acellular bone 
is the only norm for the entire skeleton, whereas in zebrafish, acellular bone is only 
found in certain tissues such as the scales and fin rays (Meunier and Huysseune, 
1992). The acellular skeleton of advanced teleosts evolved secondarily from fish 
that did possess cellular bone (reviewed by Shahar and Dean, 2013). By polarized 
deposition of new bone matrix (osteoid), osteoblasts avoid becoming entrapped 
in the bone (Meunier and Huysseune, 1992). This raises the possibility that acel-
lular bone, present in a large number of teleosts, has a physiological advantage 
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over cellular bone (Shahar and Dean, 2013). Although no direct evidence exists 
for such advantage, typical osteocyte-mediated processes such as responses to 
mechanical stress and remodeling do occurs in acellular bone (Shahar and Dean, 
2013). Remarkably, the absence of cells inside the bone matrix does not imply 
that bone cannot be resorbed. From a mammalian perspective, osteoclasts are 
generally thought of as multinucleated cells which adhere to the matrix via a spe-
cialized cytoplasmic region, the ruffled border (Kaye, 1984; Hall 2005; Novack and 
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Impact of osteoporosIs
Osteoporosis is a collective term for bone diseases characterized by an 
increased fracture risk resulting from decreased bone mass and strength. The 
two most common causes are the altered estrogen signaling in post-meno-
pausal women and the long-term use of glucocorticoid drugs. Bone diseases 
have a major impact on the human population in general, and especially on 
affected individuals and their relatives. In some cases, bone diseases lead 
directly to pain and deformity but in most cases a bone disease is a “silent” 
disorder until it results in fractures. Most recent data available on the impact 
on society date from 2004 (United States) and 2007 (The Netherlands). In the 
United States, 1.5 million osteoporotic fractures occur annually and over half a 
million fractures lead to hospitalization. Hip fractures are by far the most devas-
tating type of fracture, accounting for about 300,000 hospitalizations each year 
(U.S. Department of Health and Human Services, 2004). In The Netherlands 
approximately 148,000 patients were diagnosed for osteoporosis in 2007. The 
prevalence of osteoporosis in The Netherlands has dramatically increased 
between 1990 and 2007: incidence in the male population has doubled, while 
it has almost tripled in the female population. Due to the increasing lifespan 
of the population, estimations are that the prevalence will further increase in 
The Netherlands with 38% in 2025 (RIVM, 2012). Health and social care for 
patients with such fractures is very expensive. Studies reveal that expenditures for 
direct care of osteoporotic fractures range from $12 to $18 billion per year in 
the United States (U.S. Department of Health and Human Services, 2004). As 
bone diseases can severely affect functional abilities, indirect costs (e.g. lost 
productivity for patients and caregivers) are likely to add billions of dollars to 
this figure. This makes the demand for new therapeutics and treatment strate-
gies more important than ever. 
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Teitelbaum, 2008). Although many teleost osteoclasts are in fact similar to their 
mammalian counterparts, resorption in (zebra-)fish is not limited to multinucleated 
cells. Depending on tissue and developmental stage, mono- and multinucleated 
osteoclasts can both be involved in bone resorption (Witten and Huysseune, 2009). 
Bone can be formed either via a cartilaginous precursor (endochondral ossifica-
tion), or via intramembranous ossification, where bone is deposited directly (Hall 
2005; Mackie et al., 2011). In mammals, the endoskeleton is typically formed via 
endochondral ossification, although intramembranous ossification can occur as 
well;  e.g. in the flat bones of the skull and the clavicle. In teleosts, where the appen- 
dicular skeleton is not as extensively developed, intramembranous ossification is 
responsible for an important part of the endoskeleton, including vertebral bodies 
(Bird and Mabee, 2003). The dermal skeletal tissues, such as scales and fin rays, 
rely on intramembranous ossification only. Many structures of the dermal skeleton 
are believed to have originated from the neural crest, instead of the mesoderm, 
that gives rise to the endoskeleton (Hall 2005; Sire et al., 2009). Elasmoid scales 
and fin rays have recently been shown to be of mesodermal origin (Ho Lee et al., 
2013; Mongera and Nüsslein-Volhard 2013; Shimada et al., 2013). The two modes 
of ossification are usually regarded as separate, and very different. Although very 
distinct in origin, mode of ossification and evolutionary history, both ossification 
modes result in remarkably similar tissues when it comes to structure, cell popu-
lation and physiology.
scale morphology and sTrucTure
The (ultra)structure of the elasmoid scale has been described for several species 
(Onozato and Watabe, 1979; Meunier, 1984; Sire et al., 1997a; 1998; Khemiri et 
al., 2001; Ikoma et al., 2003). A single scale of an adult zebrafish plucked from the 
skin just caudally to the operculum is between 2 and 3 mm in diameter and has a 
thickness of 20-30 µm. As a consequence of the oblique position of the scale in the 
dermis, about one third of the scale is covered closely by the epidermis (figure 1; 
2A). The inner, hyposquamal side of a scale is smooth; the outer episquamal side 
exhibits concentric mineralized ridges (circuli) and a radial network of unmineral-
ized furrows (radii); centrally, the ontogenetically first-formed origin (focus) can be 
distinguished. 
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matrIx
In cross section, the elasmoid scale itself invariably consists of three layers (Zyl-
berberg and Nicolas, 1982; Sire and Akimenko, 2004). From internal to external 
three layers can be distinguished. 1) The elasmodin layer of collagen fibers orient-
ed in a plywood-like arrangement (also called the ‘basal plate’); 2) A mineralized 
external layer, consisting of randomly oriented collagen type-I fibers. This layer is 
also called the osseous layer; 3) The limiting layer, found only just under the epider-
mis, is a thin, heavily mineralized layer that contains no collagen. 
The elasmoid scale plate is merely acellular. In the internal layer, type-I collagen 
fibrils of 70-120 nm in diameter form layers that are perpendicularly oriented alter-
natingly in one or the other direction (an orthogonal plywood-like structure; Ikoma 
et al., 2003). The cortical bone of the mammalian tibia similarly consists of type-I 
collagen fibril arrangements that resemble this orthogonal plywood structure in the 
internal layer (Weiner et al., 1997). The external layer is mainly composed of ran-
domly oriented collagen fibrils of 20–30 nm in diameter and contains apatite crys-
tals. The external layer has a similar structure as mantle dentin or woven bone (Sire 
et al., 1997b). Indeed, mammalian osteoclasts cultured on the mineralized side of 
an elasmoid scale show behavior comparable to as if seeded on mammalian bone, 
and we conclude this from the observation that murine osteoclasts adhere to and 
resorb the scale matrix (figure 3).
Electron microscopy combined with X-ray diffraction analysis indicates that the 
main calcium mineral found in elasmoid scales is hydroxy-apatite (Ca10(PO4)6(OH)2) 
(Schönbörner et al., 1979; Ikoma et al., 2003). In scale formation and regen- 
eration, the external layer is the first to be mineralized, a process starting with 
membrane-bound matrix vesicles (Schönbörner et al., 1979). In mammalian bone, 
matrix vesicles are similarly located at initial calcification sites (Anderson, 2003). 
The outer limiting and internal layers mineralize after external layer formation and 
in the absence of matrix vesicles (Schönbörner et al., 1979; Yamada and Watabe, 
1979). It has been suggested that minerals from the external layer infiltrate the 
internal layer (Olson and Watabe, 1980; Zylberberg and Nicolas, 1982), but very 
little is known about this process. 
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the cell compartment 
Various cell types can be distinguished in association with an elasmoid scale, most 
notably osteoclasts and scale-forming cells or scleroblasts (derived from the Greek 
skleros, meaning ‘hard’; a term for skeleton-forming cells). Hyposquamal sclero-
blasts are often also referred to as osteoblasts, as they share many characteristics 
with mammalian osteoblasts, for example their respective transcriptomes are 
similar (detailed below). On the hyposquamal side, these cells form a monolayer 
and remain attached to the scalar plate, their natural substrate, when a scale is 
plucked from the skin (figure 2C). On the episquamal side, scleroblasts and mono- 
as well as multinucleated osteoclasts are present (figure 2D).
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Figure 1. Schematic cross-section of elasmoid scales embedded in the skin. Scales are obliquely 
positioned in the scale pocket (formed by scale-lining cells), inside the dermis. The scale pocket is 
covered by the epidermis on the exterior of the fish. Scale matrix consists of the unmineralized basal 
plate (elasmodin layer) and the calcified external (and outer limiting) layer. Cells lining the scale on the 
internal (hyposquamal) face and the edges (margins) are scleroblasts/osteoblasts (blue). Hyposquamal 
scleroblasts/osteoblasts of ontogenetic scales are flat and low in activity, while marginal cells mediate 
appositional growth and are active. Multinucleated osteoclasts (red) reside on the outer, mineralized 
surface (episquamal face) as well as mononucleated cells with osteoclast and/or osteocyte charac-
teristics (purple). Based on Suzuki et al., 2008, reproduced with permission of John Wiley & Sons Ltd 
(2013).
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osteoclasts 
Osteoclasts dissolve apatites and degrade bone matrix, a key process in normal 
dynamic bone turnover (Boyce et al., 2009). Osteoclastic activity in teleost scales 
can be ascribed to both mono- and multinucleated cells, although multinucleated 
cells are mainly associated with regions where the scale is damaged (Sire et al., 
1990). Later studies described the presence of at least two typical enzymatic 
osteoclast markers (both in multinucleated cells): tartrate-resistant acid phospha-
tase (TRACP) and cathepsin K (Persson et al., 1999; Suzuki et al., 2000; Azuma et 
al., 2007; Takahashi et al., 2008). Localization of TRACP and cathepsin K in those 
studies was always restricted to the episquamal, mineralized side of the scales. 
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Figure 2. Histochemical staining of zebrafish scales. A The brown color of Von Kossa calcium stain-
ing demonstrates the presence of calcium minerals (apatites) in the scale. The image shows an onto-
genetic scale. Abbreviations: e, epidermis; c, circulus; r, radius; d, demineralized area. B Magnification 
of the image in A, showing the white demineralized region in the focus of the scale in detail. Note that 
radii are not mineralized. C Cytoplasmic ALP staining (focused on the hyposquamal side) of a 15-days 
regenerated scale. Staining intensity differs among individual cells; nuclei show up white and appear 
devoid of ALP activity. D TRACP activity staining of an ontogenetic scale showing TRACP activity in 
red. A resorbed area (arrow), as well as cell nuclei (arrow heads) can be observed. Staining procedures 
are described in chapter 2.
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It is reasonable to assume that the active mediators of matrix degradation and 
demineralization of the scale are thus osteoclasts, which act in a highly similar 
mode compared to osteoclasts in mammalian bone. 
osteoblasts 
Since hyposquamal scleroblasts have many properties in common with osteo-
blasts, these two terms are often being used interchangeably in the literature 
(Persson et al., 1995; Suzuki and Hattori, 2002; Brittijn et al., 2009). Indeed the 
well-established osteoblast marker alkaline phosphatase (ALP) has been found as-
sociated with elasmoid scales independently and in many studies. Histochemical 
staining of ALP activity in zebrafish scales is restricted to the hyposquamal side 
and the activity is unevenly distributed among individual cells in a patchy pattern 
(figure 2C). During scale regeneration, osteoblasts become highly active as we 
conclude from the observation that scleroblasts/osteoblasts are more numerous 
and larger (especially prismatic rather than squamous) compared to their incidence 
and shape in ontogenetic scales (Bereiter-Hahn and Zylberberg, 1993; Yoshikubo 
et al., 2005). In addition to ALP and the aforementioned collagen type-I, two other 
osteoblast-derived proteins that are abundant in mammalian bone, have been 
demonstrated in the matrix of elasmoid scales: osteocalcin (also known as bone 
γ-carboxyglutamic acid protein or Bgp) and osteonectin. Osteocalcin in mammals 
is one of the few osteoblast-specific proteins implicated in bone mineralization and 
calcium homeostasis (Lee et al., 2007). It was purified and sequenced from both 
scale and bone extracts (Nishimoto et al., 1992). In mammalian bone osteonectin 
is secreted by osteoblasts during bone formation and the protein regulates bone 
mineralization, tissue remodeling and cell growth (Lane and Sage, 1994). For gold-
fish scales, osteonectin was cloned, sequenced and its gene expression in scales 
established by Northern blotting (Lehane et al., 1999). Presence of osteocalcin and 
osteonectin was recently confirmed in zebrafish scales (Hong et al., 2011). 
osteoblast-osteoclast InteractIons 
In mammals, a key process in bone remodeling (and hence of considerable impor-
tance in normal physiology and pathology) is the signaling pathway of the receptor 
activator of the NF-κB (RANK), its cognate ligand (RANKL) and osteoprotegerin 
(OPG; (Boyle et al., 2003). Briefly, binding of RANKL, produced by osteoblasts, 
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Figure 3. Scanning electron micrographs of murine osteoclasts cultured on denuded tilapia 
scales. RAW267.4 cells (murine macrophage-derived osteoclast precursor cell line) were stimulated 
with RANKL to form osteoclasts. Cells were seeded on tilapia scales that had been cleared of cells. 
A An osteoclast (marked with (*) seeded on the hyposquamal, unmineralized side shows poor mor-
phology and adhesion. B After removal of the cells, osteoclasts on the hyposquamal side of the scale 
create no more than very superficial and shallow resorptive areas. C On the episquamal, mineralized 
side of the scale, osteoclasts (*) have a normal appearance and clearly adhere to the scale surface via 
tightly sealed extensions of the cytoplasm (podosomes). Osteoclasts are predominantly found on the 
scale circuli where they actively breakdown and resorb (arrow) the scale matrix and minerals. D As a 
consequence, profound resorption is seen on the episquamal side. We conclude from these images 
that mammalian osteoclasts show comparable behavior to the mineralized side of the scale as they do 
to mammalian bone.
(Brief description of experimental procedure: Tilapia (Oreochromis mossambicus) scales were cleared 
of cells by sonication in water and three consecutive wash steps. Scales were transferred to MEMα, 
medium supplemented with L-glutamine and 10% (v/v) fetal calf serum. Approximately 105 murine 
RAW264.4 cells were seeded on the scales and 90 ng/ml RANKL was added to the media to induce 
osteoclastogenesis. Culture media were refreshed daily and after 8 days, scales were fixed and pre-
pared for scanning electron microscopy following standard procedures.) 
a b
c d
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to RANK, located on the surface of osteoclast precursors, leads to increased 
expression of various osteoclast genes. As a consequence, osteoclast formation 
and bone resorption is increased. This signaling pathway is inhibited by the binding 
of OPG, a decoy receptor produced by osteoblasts, to RANKL. Thus far, only one 
study shortly addressed the RANK/RANKL/OPG pathway in goldfish scales (Suzuki 
et al., 2011). Increased RANKL and RANK expression was seen, together with an 
increase of multinucleated osteoclasts, in response to parathyroid hormone (PTH) 
treatment of cultured goldfish scales. It would seem then that osteoblasts and osteo- 
clasts interact in elasmoid scales similarly as in intact mammalian bone; studies to 
shed more light on this interaction are currently carried out.
scale developmenT and regeneraTion
Elasmoid scales develop during ontogeny in the dermis and, once formed, are 
exteriorly covered by the epidermis; scales are thus not in direct contact with the 
water as many people think (erroneously). The number of elasmoid scales in a 
fish is more or less determined; in a zebrafish several hundreds, and as the fish 
grows, individual scales grow along with the fish (Sire et al., 2000). Each individual 
elasmoid scale is inserted in a pocket within the dermis. When a scale is removed 
or lost, e.g. due to an injury or predation, a new scale will be formed. The basic 
organization and structure of regenerated scales resemble those of the original 
scale. The similarity between the original (ontogenetic) and the regenerating/ 
regenerated scale supports the notion that scale development is a highly con-
served process following the same molecular and cellular program during ontogeny 
as during regeneration (Bereiter-Hahn and Zylberberg, 1993). This regenerative 
capacity and underlying mechanisms are interesting in itself as the mammalian 
skeleton can restore damaged bone to a certain extent, but cannot regenerate lost 
bones.
The process of scale formation and regeneration in teleosts is to a large extent 
comparable to the process of direct (dermal) bone formation in mammals. Cells of 
the basal layer in the epidermis initiate (by sonic hedgehog signaling; Sire and Aki-
menko, 2004) differentiation of an upper dermal cell layer into scale-pocket lining 
cells (Zylberberg and Meunier, 1996). These cells secrete the osteoid and as such 
a `bag‘ forms, the scale papilla, which harbors the developing scale disc. The scale 
is formed by scleroblasts, which are of mesenchymal origin and lay on the inner 
face (hyposquamal scleroblasts) and the outer face (episquamal scleroblasts) of a 
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scale (Bereiter-Hahn and Zylberberg, 1993). A third cell-type, the marginal sclero-
blast, is found at the peripheral edge of the scale. Marginal scleroblasts most likely 
account for appositional growth of the scale and differentiate into hypo- or epi- 
squamal scleroblasts depending on their final location as the scale plate continues 
to grow. Scleroblasts resemble mammalian osteoblasts in many aspects as argued 
earlier. The mineralization, initiated by scleroblasts starts in the center (focus) of the 
regenerating scale and extends to the upper episquamal, peripheral areas (Bereit-
er-Hahn and Zylberberg, 1993).
Upon removal of a scale, most of the cells remain attached to it (Sire, 1989b). Scale 
regeneration is in the context of bone physiology a fast process that depends 
on environmental factors like ambient calcium availability and temperature. For a 
zebrafish in a holding tank at 25°C, the first regenerating scales become exter-
nally visible in 3-5 days (Sire et al., 2000). After scale removal, scale-pocket lining 
cells divide to form new scale-forming cells (Bereiter-Hahn and Zylberberg, 1993). 
At this time a new scale papilla has formed that is much like the scale papilla 
found during initial scale development, with the difference that the scleroblasts are 
considerably larger. Scleroblasts form the external layer of the scale matrix first, 
just like during development. From this point, scale regeneration appears an accel-
erated version of ontogenetic scale development, yielding eventually a scale very 
similar to the scale that was removed.
responses of elasmoid scales To sTimuli
Not only structural, but also functional homologies should be established in scales 
to prove its value as model for mammalian bone physiology. The role of the skele-
ton in calcium and phosphate homeostasis is well established in mammals. In tele-
ost fish, this may differ among species, but the mechanistics of this are poorly un-
derstood in general. However, evidence from studies on different species indicates 
that, when the fish is challenged with low calcium and/or phosphorus availability, 
scales may serve as a buffer to supply calcium and phosphorus to guarantee ho-
meostasis of these minerals (Mugiya and Watabe 1977; Flik et al., 1986; Persson et 
al., 1994; Lall and Lewis-McCrea, 2007). Besides their skeleton, fish can also rely 
on their gills and intestines to take up calcium from the water and maintain calcium 
homeostasis (reviewed by Wendelaar Bonga and Pang, 1991; Flik and Verbost, 
1993). It is of utmost importance to emphasize that it has been shown that the 
scale compartment in Mozambique tilapia (Oreochromis mossambicus) holds up to 
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20% of the total body calcium (Flik et al., 1986; Takagi et al., 1989). It forms a rapidly 
exchangeable calcium reservoir more than 30 times the size of the plasma calcium 
pool (Flik et al., 1985). The reservoir function of scales was demonstrated in stud-
ies which demonstrate that during vitellogenesis, when there is a high demand for 
yolk calcium, significant mobilization of calcium and phosphate from scales takes 
place, while other bone is not affected (Carragher and Sumpter, 1991; Persson et 
al., 1994). In addition, starvation or treatment with 17-beta estradiol, treatments 
that alter bone density in mammals, result in scale demineralization in trout (Rigotti 
et al., 1991; Persson et al., 1995; Kim et al., 2007). In spawning goldfish, tracp and 
cathepsin k gene transcription in scales increases (Azuma et al,. 2007). Although in 
mammals these functions are limited to the endoskeleton, it can thus be concluded 
that scales, part of the dermal skeleton, can act as calcium reservoir in much the 
same way as the endoskeleton of terrestrial vertebrates.
Few in vivo experiments have shed light on the endocrine regulation of the scale 
compartment. A high affinity, low-capacity estradiol-17β binding was found in 
scleroblast cytosol of rainbow trout (Oncorhynchus mykiss) and estrogen receptors 
have immunohistochemically been detected in Mozambique tilapia and gilthead 
sea bream (Sparus auratus) scales (Persson et al., 2000; Pinto et al., 2009). 
Injections of recombinant fugu PTH1 induced hypercalcemia, which resulted from 
increased osteoblast and osteoclast activities in the scales. A decrease in scale 
calcium content after intraperitoneal PTH1 injection substantiated this observation 
(Suzuki et al., 2011a). 
As stated before, when a scale is removed from the skin, osteoblasts and 
osteoclasts remain attached to the scale surfaces. A plucked scale can be placed 
in an in vitro culture system and easily be exposed to hormones, growth factors 
and small molecules. This is a promising and powerful approach to test unknown 
substances for their ability to affect matrix and/or cells, in a natural and easily 
manipulated environment. Indeed, this strategy has already been exploited in sev-
eral studies. An enzymatic assay for ALP activity has been explored in several 
studies to quantitate osteoblast-like activity in relation to in vivo treatments of the 
fish as well as in vitro treatments of isolated scales (e.g. Suzuki and Hattori, 2002; 
Yoshikubo et al., 2005; Suzuki et al., 2011a). Moreover, direct in vitro stimulation 
of TRACP activity by estradiol-17β has been demonstrated in cultured scales of 
goldfish (Carassius auratus) and nibbler fish (Girella punctata) (Yoshikubo et al., 
2005); interestingly, in the presence of calcitonin, a classic hypocalcaemic hor-
mone, or melatonin TRACP activity was inhibited (Suzuki et al., 2000; Suzuki and 
Ge
ne
ra
l i
nt
ro
du
ct
io
n
19
1
Hattori, 2002). Ligand binding studies and gene expression data demonstrated 
the presence of a parathyroid receptor (PTH1R) in gilthead sea bream (Sparus au-
ratus) scales and in vitro exposure to parathyroid hormone-related protein (PTHrP, 
established ligand for PTH1R in teleosts) indeed stimulated TRACP activity and 
down-regulated osteonectin gene transcription in scales (Redruello et al., 2005; 
Rotllant et al., 2005). Prolactin, growth hormone and somatolactin promoted osteo-
blast activity in goldfish scales in vitro (Takahashi et al., 2008). Moreover, prolactin 
reduced osteoclast activity on the scales via induction of osteoclast apoptosis 
(Takahashi et al., 2008). Together all these observations indicate that scale matrix, 
osteoclasts and osteoblasts respond to internal and external stimuli most often 
similarly as the cells in mammalian bone.
aim of The Thesis 
As yet, an adequate and reliable animal model for human osteoporosis is lack-
ing (Rissanen and Halleen, 2010). Current biomedical bone research largely relies 
on rodent models (Rissanen and Halleen, 2010; Gomes and Fernandes, 2011). 
Throughput of these experiments is low, associated costs are high and such 
models often come with inherent high levels of discomfort for experimental 
animals. Therefore, biochemical assays in in vitro bone cell cultures (osteoblast-, 
osteoclast-, osteocyte- as well as co-cultures) are often being used; such assays 
can be run in high throughput format to identify promising new drug candidates 
from libraries of thousands of compounds. Disadvantages of such cell cultures 
are, among others, that cells do not grow on their natural substrates and that 
interactions between osteoblasts and osteoclasts are difficult to mimic and require 
complex co-culture conditions. 
Teleost fish, in particular zebrafish with its well-annotated genome, offer a unique 
solution to these impediments with their elasmoid scales. These small, transparent 
bone units have many traits in common with mammalian bone. Moreover, scales 
are easy to collect in high numbers, they regenerate, they are easily manipulated, 
provide cells attached to their natural matrix, and allow for natural cell-cell inter-
actions. 
The research described in this thesis was part of the SmartMix Program funded 
by the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of 
Education, Culture and Science. The objective of this project was to design new 
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models and screening assays based on the versatile zebrafish as a model species 
in order to develop new screening assays that can be applied as an intermediate 
between cell culture assays based on a single cell type and expensive rodent mod-
els. In this thesis, emphasis is on improvement of the understanding of molecular 
and biochemical pathways controlling bone and mineral metabolism in elasmoid 
scales as well as on cellular dynamics during bone formation and resorption. The 
outcome of this thesis’ research is a zebrafish scale-based assay that can be 
implemented in the development route of new therapeutics for skeletal diseases.
ouTline 
chapter 2 provides a characterization of the mineral component of zebrafish 
and carp scale matrix, to underline the similarities with mammalian bone matrix. 
Parallels are further substantiated in chapter 3, where different properties of the cell 
populations of elasmoid scales are investigated and discussed. In chapter 4, the 
focus is on the osteoclasts and the activity of matrix metalloproteinases (Mmps) in 
relation to remodeling of the scale plate. chapter 5 explores the effects of dietary 
supplementation with arachidonic acid on scale osteoclasts and subsequent bone 
remodeling. This study may have spin off in aquaculture research, as skeletal de-
formities cause losses in aquaculture. The link with a human bone disease is made 
in chapter 6, where glucocorticoid-induced osteoporosis is mimicked in zebrafish 
in vivo and studied in (regenerating) zebrafish scales. Development and validation 
of a high throughput in vitro assay for osteoblast activity is presented in chapter 7. 
For this assay, we generated a stable transgenic zebrafish line, which specifi-
cally expresses the firefly luciferase gene in osteoblasts and offers easy readout 
of osteoblast activity in plucked or cultured scales. Finally, the scale model and 
our major findings, is discussed in relation to evolution of the skeleton and other 
(zebrafish) models in bone research (chapter 8).
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Chapter 2
evidence for a hydroxyapatite precursor in 
reGeneratinG cyprinid scales
Erik de Vrieze
Loek Heijnen
Juriaan R. Metz 
Gert Flik
absTracT
Collagen matrices, mineralized with calcium phosphates in a hydroxyapatite 
phase, are generally found in skeletal tissues. However, mechanisms of biomineral 
formation and regulation are still poorly understood. Elasmoid scales are part of 
the dermal skeleton and regenerate quickly when damaged or lost. This makes 
scales a convenient target to study mineral composition and formation. The X-ray 
diffractogram of the mineral layer of carp scales only shows peaks corresponding 
with hydroxyapatite. Energy-dispersive X-ray spectroscopy (EDX) during scanning 
electron microscopy identifies the elements calcium and phosphorus, which are 
restricted to the external layer of the scale. In contrast with various other fish 
species, calcium phosphate crystals are not present in the elasmodine layer. The 
clean boundary between calcified and uncalcified matrix suggests that subsequent 
mineralization of the  elasmodine layer is inhibited. Quantification of the calcium and 
phosphorus content allows definition of a calcium:phosphorus molar ratio, which 
is indicative of the crystalline phase of the minerals. Through accurate measure- 
ments of total calcium and phosphorus (by ICP-MS) in zebrafish scales, different 
ratios were found for newly formed (regenerating) scales compared to ontogenetic 
or completely regenerating scales. This shows that the minerals are not at first 
deposited as hydroxyapatite, but in a precursor phase. Although the nature of this 
phase remains to be established, our first analysis shows that cyprinids scales can 
easily be used to gain insights in the dynamics of biomineralization.
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inTroducTion
Skeletons are found in many different phyla, in a wide variety of shapes, sizes, 
and compositions. Calcium salts are widely found to strengthen both endo- and 
exoskeletons. The minerals found most are calcium carbonates (e.g. in crustacea 
and echinodermata) or calcium phosphates (e.g. vertebrata) (Ascenzi et al., 1983; 
Killian and Wilt, 2008). Vertebrate skeletons are mostly mineralized with so-called 
carbonated hydroxyapatite; a calcium phosphate, partly substituted with calcium 
carbonate. This is thermodynamically the most stable phase of calcium phos-
phates in the neutral bone matrix (de Jong, 1926; Ascenzi et al., 1983; Johns-
son and Nancollas, 1992; Killian and Wilt, 2008). Calcium phosphates are almost 
exclusively precipitated on a collagen matrix (mainly type 1), which contributes to 
the tissues tensile strength (Garnero et al., 2003). The mechanisms that regulate the 
formation of apatite on biological matrices are poorly understood (Omelon et al., 
2009). The presence of a precursor calcium phosphate phase has been generally 
accepted during hydroxyapatite formation in vitro (Christoffersen et al., 1989). Both 
brushite (CaHPO4·2H2O) and amorphous calcium phosphate have been suggested 
precursors for hydroxyapatite formation (Christoffersen et al., 1989; Johnsson and 
Nancollas, 1992). The transformation of brushite to hydroxyapatite is a thermo- 
dynamically driven process that can occur under alkaline conditions, even in a 
protein free environment (Stulajterová and Medvecký, 2008). Recently, new light 
has been shed on the nature of one mineral precursor phase in vivo: amorphous 
calcium phosphate was detected next to carbonated hydroxyapatite during 
mineralization of newly formed zebrafish fin rays (Mahamid et al., 2008). 
Understanding the process of biomineralization has become increasingly impor- 
tant in relation to pathological calcifications which are for example found on the 
collagen matrices of cartilage and blood vessels. There is only little insight in what 
mechanisms or compounds normally keep these tissues refrained from mineraliza-
tion, but recent findings point towards a role for polyphosphates, which are found 
in cartilage and demineralized bone matrix (Omelon et al., 2009). Unfortunately, 
calcification usually takes place deep inside the body, which makes it difficult to 
study the principles and regulation of matrix mineralization. Up to this day, most 
knowledge is still derived from in vitro experiments. 
Elasmoid scales of fish offer a solution here as they are one of the few mineralized 
skeletal elements located superficially in the dermis. Common carp and zebrafish 
are ‘covered’ with a protective armor of hundreds of scales, systematically aligned 
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in horizontal and vertical rows. Importantly, scales can be removed easily to study 
and induce regeneration, a rapid reformation of this mineralized skeletal tissue 
(Sire and Géraudie, 1984). 
Elasmoid scales are formed in the dermis without the presence of a cartilaginous 
initium, comparable to other elements of the dermal skeleton (Sire et al., 1997a; Sire 
and Akimenko, 2004). The structure of elasmoid scales is described in the literature 
for several species, all picturing a similar structural composition of three layers (e.g. 
Sire, 1989b; Bereiter-Hahn and Zylberberg, 1993). During scale development and 
regeneration, these layers are formed in an invariable order. First, the external layer 
is formed to the full extent of the future scale. The external layer is a thin and highly 
mineralized layer of interwoven collagen fibrils. Subsequently, the scale gains 
thickness as the basal plate or elasmodin layer is formed. The basal plate is a thick 
and incompletely mineralized layer of collagen fibrils organized in a plywood-like 
structure, located deepest in the fish (hyposquamal side; Zylberberg et al., 1988; 
Sire and Huysseune, 2003). Scale formation ends with deposition of the outer 
limiting layer, a hypermineralized tissue (nearly) devoid of collagen fibrils, which 
is located next to the epidermis (Schönbörner et al., 1979). The scale is lined with 
cells that have the potential to form and resorb the scale on demand of calci-
um physiology (scleroblasts and osteoclasts respectively; de Vrieze et al., 2011). 
Although the protein matrix has been well analyzed for several fish species, for-
mation of the scale mineral component has only been studied from a histological 
perspective. Mineralization of the external layer is reported to be initiated by matrix 
vesicles. The elasmoid layer and internal layer are calcified subsequently, without 
mediation of matrix vesicles (Schönbörner et al., 1979).
In this first exploration of the biomineral component of cyprinid scales, we aim to 
identify the type of calcium phosphate minerals on ontogenetic and regenerating 
scales by means of X-ray diffraction analysis and scanning electron microscopy 
with energy-dispersive X-ray spectroscopy (EDXs). 
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Figure 1 (right page). Experimental and theoretical X-ray diffraction patterns. A Theoretical diffrac-
tion pattern of a pure hydroxyapatite crystal. B Theoretical simulation of the effects of peak broadening 
of the hydroxyapatite pattern to mimic the pattern of small sized crystals. C Pattern from the epis-
quamal side of an ontogenetic scale. The different peaks are color coded and can be ascribed to the 
corresponding colored pattern. The green bar beneath the pattern represents the general increase in 
intensity that can be ascribed to the collagen matrix. D Pattern of the double sided tape used to mount 
the scales on the sample holder. E Pattern obtained from the hyposquamal side of an ontogenetic 
scale. The arrangement of the collagen fibril results in this signal. Diffractions angles are listed on the 
x-axis in degrees. Intensity of the X-ray signal is listed on the y-axis in arbitrary units (AU).
2
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resulTs
The theoretical diffraction pattern that corresponds to hydroxyapatite (figure 1A) 
requires adjustment for the small sized crystals that are expected on the scale 
plate (figure 1B). Peak broadening of the pattern, which results from X-ray dif-
fraction of smaller crystals, was simulated with Crystallographica software. The 
thus obtained X-ray diffraction pattern of an ontogenetic scale is shown in figure 
1C. The purple coded peaks correspond to peaks that are expected for hydroxy- 
apatite. Other peaks on the diffractogram of the ontogenetic scale are on the same 
angle as the peaks from the tape (figure 1D) and the collagen matrix (figure 1E). 
The hyposquamal side of the scale plate, made of a plywood-like meshwork of 
collagen fibers, was measured to obtain the diffraction pattern of the background, 
which corresponds to collagen scale matrix. 
EDXs combined with scanning electron microscope allows for element analysis on 
scales. Specific elements (calcium and phosphorus) could be identified and visual-
ized on scale sections (figure 2) and whole mount scales (not shown). The scanning 
EM picture (figure 2A) shows the plywood-like arrangement of the basal plate with 
ridges (circuli) on the episquamal side. The calcium signal (figure 2B, green) and 
phosphorus signal (figure 2C, blue) are limited to the episquamal side. An overlay 
image shows that mineralization was detected in the external layer, but did not 
extend far into the basal plate, which thus appears unmineralized (figure 2D). 
Quantification of the EDXs signal was used to roughly estimate the calcium:phos-
phorus molar ratio. This ratio can be used to get an indication of the phase of calcium 
phosphates (figure 3). The earliest time at which a regenerating scale could be 
plucked in carp at this rearing temperature is 9 days. At this time, the calcium 
phosphorus ratio was 1.14 ± 0.24 (figure 3A). Two days later, at day 11, the ratio 
had increased to an average of almost 1.4 and was similar to the ratio found in 
ontogenetic scales. These results triggered our interest and lead to an experiment 
with much more accurate element quantifications by means of inductively coupled 
plasma mass spectrometry (ICP-MS). Zebrafish were used to get a better view of 
the mineralization as minerals are already deposited after two days of regeneration 
(data not shown) and mineral content analysis can be done as early as 4 days of 
regeneration. At this time, a calcium phosphorus ratio of 0.84 ± 0.12 was observed 
(figure 3B). One day later, on day 5 the ratio had increased to almost the same level 
as mature scales after 21 days of regeneration, or the ratio seen in ontogenetic 
scales.
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discussion and conclusion
The pattern of the X-ray diffraction analysis shows that the crystal structure of the 
scale mineralization is in a hydroxyapatite phase. When the background peaks, 
resulting from the tape and collagen, are neglected, the remaining peaks appear 
at specific angles that correspond exactly to the broadened hydroxyapatite peaks. 
The increase of the overall intensity can mostly be ascribed to the broad collagen 
peak. The broad hydroxyapatite peaks, compared to the theoretical peaks, suggest 
that the crystals of the scale matrix are small in size. Amorphous calcium phos-
phate would result in a broad peak between 25 and 35 degrees, but this would be 
indistinguishable from the hydroxyapatite pattern (Boskey, 1997). Brushite, often 
named as a hydroxyapatite precursor phase, would result in a pattern that partly 
overlaps that of hydroxyapatite, but does show additional peaks at approximately 
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Figure 2. Scanning electron microscopy images with EDAX analysis. A SEM image of a sectioned 
ontogenetic scale. B Calcium signal of the EDAX analysis from the same scale, depicted in green. C 
Phosphorus signal, derived from the same scale, depicted in blue. D Overlay image of all three images 
showing the location of calcium and phosphorus in the scale section.
A B
C D
2
21 degrees and around 30 degrees (Sakae et al., 1981; Boskey, 1997). Although 
these additional peaks can be used to demonstrate the presence of brushite next 
to hydroxyapatite on an elasmoid scale, they were not found. Scales of carp keep 
growing slowly as the fish grows, which suggests the presence of a small amount 
of precursor phase on the growing edge, as has been demonstrated for zebra- 
fish fin rays (Mahamid et al., 2008). However, the presence of amorphous calcium 
phosphate or brushite could not be verified in mineralizing carp scales with the 
techniques applied. Regenerating scales could only be subjected to X-ray diffrac-
tion analysis from 15 days of regeneration onwards and resulted in a pattern similar 
to that of ontogenetic scales (data not shown). Presence of a mineral precursor 
phase on the growing edges of ontogenetic scales is predicted based on recent 
findings in tail fin mineralization, but could not be verified with X-ray diffraction 
analysis. If present, the amount of mineral in a precursor phase is too low or its 
presence is too early in regeneration to be detected with this technique.
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Figure 3. Calcium:phosphorus ratios during scale regeneration. A Semi-quantitative analysis from 
the element specific signal intensities of the EDX analysis for ontogenetic and regenerating carp scales. 
Signal intensities were obtained from different images of the scale. B Ratios calculated from ICP-MS 
analysis of zebrafish scales during regeneration. Data are expressed as means ± SD, groups marked ‘a’ 
and ‘b’ are significantly different, tested by means of students t-test (3A, P < 0.01) or a Mann-Whitney 
U-test (3B, P < 0.01).
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EDXs was used to localize calcium and phosphorus in scale sections (figure 2). 
This analysis shows that mineralized layer of carp scales is very thin and mainly 
consists of the external layer. Little or no mineralization was found between the 
aligned collagen fibers of the elasmodin layer, but the woven fibers (external layer) 
are strongly mineralized. Contrary to our results, calcification extends deeply in the 
basal plate of scales from the closely related goldfish and has also been reported 
in some other species (Schönbörner et al., 1979; Sire and Huysseune, 2003; Ohira 
et al., 2007). Since scales of slowly growing mature broodstock fish were used, it is 
safe to assume that the mineralization of ontogenetic scales will not propagate any 
deeper into the scale plate. When tissue calcification is initiated, the extracellular 
levels of calcium and phosphate are sufficient to support continued nucleation of 
hydroxyapatite crystals on preformed templates (Anderson, 2003). The very clear 
boundary that separates the mineralized and unmineralized matrix indicates the 
presence of compounds that actively inhibit mineralization of the deep matrix. In-
creasing evidence points into the direction of polyphosphates, which are believed 
to play a role in the inhibition of matrix mineralization as their presence decreases 
the concentration of reactive phosphates (Omelon et al., 2009; Kim et al., 2010). 
Although polyphosphates have not (yet) been detected in the elasmodin layer of 
the carp scale, the clear boundary to mineralization proves to be a very interesting 
model for future study into the mechanisms that inhibit mineralization. Especially 
with today’s interest in pathological ectopic mineralization, e.g. atherosclerosis, 
the scale may provide valuable insights in the control of biomineralization.
The calcium and phosphorus signals of the energy dispersive X-ray spectroscopy 
can be quantified and expressed as a ratio. However, surface morphology may, 
amongst other factors, influence the results too much to give an indication of the 
mineral phase. In all measurements, very similar tissues were analyzed and a sig-
nificant difference in Ca:P ratios of carp scales was found between 9 and 11 days 
regeneration. This may be a first indication of a shift in mineral phase, but the large 
spread at day 9 indicates that the change may have already occurred in some 
samples. 
Since it was not possible to remove scales properly before day 9, zebrafish were 
used in a more controlled environment to get a better grip on this shift in mineral 
phase. Calcium and phosphorus analysis with inductively coupled plasma mass 
spectrometry (ICP-MS) is very accurate and could be used quantitatively with zebra- 
fish scales. The clear difference in calcium phosphorus ratios between day 4 and 
5 of regenerating zebrafish scales confirm the anticipated presence of a different 
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phase of calcium phosphate on day 4 compared to day 5. Since mineralization of 
the zebrafish scale starts already at day 2 (as judged from histological analysis of 
skin samples; data not shown), most of the measured calcium and phosphorus 
is indeed derived from the scale plate. This relative increase in calcium content 
is also observed in scales of goldfish (Ohira et al., 2007), another related cyprinid.
Identification of the phase of calcium phosphates during early regeneration proved 
to be difficult. X-ray diffraction spectra only confirmed the presence of hydroxy- 
apatite, and could not be made during early regeneration. When interpreting calci-
um:phosphorus molar ratios one should keep in mind that phosphorus is relatively 
more abundant than calcium in the cells and matrix that are inevitably included in 
the measurement, which results in lower ratios than predicted for pure minerals. 
Also, the possibility of a mixture of precursor mineral and hydroxyapatite cannot be 
disregarded, as this precursor is expected to be present on the growing edges of 
the scale. A ratio of approximately 1 is indicative of brushite, indeed hypothesized 
to be a hydroxyapatite precursor (Johnsson and Nancollas, 1992). These ratios are 
found on 4-days regenerating zebrafish scales. Taken the phosphorus contribution 
of the organic matrix into account, amorphous calcium phosphate, with a reported 
calcium phosphorus ratio of ~1.35 (Christoffersen et al., 1989), may be present as 
a precursor. Indeed, amorphous calcium phosphate was also found as precursor 
during zebrafish tail fin mineralization (Mahamid et al., 2008). Ratios lower than 
1.66 (indicative of hydroxyapatite) are detected in both ontogenetic carp scales 
and completely regenerated zebrafish scales. We have as yet no explanation for 
the discrepancy between these two results. Even though scales are possibly min-
eralized with a mixture of mineral phases (growing edge vs. mature mineral), large 
differences in ratio during scale regeneration were consistently found with differ-
ent techniques and do support a switch in main mineral component. The short 
time between the two different ratios, 24 hours, suggest that this change in phase 
occurs very fast and is likely a thermodynamical process that does not require any 
involvement of proteins (Stulajterová and Medvecký, 2008).
Taken together, two intriguing aspects of biomineralization occur during formation 
(regeneration) of cyprinid scales: the transformation of a precursor mineral phase 
into hydroxyapatite and the inhibition of calcification in the elasmodine layer. The 
ability of scales to regenerate, in combination with the ease of collecting and han-
dling them, makes the cyprinid scale an attractive model to study the enigmatic 
aspects of biomineralization.
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maTerials and meThods
experImental anImals 
Carp (Cyprinus carpio) from laboratory stock were kept in a 140 liter tank; brood-
stock animals of approximately 4 kg (used for large scales for X-ray diffraction 
analysis) were kept in a large 1000 liter basin. Carp were kept at 23°C and fed 
commercial fish food (Trouvit, Trouw, Putten, The Netherlands) at a 1.5% ration 
of the estimated body weight per day. Adult wildtype zebrafish (Danio rerio) were 
kept in standard recirculation systems (Aquaschwartz, Göttingen, Germany) at a 
density of 8 fish per 1.5 liter tank. Fish were fed flake food and Artemia at 1% of 
the estimated bodyweight. All experiments were performed according to national 
legislation and after approval of the ethical committee of the Radboud University 
Nijmegen.
collectIon of scales 
First the animals were anesthetized in 0.05% 2-phenoxyethanol (Sigma-Aldrich, 
St. Louis, USA). Scales were removed with tweezers from the second and third row 
above the lateral line of the fish. After removal of scales, the fish was placed back 
in their tank and recovered from treatment within 10 minutes. Regenerating scales 
can be observed as early as 2 days or regeneration, they are too fragile to remove 
from the skin. For carp, regenerating scales could be collected as early as 9 days 
of regeneration, for zebrafish the first regenerating scales could be collected after 
4 days.
x-ray dIffractIon 
For x-ray diffraction experiments, scales from large 4 kg fish were used as their 
scale size matches the sample size required for the analysis. After collection, the 
scales were first washed in 70% ethanol and preserved in MilliQ water. During the 
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experiments the scales were mounted on a sample holder with Scotch® permanent 
double-sided adhesive tape (3M, Leiden, the Netherlands), to prevent the samples 
from curling up. The hyposquamal side of the scale was used to obtain a diffrac-
togram of the collagen matrix. X-ray diffractograms were made with a Bruker AXS 
D8 Advance Diffractometer (Bruker AXS Inc., Madison, USA), reflection mode and 
a wavelength of 1.54056 Å (Cu-Kα1). Diffractogram analysis was done with Crys-
tallographica V1.60c software (Oxford Cryosystems Ltd, Oxford, United Kingdom).
scannIng electron mIcroscopy and energy-dIspersIve x-ray spectroscopy (edxs)
Scales were embedded in TissueTek (Sakura FineTek, Alphen aan den Rijn, the 
Netherlands), cryosectioned in 60 μm slices and mounted on the metal sample 
holder with carbon tape. The slices were not coated as this was not needed to al-
low for element-analysis. Images were recorded with an accelerating voltage of 20 
kV with a JEOL 6301 Fesem EDAX microscope, equipped with an EDS elemental 
analysis system and Genesis software (EDAX, Mahwah, USA). 
calcIum:phosphorus molar ratIo 
Genesis software was used to perform a semi-quantitative analysis of calcium and 
phosphorus signals collected with EDXs microscopy. Ontogenetic scales and re-
generating scales of 9 and 11 days after start of regeneration were imaged from 
the episquamal side. Each scale was imaged three times in different areas; scales 
from three different fish were used. Total calcium and phosphorus of regenerating 
zebrafish scales (4, 5, 6, 14 and 21 days after start of regeneration) was detected 
with inductively couple plasma mass spectrometry (ICP-MS) on the Iris Intrepid II 
(Thermo Fisher Scientific, Waltham, USA). Ten scales per fish (N=8 fish per time 
point) were dissolved in 200 µl 65% nitric acid and diluted 100 times in milliQ water 
for analysis. Results of both analysis were expressed as a ratio of calcium:phos-
phorus.
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summary
Elasmoid scales from the common carp (and other teleostean fishes) appear to 
be an exciting new model in the research of mineralized tissues. The presence 
of alkaline phosphatase (ALP), a marker of mineralization, on both sides of the 
scale was demonstrated by means of enzyme histochemistry. Tartrate-resistant 
acid phosphatase (TRACP), a marker for mineral degradation and osteoclasts, was 
observed along the radii, at the same location as the ALP activity on the episqua-
mal side. This points towards an active mineral metabolism, were scale cells are 
involved in both formation and degradation of the mineralized matrix. Cathepsin K 
staining revealed the presence of multinuclear osteoclasts along the grooves of the 
scale. Interestingly, the scales were taken from growing control fish; they were not 
induced to resorb their matrix. Presence of these enzymes in scale cells, together 
with the demineralized regions in the center of the scale suggest a more dynamic 
mineral metabolism in cyprinid scales then previously observed in other species. 
Scales are derived from odontode tissues, their formation relies on many the same 
underlying mechanisms and genes as other mineralized tissues. Moreover, a single 
scale offers the possibility to culture scale-forming and -degrading cells together 
on their original matrix. All of these unique properties substantiate the potential of 
scales to yield new insights on osteoclasts and regulation of tissue mineralization.
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inTroducTion
To study the biology of mineralized tissues, primary bone cell cultures or pieces of 
fetal bone like calvaria are often used. Hence, animals have to be killed to obtain 
cells or tissues for the experiments. This generally yields only one or two samples 
from each animal because a specific part of the skeleton is used. Another option 
is the use of isolated cells, with the disadvantage that the cells tend to dedifferen-
tiate when dissociated from their natural matrix. Scales of teleostean fishes offer a 
unique solution to (some of) these problems as fish possess several hundreds of 
these (partly) mineralized collagen structures of dermal origin. Scales can be traced 
back in evolution to odontodes, tooth-like structures embedded in the dermis 
(Sire and Akimenko, 2004). Odontodes show a close morphological resemblance 
to teeth as they contain a layer of dentin, enamel and a pulp cavity (Sire et al., 
1998). Early scales and odontodes also comprise a bony layer, the basal plate. In 
the course of evolution, scales acquired different traits; the pulp cavity was lost 
and the basal plate replaced by the partly mineralized elasmodine. Although early 
scales may contain osteocyte-like cells in the basal plate, in elasmoid scales the 
basal plate is fully acellular. However, some traits like the type and arrangement of 
collagens in the basal plate, are still reminiscent of bone (Meunier, 1984; Weiner et 
al., 1999). 
Zebrafish (Danio rerio) and common carp (Cyprinus carpio) are two popular model 
species that possess scales of the elasmoid type. These scales can easily be re-
moved with forceps without causing major harm to the fish and a new scale is 
formed subsequently. Scales, with its associated scale-forming cells (scleroblasts) 
can be kept in culture ex vivo for several days (up to two weeks for tilapia; E.J. 
Lock, personal communication). The formation of a scale occurs in an enclosed 
environment, aptly named the scale pocket. Scale forming cells, called sclero-
blasts (Sire and Géraudie, 1984), are presumed to be of neural crest origin, just as 
the odontoblast and osteoblasts of the dermal skeleton (Smith et al. 1994). During 
scale regeneration, the first mineral layer is already deposited within the first week. 
Regeneration of the entire scale may take up to 30 days, depending on the ambient 
temperature. Scale formation and regeneration have been described extensively in 
literature (Sire 1989b; Bereiter-Hahn and Zylberberg, 1993).
Scales are an ideal reservoir of phosphorus and calcium since they contain up 
to 20% of the total body calcium, mainly as calcium phosphate crystals (Schön-
börner et al., 1979; Flik et al., 1986). It has been demonstrated that this pool of 
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calcium is utilized in goldfish exposed to estrogen whereas calcium resorption 
could not be detected in the rest of the skeleton (Mugiya and Watabe, 1977). The 
mineralized side of the scale (the episquamal side) possesses concentric ridges 
(circuli) and grooves (radii) radiating from the center (focus) to the edges of the scale 
(Schönbörner et al., 1979). Along these ridges, episquamal scleroblasts are found, 
which are thought to play a role in mineral metabolism. The scale cells on the 
hyposquamal side form a flattened monolayer and appear to function similar to 
fibroblasts as they only synthesize a collagenous matrix. These unique properties 
make fish scales highly suitable to study mineral deposition and resorption directly 
on the intact mineralized tissue and its associated cells. 
enzymatIc markers of mIneral turnover 
Tissue non-specific alkaline phosphatase (TNAP) is a well-established marker of 
osteoblasts and bone formation in mammals and teleostean fishes (Witten, 1997; 
Kaunitz 2008). The role of ALP in mineralization is still under debate; it is believed 
to liberate phosphates, required for mineralization, but a role in breakdown of pyro- 
phosphates, an inhibitory factor in mineralization, is also postulated (Omelon and 
Grynpas, 2008). Enzymatic ALP activity has already been demonstrated in associ-
ation with elasmoid scales (Suzuki et al., 2000). Moreover, we detected expression 
of the predominant bone alkaline phosphatase paralogue (alpl gene) in cells asso-
ciated with zebrafish scales (unpublished results). Although ALP has many times 
been described in relation to scales, to the best of our knowledge no histological 
images that show the location of alkaline phosphatase have appeared in literature. 
Tartrate-resistant acid phosphatase (TRACP) has been the marker of vertebrate 
osteoclasts for more than twenty years (Minkin, 1982; Witten and Huysseune, 
2009). However, TRACP is not restricted to these cells, as it is also found in e.g. 
immune and prostate cells (Hayman, 2008). TRACP (from the ACP5 gene) exerts 
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Figure 1 (right page). A ALP staining, focused on the hyposquamal side. The amount of ALP varies 
between the scleroblasts. This results in differential staining of the cells. B Alkaline phosphatase stain-
ing, focused on the episquamal side. Staining is observed along the radii of the scale. C ALP/TRACP 
double staining. TRACP is stained along the unmineralized grooves on the episquamal side of the scale. 
D The brown colour of the Von Kossa calcium staining clearly shows that the grooves are unmineral-
ized. There are also unmineralized regions in the focus of the scale. E Light microscopic image of the 
scale that is stained for cathepsin K. The cell is located along one of the radii. F Fluorescent image of 
the same scale. Nuclei, stained with Hoechst, are shown in blue. G Same image as F, cathepsin K is 
demonstrated in red. H A multinuclear osteoclast found on the scale surface. The cell is positive for the 
nuclear staining (blue) and cathepsin K (red). 
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its function in the resorption pits generated by osteoclasts, where the required 
acidic pH for optimal activity is realized by hydrochloric acid (HCl) production (Kau-
nitz, 2008). TRACP is also suggested to be involved in osteoclast migration by 
weakening the interaction between proteins that bind the osteoclast to the matrix 
(Anderson, 2003). Vertebrate osteoclasts also produce and secrete cathepsin K, 
cysteine proteinase that degrades the bones protein matrix (Saftig et al., 1998; 
Nemoto et al., 2007). We searched for the presence of these marker enzymes on 
untreated cyprinid scales, to investigate whether scales can perform a function in 
mineral metabolism. 
resulTs and discussion
Alkaline phosphatase (ALP) activity is mainly detected in the hyposquamal cells 
of carp scales, although we also observed some staining at the episquamal side 
(figure 1A and 1B). TRACP activity staining on fish scales has, to the best of our 
knowledge, never been combined with ALP activity staining. In the ALP/TRACP 
double stained scales, TRACP activity staining masks the ALP activity staining, 
which can no longer be observed after double staining (figure 1C). In previous stud-
ies, with different fish species, TRACP activity could only be localized on scales 
from fish in experimental conditions where a higher calcium demand was indicated 
(Suzuki et al., 2000; Persson et al., 2000). Even after stimulation of scale resorption 
through starvation of hormonal treatment, TRACP activity was only detected on a 
few locations of scale resorption. In scales from control carp, TRACP activity was 
detected along the entire length of the grooves of the scale and in the focus. As 
the Von Kossa staining (figure 1D) demonstrates, the grooves and many areas in 
the focus are not mineralized. The presence of mineral resorbing cells is further 
established by the cathepsin K positive cells that could be detected along the 
grooves of the scale (figure 1E–G). In scales counterstained with Hoechst, a nuclear 
staining, some multinuclear cells can be observed (figure 1H). These multinuclear 
cell aggregates have been previously described as osteoclasts (Sire et al., 1990). 
As none of the scales were induced to resorb their matrix in any way, the pres-
ence of these enzymatic markers for mineral formation and degradation suggests a 
dynamic mineral metabolism in cyprinid scales. 
The exact role of alkaline phosphatase in bone formation is not established, not 
even in mammals. The location of the enzyme on scales only raises more questions 
since ALP is considered to play an important role in tissue mineralization in both 
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mammals and fish (Sindre et al., 2005; Kaunitz, 2008). Remarkably, on elasmoid 
scales of cyprinids, ALP is mainly found on the hyposquamal side, which is never 
mineralized, as new collagen is slowly deposited. Therefore, it seems unlikely that 
these alkaline phosphatases still act in mineralization as they are always located 
far from the mineralized part of the scale, and the mineral layer grows only slowly 
or not at all in hyposquamal direction. At the mineralized part of the scale, alkaline 
phosphatase activity is mainly located around the grooves and on the growing 
edges. This may be an indication of involvement in mineral deposition. However, 
we realize that histochemical detection of the enzymes does not necessarily imply 
activity in vivo. In ALP/TRACP activity double-stained scales, episquamal alkaline 
phosphatase activity can no longer be detected, as the staining for TRACP activity 
masks the ALP activity staining. This may suggest that the presence of the enzymes 
on the same locations of the scale. It is difficult to identify cells in the TRACP activi-
ty positive regions as TRACP is a secreted enzyme and present in the scale matrix. 
We found a small number of multinuclear osteoclasts with the cathepsin K staining. 
Therefore the larger part of the secreted TRACP has likely come from mononuclear 
cells or was released by migrating osteoclasts (Ek-Rylander et al., 1994). Mineral 
degradation by mononuclear cells is observed in mononuclear osteoclasts or os-
teocytic osteolysis. The latter mechanism describes cells that originate from the 
osteoblastic cell lineage, that are now able to degrade bone (Witten et al., 2000; 
Witten and Huysseune, 2009). Since most cells on the episquamal side of the scale 
are scleroblasts, it is possible that a similar underlying switch of function could be 
present in these scale-degrading episquamal scleroblasts. The origin of these cells 
may shed more light on regulation of scale degradation, as we are not aware of 
any osteoclast-like cells that originated directly from mesenchyme (scleroblasts). 
However, the dermis of fish where the scales reside is well perfused and migratory 
progenitor cells of ectodermic origin would abide.
scales as a potentIal model for mIneralIzed tIssues? 
Our results suggest a basal level of continuous deposition and resorption of scale 
minerals, as these carp were not subjected to any experimental condition, i.e. 
assumed to be in positive calcium and phosphorus balance. This requires active 
and controlled mineralization and demineralization by cells associated with the 
scale. We clearly demonstrated the presence of osteoclasts on control scales and 
the presence of alkaline phosphatase suggests episquamal scleroblasts may be 
involved in deposition of scale matrix. 
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Although scales and teeth share a common ancestor, it is clear that elasmoid 
scales evolved to a new structure that is neither tooth nor bone. It is already known 
that mineralization of bone and tooth matrix shares many similar mechanisms (e.g. 
matrix vesicles; Anderson, 2003) and genes (e.g. those encoding osteocalcin, 
osteonectin, BMPs, MMPs; Robey, 1996; Rawadi et al., 2003; Chen et al., 2003; 
Krane and Inada, 2008; Bildt et al., 2009). Moreover, experiments have shown 
that scale cells are affected by starvation of the fish and hormonal treatments; 
conditions that are known to alter mammalian bone density (Rigotti et al., 1991; 
Persson et al., 1994; Kim et al., 2007). Indifferent to their origin, several papers have 
appeared in literature where scales are already in use as a model to study bone 
formation. Scales show the same response as mammalian bone to a number of 
treatments (e.g. Suzuki et al., 2000; Redruello et al., 2005; Yoshikubo et al., 2005). 
The use fin rays, also part of the dermal skeleton, is well-described as a model to 
study direct ossification. (Quint et al., 2002; Marí-Beffa et al., 2007). Compared to 
fin rays, elasmoid scales benefit from the presence of cells with scale-forming and 
-degrading (osteoclast-like) properties, and these cells can be cultured together on 
their original substrate (Brittijn et al., 2009). Moreover, many scales can be obtained 
from a single fish and formation of the mineral layer is fast and ongoing in growing 
fish. Also, the ectothermic fish allows to study these aspects of scales at different 
temperatures set by the experimenter, and thus likely at different paces, to define 
the readout resolution. The future will point out whether or not scales are suitable 
for use as an osteogenesis model. However, our results show that all the required 
components for mineral deposition and degradation are present on normal carp 
scales. To study these may offer unique insights scale mineral metabolism, and 
possibly in mineralization of biological tissues in general. 
maTerials and meThods
All scales were obtained from growing control group carp (Cyprinus carpio). Scales 
were taken from the skin with a forceps under light sedation (0.5% 2-phenoxy- 
ethanol, 10 minutes maximally). Scales were used for histological analysis without 
fixation. For alkaline phosphatase staining, intact scales were preincubated with 
0.1 M TRIS/HCl pH 9.5 for 15 minutes. Next, samples were stained with NBT/
BCIP (Roche, Basel, Switzerland) in ALP-buffer (100 mM TRIS/HCl pH 9.5, 100 mM 
NaCl and 50 mM MgCl2) at 37
oC. Reaction was stopped by rinsing samples with 
water. If samples were double-stained for tartrate-resistant acid phosphatase, they 
were preincubated for at least 2 hours in fresh 0.2 M TRIS-buffer pH 9.0 at 37oC. 
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Samples were stained for several minutes (until the red colour became visible by 
microscopic inspection) with TRACP staining solution according to van de Wijn-
gaert and Burger (1986). To stop the reaction, samples were rinsed with water. 
Cathepsin K was stained with the commercially available Magic Red Cathepsin K 
detection kit (AbD Serotec, Düsseldorf, Germany) according to the manufacturer’s 
protocol and counterstained with Hoechst nuclear staining. 
The minerals of the scale were stained according to Von Kossa. Scales were in-
cubated with 5% silver nitrate under bright light for one hour. Scales were subse-
quently rinsed with tap water for one minute and developed for 5 minutes in 5% 
sodium thiosulfate. Finally, scales were rinsed thoroughly with tap water. 
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absTracT
Matrix metalloproteinases (MMPs) are key enzymes in the turnover of extracellular 
matrix, in health and disease, as well as in developmental and regenerative pro-
cesses. We studied zebrafish scale regeneration to ascertain the role of Mmp2 and 
Mmp9 in these processes. Scales were plucked from the surface of anesthetized 
adult male zebrafish, and the scales that regenerated in the scale pocket were 
recovered at various times after plucking. Analyses consisted of (I) mmp9 in situ 
hybridization, followed by histological sectioning; (II) Mmp9 immunocytochemistry 
combined with TRACP activity staining, (III) qRT-PCR for mmp2 and mmp9, and 
(IV) zymography for gelatinase activity. We found that mmp9 positive cells were 
confined to the epiquamal side. Ontogenetic scales had irregular clusters of multi- 
nucleated aggregates of mmp9 expressing cells along their lateral margins, as well 
as mononucleated mmp9 expressing cells along the radii. During regeneration, 
aggregates were not present along the lateral margins, but multinucleated osteo-
clasts were seen on the scale plate. During this early phase of scale regeneration, 
mmp2 and mmp9 transcripts increased in abundance in the scale, enzymatic Mmp 
activity increased and collagen degradation was detected by means of hydroxy-
proline measurements. Near the end of regeneration, all these parameters returned 
to the basal values seen in ontogenetic scales. These findings suggest that MMPs 
play an important role in remodelling of the scale plate during regeneration, and 
that this function resides in mononucleated and multinucleated osteoclasts. Our 
findings suggest that the fish scale regeneration model may be a useful system in 
which to study the cells and mechanisms responsible for regeneration, develop-
ment and skeletal remodelling. 
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inTroducTion 
The elasmoid scales of zebrafish (Danio rerio) have the ability to regenerate when 
removed from the skin, e.g. by abrasion. Like regenerating fin rays (Nakatani et 
al., 2007), scales can be studied to get a better understanding of the underlying 
mechanisms of skeletal development, such as matrix formation and degradation, 
cell differentiation and mineralization. 
Elasmoid scales are components of the dermal skeleton. They are composed of a 
collagen matrix that is mineralized on the external (episquamal) side with hydroxy-
apatite crystals (Bigi et al., 2001). The episquamal side of the scale possesses 
concentric ridges (circuli) and grooves (radii) radiating from the central focus to 
the edges of the scale. Each radius is covered by a dermal space with cells and 
blood vessels embedded within a loose matrix (Sire et al., 1997b). Scleroblasts 
synthesize and shape the scale matrix during ontogeny and regeneration (Sire and 
Akimenko 2004). The external layer is synthesized first, followed by the elasmodin 
layer, composed of type I and V collagen fibers in a plywood-like arrangement (Le 
Guellec and Zylberberg, 1998). The collagens of the elasmodine layer are similar 
in arrangement to mammalian lamellar bone (Giraud-Guille, 1988) and mineralize 
slowly from the external layer (Sire and Huysseune, 2003). When a zebrafish scale 
is plucked from its scale pocket, formation of a new scale is initiated immediately 
(Sire, 1989b). Already after two days, a new mineralized scale plate can be seen, 
but it takes up to 4 weeks for a new scale to grow to the size and thickness of 
the removed scale. As a consequence of this rapid reformation, the focus of early 
regenerating scales is less structured than that of ontogenetic scales. The typical 
grooves and radii appear later in scale regeneration, which is believed to be the 
result of basal plate remodelling (Bereiter-Hahn and Zylberberg, 1993; Ohira et al., 
2007). Note that in this context, the term ‘ontogenetic’ scale is used to denominate 
the scales that developed during the early ontogeny of the fish, in contrast to the 
scales that regenerated after plucking. 
The scale compartment constitutes a significant, readily accessible calcium source 
of fish as it can contain up to 20% of the total calcium in the body (Flik et al., 1986). 
Fish withdraw calcium from their scales in periods of high calcium demand, rather 
than from their axial skeleton as mammals do (Mugiya and Watabe, 1977; Flik et 
al.,1986; Carragher and Sumpter, 1991; Persson et al., 1994). Such mobilization of 
scale calcium demands the same active and controlled mineralization and  demin-
eralization as is well known for the mammalian skeleton (Hadley and Levine, 2006). 
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Scales are covered with a monolayer of cells, originally called scleroblasts, on both 
the mineralized and unmineralized side (Sire et al., 1997a). More recent literature 
subdivides the scleroblasts in osteoblasts and osteoclasts, based on their scale 
forming and resorbing properties, respectively (Onozato and Watabe, 1979; Pers-
son et al., 1999; Suzuki and Hattori, 2002). This is substantiated by the classical 
osteoblast marker alkaline phosphatase (ALP), found in hyposquamal scleroblasts 
(de Vrieze et al., 2010). Both in mammals and in teleosts, staining of tartrate-resis-
tant acid phosphatase (TRACP) activity demonstrates bone surfaces that are being 
actively resorbed or have been resorbed (Witten and Huysseune, 2009). Indeed, 
mononucleated and occasional multinucleated osteoclasts, positive for TRACP 
activity but also the osteoclast marker cathepsin K, were found on the episquamal 
side of scales of different fish species (Azuma et al., 2007; de Vrieze et al., 2010). Multi- 
nucleated osteoclasts resorbing the scale matrix have also been identified by 
means of electron microscopy (Sire et al., 1990; Persson et al., 1999). 
Matrix degradation by osteoclasts is a key process in both normal bone turnover 
and the bone disease osteoporosis (Boyce et al., 2009). Osteoclasts are classi-
cally described (at least in mammals) as multinucleated giant cells of the myeloid 
(monocyte-macrophage) lineage (Datta et al., 2008; Witten and Huysseune, 2009). 
They display a characteristic ruffled border where proteases and acid are secret-
ed, allowing for bone resorption and formation of ‘resorption pits’ in the bone 
surface (Zelzer and Olsen, 2003). Osteoclast morphology varies between mammals 
and teleosts (bony fishes), and also between different groups of teleosts (Witten 
and Huysseune, 2009). In the skeleton of young zebrafish for example, osteoclast 
activity is carried out by both mononucleated and multinucleated cells (Witten et 
al., 2001). In fact, there is an ontogenetic progression from mono- towards multi-
nucleated osteoclasts. In juvenile zebrafish, bone-resorbing cells in the developing 
lower jaw are at first mononucleated. In thin skeletal tissues such as the neural 
arch, mononucleated cells are even predominant in adults (Witten et al., 2001). 
In rainbow trout, scale resorption is predominantly carried out by mononucleated 
osteoclasts (Persson et al., 1999). Although in mammals these mononucleated 
cells are often just regarded as osteoclast precursors, fish mononucleated osteo-
clasts are active bone resorbing cells (Lopez et al., 1980; Witten, 1997).
One family of osteoclast proteases are the matrix metalloproteinases (MMPs). 
They are involved in the breakdown of extracellular matrix by osteoclasts, but 
also by other cell types like fibroblasts (Cawston and Wilson, 2006). MMPs are 
multi-domain enzymes that require zinc as cofactor for proteolytic activity. 
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Figure 1. In situ hybridization of zebrafish mmp9 on whole ontogenetic scales and in transverse 
sections. A whole mount ontogenetic scale, arrowheads indicate the mmp9-positive clusters on the 
scale margins; bar = 300 µm. B Another ontogenetic scale showing mmp9 positive cells on the margin 
and radii of the scale; bar = 100µm. C Section of an ontogenetic scale, showing the mmp9 positive 
marginal cells (arrowhead); bar = 100 µm. D Multinucleated cell(s) expressing mmp9 on the radii (r) 
of an ontogenetic scale; bar = 100 µm. E Section of an ontogenetic scale with a multinucleated cell 
(arrowheads) on the episquamal side (towards top of picture); bar = 50 µm. F Superimposed Z-stack 
confocal image of ConA-FITC (green) stained cell on scale margin with nuclei counterstained with DAPI 
(blue); bar=10 μm.
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Extracellular matrix turnover occurs in a wide range of physiological processes, 
including embryonic development and morphogenesis, bone resorption and tissue 
regeneration. Moreover, MMP-mediated breakdown of the extracellular matrix has 
been implicated in disease processes including cartilage destruction in osteoar-
thritis (Burrage and Brinckerhoff, 2007). The importance of MMPs in bone devel-
opment is underlined by studies on Mmp2 and Mmp9 null mice, which suffer from 
bone abnormalities, osteoporosis and osteopetrosis respectively (Krane and Ina-
da, 2008). In view of their role in physiological and pathological processes, MMPs 
are important targets in pharmaceutical research and drug development. 
In bone turnover, secreted MMPs participate in the breakdown of collagen, which 
in turn allows osteoclast attachment (Everts et al., 1992). Furthermore, MMP9 is 
associated with osteoclast migration through the collagen matrix (Spessotto et 
al., 2002). Matrix metalloproteinases may also break down residual collagen left 
by cathepsin K after the pH rises in the resorption pit (Everts et al., 1998). MMP2 
and MMP9 (gelatinase A and B, respectively) are particularly active against gelatin 
(denatured collagen) and intact collagen type I and IV. In bone of dermal origin, 
matrix degradation is thought to rely more on MMPs and less on cathepsin K 
(Everts et al., 2006). MMP2 has also been described to play a crucial role in 
formation and maintenance of the osteocytic canalicular network whereas MMP9 
is active in early calvarian bone development and in orthodontic tooth movement 
(Rice et al., 1997; Takahashi et al., 2006; Inoue et al., 2006). Regenerating fins 
of adult zebrafish express mmp2 and regeneration can be inhibited by the MMP 
inhibitor GM6001 (Bai et al., 2005). More recently, MMPs have also been implicated 
in angiogenesis and liberation of growth factors (McCawley and Matrisian, 2001; 
Ortega et al., 2003). 
Given the involvement of matrix metalloproteinases in bone remodelling and fin 
regeneration, we predict the presence of Mmp2 and Mmp9 in scale cells. We 
furthermore predict an increased Mmp activity in scale regeneration associated 
with scale matrix remodelling. In the current study, we investigated both expres-
sion of mmp genes and actual activity of Mmp enzymes in the process of scale 
regeneration. 
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resulTs
mmp9 expressIon In ontogenetIc scales
In ontogenetic or non-plucked scales of adult male zebrafish, mmp9 expression 
was confined to cells along the radii and margins of the scale. Hyposquamal sclero-
blasts were negative for mmp9. The marginal cells were a conspicuous feature of 
ontogenetic scales, and consisted of irregular clusters, often resembling multi- 
nucleated aggregates, of mmp9-positive cells along the lateral margins of the 
53
Figure 2. In situ hybridization of zebrafish mmp9 on transverse sections of regenerating scales. 
A, B sections through the skin with 2 days regenerated scales. Mononucleated cells positive for mmp9 
are situated on the newly-deposited matrix (arrowheads); m = melanocyte; bar in A = 50 µm, bar in 
B = 50 µm. C Section through the skin and scale at 4 days regeneration. Numerous positive cells are 
distributed along the whole scale; bar = 100 µm. D Section through the skin with an 8 days regenerated 
scale showing mononucleated mmp9-positive cells (arrowheads) at the radii bar = 100 µm; E Section 
through 8 days regenerated scale showing mmp9-postive cells lying on the episquamal surface of the 
newly-formed scale matrix (indicated by the bracket and asterisk). m, melanocyte; bar = 25 µm.
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scale (figure 1A, B). In situ hybridization demonstrates that the mmp9-positive cell 
population was confined mainly to the episquamal surface of the scale and included 
both mono- and multinucleated aggregates (figure 1C, E). Many mono-nucleated 
cells, and a few multinucleated aggregates expressing mmp9 are found along the 
radii of the scale. Transverse sections of ontogenetic scales also showed multinu-
cleated aggregates on the episquamal surface (figure 1E). The extent and position 
of these marginal aggregates varied between scales of the same fish, and between 
individual fish. In some scales they were absent. A point to be noted here is that 
not all scales, ontogenetic or regenerated, have uniform distribution or abundance 
of mmp9-positive cells. Despite this irregular distribution, the differences in mmp9- 
expressing cells as a result of scale regeneration are far more pronounced.
mmp9 expressIon In regeneratIng scales
In scales regenerating for 2 days, mmp9 transcripts were present in cells scat-
tered on the episquamal, mineralized side of the newly-formed scale matrix (figure 
2A, B). These cells were mainly mononucleated, and there were no multi- 
nucleated marginal aggregates as seen in ontogenetic scales. Quantification of the 
number of positive cells reveals that there are less mmp9-positive cells on day 2 
(figure 3). However, after 4 days of regeneration, mmp9-expressing cells are more 
abundant (figure 2C, 3). The 4 days regenerating scales possessed aggregates of 
cells, which appear multinucleated by light microscopical observations. Some ap-
parently multinucleated cells were also seen at different regions on the episquamal 
side of the matrix. In the sections of 4 days regenerating scales, the collagenous 
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Figure 3. Analysis of the number of mmp9-express-
ing cells in 2 days and 4 days regenerating scales 
compared to ontogenetic scales. Significance com-
pared to ontogenetic scales was calculated by means 
of a Mann-Whitney U test. Bars represent the mean val-
ue, error bars indicate S.D. ( N=68-116, **: P<0.01; ***: 
P<0.001).
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matrix was thinner than that of ontogenetic scales and radii had not yet formed. As 
in 2 days regenerated scales, 4 days regenerating scales had no mmp9-positive 
cells on their lateral margins.  In the sections of 8 days regenerating scales, mmp9 
expression was similar to that of 4 day regenerating scales (figure 2D). In the 8 days 
regenerating scale sections, multinucleated cells were present, as were single cells 
along radii all over the entire scale (figure 2D, E). 
mmp9 and tracp doublestaInIng
Ontogenetic scales show positive staining for TRACP activity on the episqua-
mal side, predominantly along the radii (figure 4A). Upon larger magnification, 
also Mmp9-positive cells can be detected (figure 4B, C). Some mononucleated 
osteoclasts along the grooves show colocalization of Mmp9 immunoreactivity and 
TRACP activity (figure 4C). On regenerating scales, the TRACP activity appears 
increased and irregularly spread compared to ontogenetic scales (figure 4D). 
Mononucleated osteoclasts that both express Mmp9 and secrete TRACP are seen 
along the grooves of the scale (figure 4E). At more irregular areas of TRACP activity 
staining, multinucleated osteoclasts with Mmp9 immunoreactivity appear to be 
present as well (figure 4F).
qrt-pcr profIlIng of mmp2 and mmp9 expressIon
Expression of the mmp2 and mmp9 genes in ontogenetic and regenerated scales 
is illustrated in figure 5. Note that scales could not be collected earlier than 4 days 
of regeneration because of their small size. In 4 days regenerating scales, mmp2 
expression is increased compared to ontogenetic scales (figure 5A). On days 5 
and 8 of regeneration, mmp2 expression is significantly increased (by as much as 
four-fold). Expression of mmp9 is already upregulated significantly after 4 days, 
and remains upregulated until day 8 (figure 5B). After 2 weeks, expression of both 
genes has returned to levels seen in ontogenetic scales.
zymographIc analysIs
The medium from an overnight culture of scales demonstrates the presence of 
several molecular species with gelatinolytic activity (figure 6A). To identify the 
molecular species and normalize the Mmp activity, human recombinant MMP2 
and -9 were loaded in lanes 1 and 2, respectively. The largest molecular species 
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secreted by scale cells, can be identified as the inactive proMmp9, which has been 
activated after electrophoresis by autocatalysis. The gelatinase with a weight of 
approximately 77 kDa, has been confirmed to be active Mmp9 with Western blot 
(figure 6A). The other two clear bands are predicted to be Mmp2, the other matrix 
metalloproteinase with a preference for gelatin. Both the latent form (approximately 
67 kDa) and the active form (approximately 59 kDa) of zebrafish Mmp2 are several 
amino acids smaller than their mammalian counterparts (Lafleur et al., 2001). The 
faint and heavy bands located around 150 kDa are Mmp dimers, which are normal-
ly observed in zymograms (Snoek-van Beurden and Von den Hoff, 2005). 
The total amount of secreted gelatinases is increased in regenerating scales. Es-
pecially the activity of the lightest molecular species (active Mmp2) has increased, 
and the inactive proMmp9 disappeared (figure 6B). An analysis of the intensity 
of the bands sheds more light on the changes in gelatinases expressed in onto- 
genetic and regenerating scales (figure 7). As mentioned above, no bands of 87 
kDa could be detected in the regenerating scales. Significantly more of the putative 
active Mmp2 and Mmp9 was present in the culture medium of regenerating scales. 
The amount of latent Mmps remained the same (67 kDa), or decreased (87 kDa). 
The zymographic analysis of scales from fish exposed via the water to GM6001 
show clear differences compared to the control group (figure 6C). Although the 
scales have not been subjected to GM6001 during culture, the in vivo GM6001 
exposure resulted in bands of lower intensity compared to the control group. 
hydroxyprolIne
The modified amino acid hydroxyproline, a major component of collagen, was 
used as a measure of matrix degradation. In culture medium of ontogenetic scales, 
hydroxyproline could not be detected. However, it could be detected in the culture 
medium of 6 days regenerating scales at a level of 0.2 ± 0.17 ng hydroxyproline per 
scale, which indicates increased matrix degradation in regenerating scales.
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Figure 4 (left page). Immunocytochemical staining of Mmp9 (black) combined with enzymatic 
TRACP staining (red) in ontogenetic (A, B, C) and 8 days regenerating scales (D, E, F). A overview 
of a ontogenetic scale with TRACP activity staining along the radii (arrows); bar = 250 µm. B Mmp9 
positive cells (black arrows) with little TRACP activity stainig in a typical resorption pit (white arrow) 
along a radius; bar = 50 µm. C mononucleated osteoclast with Mmp9 immunoreactivity (arrow) along a 
radius; bar = 50 µm. D overview of a regenerating scale with irregular distributed TRACP positive areas 
(arrows); bar = 250 µm. E Typical Mmp9 positive cells with TRACP secreted to the surrounding matrix 
(arrow) ; bar = 50 µm.  F Typical multinuclear cells (arrows) positive for TRACP activity and Mmp9. Note 
that nuclei are smaller in these cells; bar = 50 µm. 
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discussion 
We have shown both by in situ hybridization and immunocytochemistry the pres-
ence of mononucleated and multinucleated Mmp9 positive cells on the episquamal 
side of (regenerating) adult zebrafish scales. We found an increase in expression 
of mmp genes, cell abundance, activity of Mmps and hydroxyproline levels during 
scale regeneration. These results combined confirm that Mmps and anticipated 
osteoclasts play an important role in scale resorption and remodelling. 
Although many other types of cells, such as fibroblasts and macrophages, are 
known to express MMP9 (Kessenbrock et al. 2010), the epidermis that covers 
the scale is completely devoid of mmp9-expressing cells. The wound that is the 
resultant of scale removal, has already been closed two hours after scale removal 
(Bereiter-Hahn and Zylberberg 1993). This is consistent with the prerequisite that 
gene expression and enzymatic activity reported here is not from inflammatory 
cells, but exclusively from scale cells. 
Scales keep growing concentrically as long as the fish grows. Expression of mmp9 
in marginal cells of ontogenetic scales is likely related to this scale growth. The 
irregular distribution of positive cells along the margins of ontogenetic scales 
shows that growth does not take place along the entire margin at the same time 
but is probably confined to different spots. The other group of Mmp9-positive 
cells are situated on the mineralized episquamal side. Hyposquamal scleroblasts, 
assumed to have osteoblast-like characteristics, do not express Mmp9. TRACP 
activity staining confirms that these cells are indeed osteoclasts (Persson et al., 
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Figure 6. A Anti-zfMmp9 Western blot (left) and zymogram (right) of the same medium sample from 
an overnight scale culture. The same band of 77 kDa is observed on the Western blot for Mmp9 and 
the zymogram. Mmp multimeres are also observed. B Zymographic analysis of medium from over-
night scale cultures. The positive control, human recombinant proMmp9 (2 ng) is shown in the first 
lane. Lane 2 to 5 show the gelatinolytic activity of Mmps excreted by ontogenetic scales. Lane 6 to 
10 show an increase in gelatinolytic activity of Mmps secreted by scales after 6 days of regeneration. 
C Zymographic analysis of 4 and 7 days ontogenetic and regenerating scales  from fish exposed to 
GM6001 or vehicle. Gelatinolytic activity was attenuated in all groups of fish exposed to GM6001.
Figure 5 (left page). A expression of mmp2 in ontogenetic (day 0) and regenerating scales. B ex-
pression of mmp9 in ontogenetic (day 0) and regenerating scales. The bar represents the expression 
in ontogenetic scales. Significance was calculated by means of a Mann-Whitney U test. Points rep-
resent the mean value, error bars indicate S.E.M. ( N=5, *: P<0.05; **: P<01).
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1999) and able to resorb bone as judged from “resorption pits” seen next to these 
cells. In ontogenetic scales, these cells are mainly found along the radii where in 
ontogenetic scales most areas of scale resorption are found. Since the radii are 
mineral free and grooves the scale plate, with blood vessels nearby (Sire et al., 
1997b), the surrounding osteoclasts likely act in resorbing calcium and phosphates 
from the scale matrix. Just as in other thin zebrafish skeletal elements, most Mmp9 
positive cells are mononucleated. Several multinucleated cells can be detected as 
well, especially on regenerating scales from day 4 onwards. Changes in scale plate 
morphology during regeneration (remodeling) have been described in literature 
(Bereiter-Hahn and Zylberberg, 1993; Ohira et al., 2007). Our finding of mono- and 
multinucleated osteoclasts, expressing both Mmp9 and TRACP, indicate that this 
is an active and controlled process. 
Both in situ hybridization and quantitative PCR show that expression of mmp genes 
is significantly increased in regenerating scales from day 4 onwards. Interestingly, 
only a few mononucleated mmp9-positive cells are present on early regenerating 
scales (2 days). At this point in regeneration, the first collagen matrix is depos-
ited and has just started to mineralize (de Vrieze, unpublished observation). The 
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Figure 7. Semiquantitative analysis of gelatinolytic activity on ontogenetic (closed bars) and re-
generating (open bars) zebrafish scales. ND, not detectable. Bars represent mean values, error bars 
indicate S.E.M. Increase in the putative active Mmps tested for significance by means of a Mann-Whit-
ney U test, N=4-5 (** P<0.01; ***P<0.001).
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increase in mmp2 and mmp9 expression is at its maximum around day 5. At this 
point, the scale plate has formed, the focus is already mineralized (de Vrieze, un-
published observation) and multinucleated osteoclasts are found. After 10 to 14 
days, expression of the mmp2 and mmp9 genes declines and returns to levels of 
ontogenetic scales. The scale plate is now formed and mineralized to its full extent, 
and will be remodeled to its original design (Bereiter-Hahn and Zylberberg, 1993). 
To further establish the role of Mmps in scale regeneration, we have investigated 
actual secretion of Mmp enzymes by scale cells. After an overnight culture of 
scales with their associated cells, the Mmps secreted in the medium were analyzed 
by means of gelatin zymography. Our results show that the increase in secret-
ed Mmp activity correlates with the upregulation in gene expression during scale 
regeneration. A significant increase is observed in both putative active forms of 
gelatinases. The amount of latent proMmp in the medium has remained the same 
or has decreased, which indicates that more Mmps are activated. Activity of these 
Mmps could be inhibited by in vivo exposure to GM6001, further underlining the 
parallels between zebrafish and mammalian Mmps. 
The preferred substrates of active Mmps are gelatins, a product of collagen deg-
radation, and to a lesser extent native collagen. The switch to higher Mmp activity 
indicates an increase in gelatin degradation and thus an increase in scale matrix 
degradation. As there are other substrates that Mmps can process (McCawley 
and Matrisian, 2001), additional roles of Mmps in scale regeneration cannot be 
excluded. In mammalian bone development, MMP9 also regulates bioavailability 
of growth factors (Ortega et al., 2003). Nothing is known about the presence of 
growth factors in the scale matrix, but gelatin and collagen are present to a large 
extent. The release of hydroxyproline from regenerating scales confirms that the 
scale matrix is indeed degraded during regeneration as a result of remodeling. 
These data suggest that matrix proteolysis is an important function of matrix 
metalloproteinases during scale regeneration. 
conclusion
The gelatinases Mmp2 and Mmp9 expressed in mono- and multinucleated osteo-
clasts, play a pivotal role in the regeneration of zebrafish scales. These enzymes 
are specialized in degradation of extracellular matrix, and are likely to be involved 
in the remodelling and organization of the scale surface, probably by shaping the 
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radii and circuli. In mammalian bone of dermal origin, Mmps also function in osteo-
clastic matrix degradation. As a result of these parallels, scale may offer a unique 
model to study the underlying mechanisms of osteoclastic bone resorption (Brittijn 
et al., 2009). Their size, regeneration speed and cells that express important osteo- 
blast and osteoclast markers, make them more easy to handle than most of the 
classical, mammalian models. 
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maTerials and meThods
anImals and scale collectIon 
Experimental procedures were approved by the ethical committee of the Radboud 
University. Wildtype adult male zebrafish (Danio rerio) of approximately one year old 
were kept at 26°C in 1.5 liter tanks under 12 hours light: 12 hours dark cycle. Fish 
were fed twice a day with commercially available food (Tetramin, Tetra, Melle, Ger-
many). Prior to scale harvesting, fish were anesthetized in 0.05% v/v 2-phenoxy- 
ethanol. Scales were carefully removed under a microscope from the left side of the 
body using watchmaker’s forceps. When necessary, fish were euthanized using an 
overdose of 2-phenoxyethanol (0.5% v/v) and then scales or skin were collected. 
To induce regeneration, approximately 50 scales were removed under anesthesia 
from the left side of a fish. For analysis of gene expression and enzyme activity, onto-
genetic (non-plucked) and regenerating scales were taken from the same fish (right 
and left side of the body respectively). Fish were sacrificed for scale collection on at 
day 4, 5, 6, 8, 11 and 14 (note that scales before 4 days of regeneration are too small to 
collect). At these time points, 40 ontogenetic (right side) and 40 regenerating (left side) 
scales were collected for RNA isolation and zymography. Additional fish were used 
for in situ hybridization and histological analysis on days 2, 4 and 8 of regeneration. 
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gm6001 exposure
GM6001 (ilomastat) from Millipore (Billerica, USA) was dissolved in DMSO at a 
concentration of 1 mg/ml. From two groups of six fish each, approximately 50 
scales were removed from the left. To specifically investigate Mmp activity during 
scale plate remodelling, GM6001 exposure (100 nM) was started at day 2 in one 
group while the other group was exposed to the vehicle. Water was replaced every 
other day. On day 4 and day 7, three fish from each tank were sacrificed.  
In sItu hybrIdIzatIon
Primers were designed based on the Danio rerio mmp9 sequence (table 1). The 
probe sequence was amplified by PCR, cloned in a TOPO vector (Invitrogen, 
Carlsbad, USA), which was used to transform competent cells. Samples of posi-
tive clones were then sent for sequencing to Macrogen Inc. (Seoul, South Korea). 
Linearization of template was done using enzyme Xho1. The PCR product was 
cleaned using Wizard SV Gel and PCR Cleanup system (Promega, Leiden, The 
Netherlands). 
Skins samples were fixed overnight in 4% paraformaldehyde in phosphate-buff-
ered saline (PBS, pH 7.4, 4oC). Samples were subsequently dehydrated in a graded 
series of RNAse-free methanol solutions to 100%, and then stored at -18oC. Prior 
to hybridization, the skin samples were cut into 25mm2 pieces and impaled on 
Drosophila pins (Watkins & Doncaster, Cranbrook, UK) to prevent the tissue from 
curling during incubation. The skin pieces were rehydrated through a graded se-
ries of methanol and processed for in situ hybridization using standard protocols 
adapted with minor changes from (Wilkinson, 1998). 
After in situ hybridization, the skin pieces were embedded in Technovit 7100 (Her-
aeus Kulzer GmbH, Wehrheim, Germany), according to the manufacturer’s instruc-
tions. In some cases, the tissue was first decalcified in Osteosoft® (Merck KGaA, 
Darmstadt, Germany) for 24h before embedding. Sections were cut at 5µm, coun-
terstained with neutral red and cover-slipped with Permount™ (Fisher Scientific, 
Fair Lawn, New Jersey).
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antI-mmp9 tartrate-resIstant acId phosphatase doublestaInIng
Ontogenetic and regenerating scales (8 days) were fixed for 30 minutes 4% parafor-
maldehyde in PBS at 4oC and subsequently washed with PBS. Whole scales were 
incubated for 1 hour with block buffer (1% normal donkey serum in PBS) and sub- 
sequently incubated overnight at room temperature with zebrafish anti-Mmp9 
(1:100; Anaspec, Fremont, USA) in block buffer. Next, scales were rinsed three 
times with PBS and incubated at room temperature with biotinylated anti-rabbit 
IgG (Vector Laboratories, Burlingame, USA) in blockbuffer at a dilution of 1:200 for 
1 hour. Scales were again rinsed three times with PBS and Mmp9 was visualized 
with Vectastain ABC kit (Vector Laboratories, Burlingame, USA) according to man-
ufacturer’s instructions for staining with nickel-diaminobenzidine (Ni-DAB). Scales 
were subsequently stained for TRACP activity according to the method described 
by van de Wijngaert and Burger (1986). Nuclei were stained with haematoxylin.
qrt-pcr
Total RNA was isolated from regenerating scales and ontogenetic scales using 
Trizol (Invitrogen, Carlsbad, USA) according to manufacturer’s instruction and 
subsequently treated with DNase I (Invitrogen). cDNA was synthesized using 
Superscript Reverse Transcriptase II enzyme (Invitrogen) according to manufac-
turer’s instructions. Thus obtained cDNA was 10x diluted in ultrapure water for 
quantitative PCR as described by Gorissen et al. (2009). Primer sequences for 
the different target genes are listed in table 1. The expression levels of the house-
keeping genes β-actin and 40s were combined in an index using the software tool 
BestKeeper (Pfaffl et al. 2004). Expression of mmp genes was corrected for primer 
efficiency and reference genes, and plotted relative to expression in ontogenetic 
scales collected on day 0. 
gelatIn zymography
Activity of putative matrix metalloproteinase 2 and 9 were detected with gelatin zy-
mography. Ten ontogenetic and 10 regenerated zebrafish scales were cultured 20 
hours in 100 µl MEMα (Invitrogen, Carlsbad, USA). Zymography was done accord-
ing to Bildt et al. (2009). Relative Mmp activity was calculated from band intensity 
with Quantity One software (Bio-Rad, Hercules, USA) and related to 2 ng human 
recombinant proMMP2. 
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Table 1. Sequences of the primers used to quantify relative mRNA expression levels and develop 
the in situ hybridization probe.
Gene Accession nr. Sequence (5’-3’)
β-actin AF057040 Fw: CTTGCTCCTTCCACCATGAA
Rv: CTGCTTGCTGATCCACATCT
40s AY648802 Fw: GTGTGGTGACCAAGATGAAGATG
Rv: ACGGTTGTACTTGCGGATGTAA
mmp2 NM_198067 Fw: GAGAACCAACAGACAAGCCATTG
Rv: TCTGATCTGGGCTACAGCATCA
mmp9 NM_213123.1 Fw: CCAGTTGTGCCAACGAAACC
Rv: GAAGGGACCACCTGAGTTGTG
mmp9 ISH NM_213123.1 Fw: CACAGCTAGCGGATGAGTATCTGAAGC (pos. 253)
Rv: AATGGAAAATGGCATGGCTCTCC (pos. 1135)
Western blot
Medium from overnight scale cultures were loaded on a SDS-PAGE gel according 
to standard procedures. Proteins were transferred to an Immobilon-P PVDF mem-
brane (Sigma-Aldrich, st. Louis, USA) and used for Western blot with anti-Mmp9 
(Anaspec, Fremont, USA) at a dilution of 1:1000. Biotinylated anti-rabbit IgG (Vec-
tor Laboratories, Burlingame, USA) was used as second antibody at a dilution of 
1:1500. The Western blot was developed with Vectastain ABC kit (Vector Labora-
tories, Burlingame, USA) according to manufacturer’s instructions for staining with 
nickel-diaminobenzidine (Ni-DAB).
hydroxyprolIne assay
Twenty scales (ontogenetic or 6 days regenerating) were taken from 6 fish and 
cultured overnight in 200 µl MEMα. Collected culture medium was mixed with 400 
µl 100% ethanol and allowed to precipitate overnight. Samples were centrifuged 
15 minutes at 1710g and supernatants were collected. Pellets were washed with 
200 µl 70% ethanol and supernatants were added to previously obtained superna-
tants. Samples were dried in a hot stove and then resuspended in 50 µl 2M NaOH. 
Samples were autoclaved for 30 minutes and hydroxyproline was measured 
according to the method described by Reddy and Enwemeka (1998).
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Chapter 5
arachidonic acid enhances turnover of 
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absTracT
In fish nutrition, the ratio between omega-3 and omega-6 poly-unsaturated fatty 
acids influences skeletal development. Supplementation of fish oils with vegetable 
oils increases the content of omega-6 fatty acids, such as arachidonic acid in the 
diet. Arachidonic acid is metabolized by cyclooxygenases to prostaglandin E2, an 
eicosanoid with effects on bone formation and remodeling. To elucidate effects of 
poly-unsaturated fatty acids on developing and existing skeletal tissues, zebra- 
fish (Danio rerio) were fed (micro-) diets low and high in arachidonic acid content. 
Elasmoid scales, dermal plates, are ideal to study skeletal metabolism in zebrafish 
and were exploited in the present study. The fatty acid profile resulting from a high 
arachidonic acid diet induced mild but significant increase in matrix resorption in 
ontogenetic scales of adult zebrafish. Arachidonic acid affected scale regeneration 
(following removal of ontogenetic scales): mineral deposition was altered and 
both gene expression and enzymatic matrix metalloproteinase activity changed 
towards enhanced osteoclastic activity. Arachidonic acid also clearly stimulates 
matrix metalloproteinase activity in vitro, which implies that resorptive effects of 
arachidonic acid are mediated by matrix metalloproteinases. The gene expres-
sion profile further suggests that arachidonic acid increases maturation rate of the 
regenerating scale; in other words, enhances bone turnover. The zebrafish scale 
is an excellent model to study how and which fatty acids affect skeletal formation. 
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inTroducTion 
Suboptimal nutrition in fish aquaculture may cause skeletal deformities that have 
major economic and ethical implications (reviewed by Boglino et al., 2012). Essential 
fatty acids, in particular the long chained poly-unsaturated fatty acids (PUFAs), 
influence fish larval development. Effects can be mediated both via the level of PUFAs 
and via the ratio between omega-3 and omega-6 fatty acids (Izquierdo, 1996; 
Boglino et al., 2012). High levels of arachidonic acid (ARA, 20:4(ω-6)) have been 
linked to malpigmentation and skeletal deformities (Villalta et al., 2005; Lund et al., 
2007; Kjorsvik et al., 2009; Boglino et al., 2012). Changes in dietary PUFA content 
can affect bone health of teleost fish (and mammals) and is reflected in bone cell 
make-up and matrix quality (Gil Martens et al., 2010; Kruger et al., 2010). Dietary 
PUFA deficiency impairs synthesis of bone matrix and facilitates bone demineral-
ization and resorption (Kruger and Schollum, 2005; Watkins et al., 2006). Surpris-
ingly, changes in the dietary fatty acid profile can also have detrimental effects on 
both mammals and fish (Watkins et al., 2000; Poulsen and Kruger, 2006; Kjorsvik 
et al., 2009; Gil Martens et al., 2010). High dose dietary fatty acid supplementation 
results in lower bone mineral density, decreased rate of bone formation and skeletal 
malformations. In aquaculture, this becomes particularly apparent as deformities 
during early skeletal development (Lall and Lewis-McCrea, 2007), urging the need 
to pursuit optimal dietary PUFA content.
Fish oils in aquaculture feeds are increasingly replaced by vegetable oils to reduce 
cost and pressure on wild fish stocks (Turchini et al., 2009). The high omega-6 PUFA 
content in vegetable oils can however have dramatic effects on the teleost skel-
eton as desaturase and elongase enzymes metabolize omega-6 PUFAs into ARA 
(Smith, 1989; Tocher et al., 2001; Jaya-Ram et al., 2008). Cyclooxygenases convert 
ARA into prostaglandin E2 (PGE2), an eicosanoid with potent regulatory actions in 
bone physiology and stress- and immune responses (Coetzee et al., 2007b; Rivest, 
2010). In contrast, omega-3 fatty acids, enriched in fish oils (e.g. eicosapentaenoic 
acid; EPA, 20:5(ω-3)), are converted into the less potent eicosanoid prostaglandin 
E3 (PGE3) (Watkins et al., 2000). An increase in ARA may therefore alter signaling 
pathways in bone cells via increased PGE2 production. During mechanical loading 
of mammalian bone, osteocytes and mature osteoblasts release PGE2 as a 
signal to stimulate bone resorption (Klein-Nulend et al., 1997; Searby et al., 2005). 
PGE2 shifts the balance between the production of osteoclast-stimulating, os-
teoblast-derived RANKL (receptor activator of nuclear factor kappa-B ligand) and 
5
ar
ac
hi
do
ni
c 
ac
id
 en
ha
nc
es
 tu
rn
ov
er
 o
f t
he
 d
er
M
al
 sk
el
et
on
69
its decoy receptor OPG (osteoprotegerin) towards increased RANKL-signaling 
and osteoclast activation (Coetzee et al., 2007b; Poulsen et al., 2007). ARA further 
attenuates alkaline phosphatase (ALP; an osteoblast marker of bone formation) 
activity in vitro, while it stimulates secretion and expression of matrix metallopro-
teinase 9 (MMP9; an osteoclast-derived collagen-degrading enzyme). Both effects, 
described for cultured mammalian cells, are believed to be indirect and mediated 
by PGE2 (Solakivi et al., 2009; Coetzee et al., 2009). Moreover, mineralization of the 
extracellular matrix by VSa16 cells (osteoblast-like cells from gilthead seabream 
vertebra) has been shown to decrease dramatically upon exposure to ARA, 
corroborated by a decreased expression of several bone matrix genes (Viegas et 
al., 2012). In mammalian bone, PGE2 stimulates osteoblastogenesis and osteo-
clast activity simultaneously, thus increasing the rate of bone remodeling (Cherian 
et al., 2005; Poulsen et al., 2007). Likewise, goldfish scales treated with prosta-
glandin E2 responded with increased enzyme activity of typical osteoblast and 
osteoclast associated phosphatases (Omori et al., 2012). Clearly, both osteoblasts 
and osteoclasts are targets of ARA and/or PGE2. 
The zebrafish is a valued model in biomedical bone research (Lieschke and Currie, 
2007; Brittijn et al., 2009), but as yet surprisingly under-appreciated as a model 
for other teleost fish species. All the well-known advantages of zebrafish over 
numerous mammalian models apply evenly well to aquaculture research. So far 
few studies, if any, looked at the zebrafish requirement of essential nutrients. We 
here report how essential fatty acids affect growth and metabolism of the zebrafish 
scale, which is a superb model to study the dynamics of mineralized skeletal 
tissues in adult fish (Metz et al., 2012; Thamamongood et al., 2012). Zebrafish, 
like many other teleost fish, possess scales of the elasmoid type. Elasmoid 
scales provide the researcher with a sample of mineralized collagen matrix 
and associated scleroblasts and osteoclasts (Metz et al., 2012). The scleroblast 
(scale forming cell) is often referred to as osteoblast, since the similarity 
with mammalian osteoblasts, e.g. in their respective transcriptomes, becomes 
increasingly apparent (reviewed by Metz et al., 2012). Although scales are con-
sidered to be dentin-derived tissues, and thus not regarded bone (Sire and Huys-
seune, 2003), their abundance on a single fish and ease of handling does make 
them an attractive alternative model to study the dynamics of skeletal formation. 
Over the last decade, it has been shown that scale cells, treated with hormones 
such as parathyroid hormone (PTH), calcitonin, prolactin, glucocorticoids and 
estrogens, responded as anticipated from mammalian bone studies (Suzuki et al., 
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2000; Yoshikubo et al., 2005; Rotllant et al., 2005; Takahashi et al., 2008; de Vrieze 
et al., 2013). This indicates that processes and signaling pathways involved in ma-
trix deposition, mineralization and matrix resorption are shared between bone cells 
and elasmoid scale cells. 
As teleost fish continue to grow throughout their life, and the scale compartment 
is an important calcium and phosphorus reservoir (Flik et al., 1986; Lall and Lewis- 
McCrea, 2007), it may come as no surprise that demineralization of the scale 
matrix occurs (de Vrieze et al., 2011). acellular, i.e. cells are not entrapped within, 
but lined along the collagenous scale matrix. When a scale is removed, lining cells 
that remain in the scale pocket differentiate to start formation of a new scale (Sire, 
1989b; Metz et al., 2012; Thamamongood et al., 2012). In zebrafish kept at 28oC, 
deposition of new scale matrix starts within two days and within a matter of weeks, 
the new scale is fully regrown and mineralized (de Vrieze et al., 2011; 2013). The 
regeneration paradigm thus offers a model to study principles underlying early 
skeletal development in an adult fish. 
We here present the zebrafish scale as a practical model system to study effects 
of dietary fatty acid supplementation on the skeleton. Adult fish were fed a diet 
either low or high in ARA for four weeks. Scale mineralization and markers of 
matrix formation and resorption were investigated to elucidate the effects of ARA 
on the existing skeleton. In addition, regenerating scales were used to investigate 
the effects of ARA on skeletal growth and development.  
resulTs
Whole body fatty acId profIles
At the end of the entire experiment, after feeding the experimental diets for 
six weeks, the fatty acid profile of the zebrafish had changed predictably and 
according to our intention between the groups (table 1). There was a twenty-fold 
difference in ARA content between the low and high ARA fed groups. The EPA/ARA 
ratios were 3.8 and 0.4, respectively, in the low and high ARA diet fed groups and 
there was very little difference in whole body DHA content between the two diets 
as intended. The feeding regime did not result in differences in growth of the fish; 
there were no significant differences in weight at the end of the experiment (data 
not shown). 
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Table 2. Fatty acid profiles of the diets and of the zebrafish fed the respective diets for 6 weeks.
Diet Fish
Low ARA High ARA Low ARA High ARA P-value
Sum unidentified % 1.6 1.2 1.29±0.05 1.16±0.02 0.4562
Sum identified % 98.4 98.8 98.71±0.05 98.84±0.02 0.4562
Sum saturated % 13.2 20.6 20.33±0.25 24.04±0.12 < 0.001
Sum mono-unsaturated % 53.2 30.8 46.54±0.46 33.84±0.20 < 0.001
Sum poly-unsaturated % 32 47.4 31.87±0.24 40.96±0.18 < 0.001
18:3ω-3 % 5.3 0.6 4.53±0.07 2.67±0.04 < 0.001
20:5ω-3 (EPA) % 4.6 2.5 2.59±0.06 1.31±0.01 < 0.001
22:6ω-3 (DHA) % 6 3.3 8.06±0.12 6.01±0.10 < 0.001
Sum ω-3 % 18.5 7.6 18.40±0.24 12.24±0.12 < 0.001
20:3ω-6 % <0.1 2.1 0.37±0.04 1.68±0.02 < 0.001
20:4ω-6 (ARA) % 0.3 27 0.67±0.41 15.04±0.17 < 0.001
Sum ω-6 % 13.3 39.8 13.38±0.44 28.66±0.17 < 0.001
Sum EPA + DHA % 10.6 5.7 10.63±0.16 7.31±0.09 < 0.001
 (ω-3)/(ω-6) 1.4 0.2 1.38±0.13 0.43±0.05 < 0.001
Results of the zebrafish fatty acid profiles are expressed as average ± SEM of 9 fish. Statistical analysis 
was done with the Student’s t-test.
ontogenetIc scale physIology
Scales sampled from fish fed the high ARA diet for four weeks had a significantly 
lower molar Ca:P ratio compared to scales from fish fed the low ARA diet (figure 
1A). No differences were observed in size between scales sampled from either 
group (figure 1B). The percentage of resorbed scale area, characterized by absence 
of mineral staining, was increased in the high ARA group (figure 1C). Accordingly, 
the number and perimeter of resorption pits were significantly higher in scales from 
fish fed the high ARA diet (figure 1D, E). Furthermore, these scales had a signifi-
cantly more areas of TRACP activity staining, indicative of increased osteoclast 
activity (figure 1F).
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Representative pictures of the scales used for quantifications are shown in figure 
2. Von Kossa stainings revealed some resorption pits, the obvious result of osteo-
clastic matrix degradation, on scales from fish fed the low ARA diet. Resorption 
pits were mainly restricted to the scale focus (figure 2A, B). Significantly more 
resorption pits were observed on scales from fish fed the high ARA diet and these 
were found more often in the periphery of the scale (figure 2D, E). TRACP staining 
could be detected both in osteoclasts and in matrix, as a remnant of osteoclastic 
matrix resorption activity (figure 2C, F). Moderate TRACP activity staining was 
found on scales from fish fed the low ARA diet (figure 2E). More TRACP positive 
regions were observed in scales obtained from fish fed the high arachidonic acid 
diet (figure 2F). 
The expression of several genes key in bone formation and resorption pathways 
were analyzed in ontogenetic scales from fish of both groups (figure 3A). No signif-
icant differences in gene expression could be detected between the two groups. 
For osteocalcin (also known as bone gla protein, bgp), the variation in expression 
within the low ARA group was particularly high. 
Zymographic analysis of enzymatic Mmp2 and Mmp9 activities revealed increased 
band intensity in scale samples from the high ARA group compared to the low ARA 
group (figure 3B). This was confirmed by semi-quantitative band-intensity analysis, 
which further revealed that total gelatinolytic activity was significantly increased in 
scales of fish fed the high ARA diet (figure 3C).
regeneratIng scale physIology
During regeneration, the contents of calcium, phosphorus and magnesium in the 
scale steadily increased, indicative of ongoing mineralization (shown for calcium; 
figure 4A). There was however no detectable difference in scale mineral content 
between low and high ARA fed groups. During scale regeneration, the Ca:P molar 
ratios were found increased in both groups between day 4 and day 7. After 7 days 
of regeneration, the Ca:P molar ratio was however significantly higher in scales 
from the high ARA group (figure 4B). Morphometric analysis of regenerating scales 
did not reveal any significant differences in size, perimeter or number of circuli be-
tween the two groups (data not shown).
In 4-days regenerated scales, significant changes were found in the gene expression 
profiles of osteoblast and osteoclast marker genes (figure 5A). Expression of the 
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osteoblast-specific gene sp7, a transcription factor that activates a variety of 
genes involved in matrix formation and mineralization, was higher in scales from 
the high ARA group. Accordingly, rankl, the osteoblast-derived stimulator of osteo- 
clastogenesis was upregulated in the high ARA group. Expression of mmp9 had 
also increased in fish fed the high ARA diet. After 7 days of regeneration, the effects 
on mmp9 expression were however reversed (figure 5B). After 7 days regeneration, 
expression of most genes was attenuated in the high ARA group compared to 4 
days regeneration, with significant decreases in sp7 and rankl expression (P < 0.001 
and P < 0.05, respectively). In the low ARA group, expression of most genes was 
increased at day 7 of scale regeneration compared to day 4, with significant differ-
ences found for osteocalcin, mmp9 and rankl (P < 0.05). At 7 days regeneration, the 
only statistically significant difference in expression found between the two diets 
was in the expression of rankl, which was now lower in the high ARA group. 
Gelatin zymography is indicative of the actual proteolytic activity of Mmp2 and 
Mmp9 (figure 5C), which are secreted by osteoclasts. On day 4, both total activity 
of secreted Mmps (P = 0.06), as well as individual Mmp2 (P = 0.07) and Mmp9 
(P = 0.22) activity, was increased near statistical significance in scales sampled 
from fish fed the high ARA diet compared to fish fed the low ARA diet; on day 
7 total gelatinolytic activity was increased in the high ARA group, which could 
completely be ascribed to Mmp9 (P = 0.05; figure 5D).
In vItro exposure to ara 
To assess if ARA directly affects scale cells, we exposed scales to ARA in vitro. 
After 24 hours in vitro ARA exposure (5, 50 and 150 µM) of scales in culture, no 
effects were observed on Mmp2 (figure 6A) and Mmp9 activities (figure 6B). How-
ever, after 48 hours both Mmp2 (not significant, P = 0.123) and Mmp9 activities had 
increased in the presence of arachidonic acid (figure 6C, D).
Figure 1 (left page). Effects of the different diets on scale mineralization. Analyses of the mineral-
ized layer of ontogenetic scales were done after feeding the low ARA diet (solid dots) or the high ARA diet 
(open dots) for 4 weeks. A Calcium:phosphorus molar ratios were significantly lower in high ARA fed fish. 
B Size (surface area) of the scales was unaffected. C The number of resorption pits per individual 
scale was higher in the high ARA fed fish. D Indeed, total perimeter of resorption pits also increased. 
E Percentage of each scale that is demineralized (as a result of osteoclast activity) was also increased in 
high ARA fed fish. F Number of TRACP activity-stained regions per scale. Each replicate is shown; the 
horizontal lines represent means of 36 replicates. Statistical analysis was done with the Students T-test 
(*** p < 0.001) except for (E) which required non-parametric testing (Mann Witney-U test, ** p < 0.01).
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discussion
Elasmoid scales of (zebra-)fish are an ideal model system to study how nutrients 
subtly modulate skeletal physiology in vitro as well as in vivo. The use of ontogenetic 
and regenerating scales provides us with different resolutions as the rate of bone 
formation and resorption is different between ontogenetic and regenerating scales 
(de Vrieze et al., 2011; 2013). In the present study we show that six  weeks of feed-
ing zebrafish with either low or high levels of ARA in the diets dramatically changes 
whole body fatty acid profiles according to the respective diet. As a consequence, 
mineralization of scales was negatively affected and osteoclast activity and mark-
ers of bone turnover were increased in scales of fish fed the high ARA diet. 
Figure 2. Effects of the different diets on scale mineralization. Representative examples of scales 
on which the quantifications from figure 1 were based. A Example of a scale from the low ARA group 
stained for mineralization (Von Kossa staining, calcium phosphates stained brown). The scale is almost 
completely mineralized and the brown staining is only absent in the focus (lower central region) of the 
scale. Bar = 250 μm. B Detailed image of the focus of the scale shown in (A) with several unmineralized 
small resorption pits where staining is absent (arrows). Bar = 100 μm. C TRACP activity-stained onto-
genetic scale from the low ARA group with few red-stained areas positive for TRACP activity, indicated 
by arrows. Bar = 250 μm. D Von Kossa stained ontogenetic scale from the high ARA group. Arrows 
indicate resorption pits outside the focus, seen more often in scales from high than from low ARA fed 
fish. Bar = 250 μm. E Detailed image of the scale shown in (D) with more resorption pits with typical 
round edges as a result of osteoclastic matrix degradation. Bar = 100 μm. F TRACP activity-stained 
ontogenetic scale from the high ARA group with more spots stained red for TRACP activity than in the 
low ARA group, indicating the presence of more osteoclasts in this group. Bar = 250 μm.
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D E F
76
di
sc
us
si
on
5
Despite large differences in whole body ARA levels between the two groups, only 
subtle (yet significant) differences were observed in terms of mineral composition. 
As discussed in previous work, the small size of the zebrafish scale poses a technical 
limitation to measure parameters of bone mineral density (BMD); best alternatives 
are histomorphometry of demineralization and calculation of the Ca:P molar ratio 
(de Vrieze et al., 2012; 2013). The Ca:P ratio was decreased in ontogenetic scales 
of fish fed the high ARA diet, which we take as evidence that (scale) mineralization 
is affected by dietary ARA. Lower Ca:P ratios of biological samples (< 1.6, the ratio 
for pure hydroxyapatite) generally point towards altered crystalline phase, impuri-
ties or defects, all of which make the mineral less stable and more easy to dissolve 
by osteoclasts (Dorozhkin, 2007). Scales grow continuously throughout life and 
formation and resorption is ongoing, albeit at a very low pace (de Vrieze et al., 
2011). The effect seen is likely the result of delicate changes in scale growth and 
demineralization and could be mediated via increased incorporation of e.g. magne-
sium (leading to whitlockite) and/or carbonate (defective apatites), or via increased 
deposition of amorphous calcium phosphates (de Vrieze et al., 2012). During scale 
regeneration, the Ca:P ratio increased from approximately 1.2 early in regeneration 
(day 4), to a value of approximately 1.4 when mineralization of the scale matrix 
progressed and the scale ‘matured’. This increase in Ca:P ratio is typical for the 
early phase of scale regeneration and is consistent with previous findings in zebra- 
fish (Vrieze et al., 2012; 2013) and sea bass (Dicentrarchus labrax) (Guerreiro et al., 
2012). We further observed a higher Ca:P ratio in 7-days-old regenerating scales 
of fish fed the high ARA compared to those fed the low ARA diet. As the increase 
in Ca:P ratio is typical for elasmoid scale maturation, the increase measured in 
the high ARA group may suggest that ARA increases the rate of development and 
maturation.
For ontogenetic scales, increased osteoclastic activity in the high ARA group is 
particularly evident from the histomorphometric analyses. An increase in the area 
positive for TRACP activity was detected, as well as increased resorption (in total 
perimeter and absolute number of pits). This indicates that osteoclasts degrade 
more and/or longer stretches of scale matrix. Bone resorption, the catabolic phase 
of the bone remodeling process, is characterized by increased proteolytic activity 
to degrade matrix following mineral dissolution (Kaunitz, 2008; Krane and Inada, 
2008). Although no significant differences were found in expression of genes en-
coding proteins involved in bone resorption (and formation), actual secretion of 
Mmps enzymes was significantly increased in the high ARA group. This shows 
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Figure 3. Gene expression profile and Mmp activity of ontogenetic scales after feeding the 
different diets. A Gene expression analysis of ontogenetic scales from fish fed the low ARA diet 
(black bars) or the high ARA diet (white bars). No statistically different effects of the different diets were 
observed, not even in osteocalcin expression (P = 0.900; non-parametric test). Transcript abundance is 
expressed relative to an index of the reference genes rpl13a and tuba1. Results are displayed as means 
± SEM of 16 scales randomly obtained from all of the 4 replicate tanks. B Example of a Coomassie-
stained gelatin gel showing increased MMP activity in ontogenetic scales from the high ARA group (two 
lanes to the right) compared to the low ARA group (left lanes). Protein mass ladder is given in kiloDalton 
(kDa). C Semiquantitative analysis of gelatinolytic activity demonstrates that total of Mmp2 and Mmp9 
activity, secreted by cultured ontogenetic scales, is higher in scales from fish fed the high ARA diet 
compared to the low ARA diet. The total amount of secreted gelatinolytic activity is significantly 
increased in the high ARA group (P < 0.05; One sample T test). Results of high ARA samples are ex-
pressed relative to low ARA samples analyzed on the same gel. Bars represent the mean ± SEM of 8 
samples.
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that the observed effects on the mineralized matrix are the result of increased 
osteoclast activity and do not depend on increased expression of osteoclast 
genes. Moreover, a small increase in osteoclastic activity or number may already 
account for the substantial increase of resorption.
Increased matrix resorption is a natural aspect of scale regeneration (de Vrieze et 
al., 2011) and likely obscures the subtle differences that may be the result of the 
different diets. We did however find evidence of increased osteoclastic activity 
on the level of gene expression; rankl and mmp9 were upregulated in 4-day-old 
regenerating scales of fish fed the high ARA diet. At day 4 of regeneration the 
increased enzymatic activity in regenerating scales of fish fed the high ARA was 
also increased near significance. For Mmp9, the increased enzymatic activity was 
maintained until day 7 and is apparently sustained (for a certain period) when gene 
expression already declines. The effects of high dietary ARA levels on both mmp 
genes and rankl (and subsequent osteoclastic activities) in regenerating scales are 
in line with the results found in several mammalian in vitro studies (Coetzee et al., 
2007a; Solakivi et al., 2009; Coetzee et al., 2009).
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Figure 4. Analysis of scale mineralization during regeneration. A Absolute calcium contents in 
regenerating scales sampled at different time points after scale removal. Calcium content increases 
similarly in both groups as the scale grows during regeneration. B Calcium:phosphorus molar ratio of 
regenerating scales of different ages. The ratio increases in both groups from day 4 to 7, indicative of 
a changed mineral composition on the scale matrix. Effect of the diet is only observed on day 7; the 
Ca:P ratio in the high ARA groups is significantly increased compared to the low ARA group. Samples 
are expressed as mean ± SEM (N=9); black bars represent samples obtained from fish fed the low ARA 
diet, and white bars represent samples from fish fed the high ARA diet. Statistical testing was conduct-
ed with the Students T-test (* p < 0.05).
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In the present study, both enzymatic activity of Mmps and gene expression 
showed a high degree of individual variation, which is likely intrinsic to differences 
in size and cellular activity between individual scales. Zebrafish possess hundreds 
of elasmoid scales, which allows for substantial individual variation in the scale 
compartment that apparently functions as a whole (de Vrieze et al., 2011; 2013). In 
this study, the variation in enzymatic activities appears to partly conceal the effects 
of ARA and the resolution of band-intensity measurements is fairly low. Yet in all 
scales analyzed, it is apparent that more proteolytic enzyme was secreted from the 
osteoclasts associated with scales from fish fed the high ARA diet. 
The effects of ARA on proteolytic activity, derived from mono- and multinucle-
ated osteoclasts (de Vrieze et al., 2011), were much more pronounced in vitro, 
when scales were exposed directly to ARA (5-150µM). Already at the lowest con-
centration applied (5 µM), enhanced secretion of Mmp9 was seen, in line with 
in vitro studies on mammalian osteoclast-like cells; Yuan and coworkers showed 
that 10µM ARA enhanced osteoclastogenesis directly in bone marrow-derived 
macrophages through the ARA metabolite prostaglandin E2 (PGE2) (Yuan et 
al., 2010). Using scales from goldfish (Carassius auratus), Omori and colleagues 
showed that PGE2 increased both osteoclastic and osteoblastic activity in vitro 
as well as in vivo (Omori et al., 2012). Taken together, the observations made on 
ontogenetic scales show that dietary ARA has a mild but significantly stimulatory 
effect on osteoclastic matrix degradation in scales. From the in vivo and in vitro 
experiments combined, we conclude that ARA exerts direct effect on scale cells, 
most likely orchestrated by the cyclooxygenase product PGE2 (Nolan et al., 1983).
Several studies show effects of ARA on differentiation and activity of mammalian 
osteoblasts, suggesting that ARA has a negative effect on matrix deposition and 
mineralization (Coetzee et al., 2009; Kruger et al., 2010). Recently this was also 
demonstrated for osteoblasts of teleost fish; treatment of seabream (Sparus auratus) 
osteoblasts with 100 µM ARA (and EPA) increased proliferation but decreased 
mineralization in vitro (Viegas et al., 2012). In contrast, one of the few effects we 
observed on osteoblast-associated genes is the increased expression of sp7 in 
4-days-old regenerating scales. In addition, we observed increased expression 
of the rankl gene, which encodes a powerful osteoblast-derived stimulator of 
osteoclast activity and according matrix resorption (Hofbauer et al., 2004; To et al., 
2012). Scale regeneration is characterized by a typical, phased gene expression 
profile that includes increased expression of sp7, rankl and mmp9 (de Vrieze et al., 
2011; 2013). Expression of these genes is increased on day 4 of scale regeneration 
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Figure 5. Gene expression profile and Mmp activity of regenerating scales of fish fed the different 
diets. A Gene expression of sp7 and rankl (osteoblast), as well as mmp9 (osteoclast) is higher in the 
high ARA group compared to the low ARA group in 4-day-old regenerating scales. B After 7 days of 
scale regeneration, these differences mostly disappeared. Gene expression of the low ARA group has 
increased compared to expression levels at day 4 and expression of rankl is also significantly higher 
compared to the high ARA group. Gene expression is shown as mean normalized expression (MNE). 
MNE for scales obtained from fish fed the ARA-restricted diet (low ARA) are shown with black bars and 
for scales from fish fed the ARA-enriched diet (high ARA) with white bars. Bars represent the mean ± 
SEM of 9 replicates. After assessment of normal distribution (D’Agostino & Pearson normality test), sta-
tistical analysis was done with either Student’s t-test, or Mann-Whitney U-test (* p < 0.05, ** p < 0.01). 
C Enzymatic Mmp9 activity of 7-day-old regenerating scales is higher in the high ARA group, as seen 
on gelatin zymography. Protein mass ladder is depicted in kiloDalton (kDa). D Semiquantitative analysis 
of enzymatic Mmp2 and Mmp9 activity and total Mmp activity in 4-day-old and 7-day-old regenerating 
scales shows the increased Mmp9 activity observed in (C). Mmp activity of scales from high ARA fish 
is expressed relative to those of low ARA fish analyzed on the same gel. Bars represent the mean of 
4 samples; horizontal line represents the low ARA samples. One sample t-test was used to compare 
the mean Mmp activity to 1. P-values for 4 days regeneration: P = 0.07 for Mmp2, P = 0.22 for Mmp9 
and P = 0.06 for total. P-values for 7 days regeneration: P = 0.72 for Mmp2, P = 0.05 for Mmp9 and 
P = 0.29 for total. 
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Figure 6. In vitro exposure of scales to arachidonic acid. Semiquantitative analysis of gelatinolytic 
matrix metalloproteinases of culture medium after in vitro exposure of ARA for 24 hours (A and B) 
and 48 hours (C and D). A ARA has no effect on Mmp2 activity after 24 hours of culture. B A tran-
sient, non-significant increasing trend is measured in Mmp9 activity with increasing ARA concentration. 
C Stimulatory effects of ARA on Mmp2 are not significant. D ARA significantly increases MMP9 after 48 
hours of culture, with a concentration-dependent trend. Activities of Mmp2 (A, C) and Mmp9 (B, D) are 
presented relative to the Mmp activity of samples taken from control cultures. Samples are expressed 
as mean ± SEM of 2 (24h) or 6 replicates (48h). Statistical analysis was done with the Student’s t-test 
or Mann-Whitney U-test when results were not normally distributed (* p < 0.05, ** p < 0.01).
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in the high ARA group, while scales of the low ARA group reached similar expres-
sion levels on day 7, when expression had significantly increased compared to day 
4. We take this as evidence that the typical and transient phased expression profile 
is accelerated in the high ARA group. Accordingly, the effects on mineral composi-
tion of the matrix at day 7 are the result of the combined (and delayed) mineralizing 
and resorptive activity up to that moment. 
Considering the large differences in ARA content between the two feeds (and as 
a consequence in the fish), the effects on mineral deposition are relatively small, 
indicative of the subtle yet important and robust modulatory role of ARA/PGE2 in 
bone physiology. Data originating from in vitro experiments are usually more pro-
found as they focus either on osteoblasts or osteoclasts separately. It is however 
not uncommon for these effects to be more subtle in intact bone tissue and in in 
vivo experiments, as the osteoblasts and osteoclasts are known to maintain tight-
ly controlled balance resulting from bidirectional communication (Watkins et al., 
2006; Poulsen and Kruger, 2006; Negishi-Koga et al., 2011). Here, the in vitro scale 
model has an advantage over cell monocultures, as the scale culture benefits from 
the presence of both osteoblasts and osteoclasts, a natural co-culture (Metz et al., 
2012). Our results are in agreement with the in vitro work of Omori and colleagues, 
who showed that PGE2 (an active metabolite of ARA) increases enzymatic activity 
of the osteoblast-marker alkaline phosphatase in goldfish elasmoid scales (Omori 
et al., 2012). Although their study shows that PGE2 is able to activate scleroblasts 
(referred to as osteoblasts), they also provide strong evidence that PGE2 stimulates 
osteoclast activity. Similarly, from our study it follows that ARA affects both cell 
types, which may explain the different outcomes in existing bone and new-forming 
bone, with the characteristic high level of expression of osteoblast-related genes 
in the latter (de Vrieze et al., 2013). 
Another consideration is a hyperbolic relation between ARA concentration and ef-
fects exerted. Interestingly, Senegalese sole (Solea senegalensis) larvae fed Artemia 
enriched with different levels of ARA showed the highest increase in growth and 
mineralization in the group receiving an intermediate concentration of ARA (5.7% 
ARA of total fatty acid, TFA) compared to groups receiving a lower (2% of TFA) and 
higher (7.3% of TFA) concentration (Boglino et al., 2012). This effect was confirmed 
in sea bream and sea bass (Bessonart et al., 1999; Atalah et al., 2011), indicating 
a possible critical level of ARA needed to sustain optimal growth. Thus it could 
be speculated that the effects seen on scale development in vivo in the present 
study is a result of attenuated growth in the low ARA group and not necessarily the 
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direct effect of free ARA on bone metabolism as demonstrated in vitro in previous 
as well as in the current study. To the best of our knowledge there are no reports 
on optimal fatty acid composition for zebrafish feed to which we can relate the fatty 
acid composition of our experimental diets. Future studies will address hyperbolic 
relationships between ARA treatments and their effects on bone physiology. It is 
clear though that ARA has a modulatory effect on scale metabolism predominantly 
mediated via enhanced osteoclastic matrix degradation. Hence, ARA requirements 
in different species and of developmental stages need attention to secure fish 
welfare in aquaculture. 
conclusion
We conclude that an ARA-enriched diet, and consequent changes in whole-
body fatty acid profile, influences scale mineralization and remodeling in existing 
(ontogenetic) and regenerating scales. The effects found in this study correlate 
with the skeletal deformities found as a result of sub-optimal dietary fatty acid 
composition. We thus conclude that the scale model can be used in aquaculture to 
quickly predict the effects of dietary composition on the entire skeleton. Feeding 
trials are notoriously difficult as they depend strongly on dose and composition of 
fatty acid supplementation (and many more variables). Many such studies though 
point towards increased turnover of bone as results of dietary fatty acid supple-
mentation (Poulsen et al., 2007). Small differences in mineralization of skeletal tis-
sues are known to lead to malformations and fractures, especially when subjected 
to great forces ( De Laet et al., 1997; Kjorsvik et al., 2009; Gil Martens et al., 2010). 
We show that studies on elasmoid scales of zebrafish, including the regeneration 
paradigm, may provide an excellent tool for future studies to elucidate underlying 
molecular mechanisms of (dietary) fatty acids on subtle aspects of skeletal biology.
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maTerials and meThods
ethIcs statement
This study was carried out in strict accordance with directive of the European 
Union on the protection of animals used for scientific purposes. The protocols 
were approved by the Committee on the Ethics of Animal Experiments of the 
Radboud University (Permit Numbers: RU-DEC2010-105; RU-DEC2011-266). 
Removal of scales was always done under 2-phenoxyethanol anesthesia, and all 
efforts were made to minimize suffering. 
formulatIon and preparatIon of dIets
Two mixes of different oils were used to prepare diets containing low and high 
levels of ARA, respectively. The oils were combined so that each of the two diets 
contains equal amounts of DHA (docosahexaenoic acid, 22:6(ω-3)), but different 
levels of ARA. Diets were prepared using the ingredients listed in table 2 and as 
described previously by Halver (2001). Compositions of mineral, vitamin and amino 
acid mixes used to prepare the diets are listed in tables 3, 4 and 5, respectively. 
experImental setup
Adult zebrafish (Danio rerio, tupfel long fin) with an average weight of 0.44 ± 0.084 
gram, were kept in 2-L tanks of nine fish each in a recirculating system. Four tanks 
were fed the ARA-restricted diet (low ARA), and four tanks were fed the ARA- 
enriched diet (high ARA). Fish were left undisturbed and fed twice daily at a total 
ration of 0.12 ± 0.02 grams (2% of the estimated bodyweight) for four weeks. After 
4 weeks of applying one of the two diets, from all fish approximately 50 scales were 
removed from the left flank under mild anesthesia (0.05% (v/v) 2-phenoxy-ethanol, 
Sigma Aldrich, Carlsbad, USA) to induce scale regeneration (day 0). 
After 4, 7, 10 and 14 days of regeneration, all nine fish from one tank provided with 
low ARA diet and one with high ARA diet were sacrificed. Regenerating scales were 
sampled from all groups and stored for different analyses. Anesthetized whole fish 
were frozen at -80oC for whole-body fatty acid analyses. 
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Table 2. Zebrafish feed composition Table 3. Composition of mineral mix
Ingredients Low ARA 
diet (g/kg)
High ARA 
diet (g/kg)
Ingredients Content (g/kg)
Casein1 480 480 CaHPO4.2H2O 15
Gelatin2 119 119 CoCl2.6H2O 0.002
Dextrin3 125 125 CuSO4.5H2O 0.01
Cellulose4 50 50 FeSO4.7H2O 0.4
Fish oil5 55 33 KCl 15
ARA-rich oil 
(Vevodar oil®)6
- 77 KI 0.01
Canola oil7 55 - MgSO4.7H2O 5
Mineral mix* 40 40 MnSO4.H2O 0.08
Vitamin mix* 10 10 NaCl 4.148
Amino acid/ 
betaine mix*
50 50 ZnSO4.7H2O 0.2
Astaxanthin8 1 1 Yeast (Zn source) 0.15
Lecithin4 15 15
1MP Biomedical, Solon, OH, USA, cat. no. 
02901293; 2Idun Industri AS, Skjetten, Norway; 
3Fluka Chemie, Buchs, Switzerland cat. no. 31400; 
4Sigma-Aldrich, St Louis, MO, USA; 5Møllers tran, 
Oslo, Norway; 6DSM nutritional products, Oslo, 
Norway ; 7Eldorado, Oslo, Norway ; 8Carophyll 
Pink, Hoffman-La Roche, Basle, Switzerland; *De-
tails on mineral mix, vitamin mix and amino acid mix 
composition can be found in supplementary tables 
3, 4 and 5.
calcIum and phosphorus analysIs
Per fish, ten scales (with cells attached), either ontogenetic or regenerating, of the 
same individual fish were pooled, dried and dissolved in 200μl nitric acid (65%). 
The thus obtained sample was diluted 100x with ultrapure water. Calcium, phos-
phorus and magnesium content were measured in duplicate with ICP-MS (induc-
tively coupled plasma mass spectrometry; Thermo Fisher Scientific, Waltham, 
USA). Four measurements (on a total of 220) with duplicates that varied more than 
15% were discarded. 
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fatty acId analysIs
Whole body and dietary fatty acid compositions were analyzed using gas liquid 
chromatography (GLC) as previously described by Lie and Lamberdsen (1991).
hIstochemIstry and morphometrIc analysIs
Regenerating and ontogenetic scales were fixed overnight in 4% paraformalde-
hyde in PBS (phosphate-buffered saline) at 4oC and, following two wash steps 
with PBS, stained for either mineralization or TRACP (tartrate-resistant acid phos-
phatase). To stain calcium phosphates, according to Von Kossa, fixed samples 
were rinsed with MilliQ water and subsequently incubated for 1 hour in 5% (w/v) 
silver nitrate under strong light. Scales were then washed twice with MilliQ water 
and fixed for 5 minutes in 5% (w/v) sodium thiosulfate, rinsed again, mounted and 
coverslipped. TRACP activity staining was done as recently described in detail (de 
Vrieze et al., 2013). 
All samples were photographed under a Leica DMRBE microscope with a PFC-
450C camera (Leica microsystems, Wetzlar, Germany) and morphometric analysis 
was done with Photoshop® (Adobe, San Jose, USA). The scale surface area was 
measured as the total area within the perimeter of a Von Kossa-stained scale. 
Measurement of the resorption pits included all regions within the perimeter of the 
scale that were not stained for mineralization with the exception of the unmineral-
ized grooves (radii) that radiate from the center focus. Quantification of the TRACP 
activity staining included both the surface covered by osteoclast as well as the 
TRACP secreted in the scale matrix. 
scale culture and gelatIn zymography 
Scales obtained from the feeding trial were cultured in minimal essential culture 
medium (MEMα) supplemented with 1% (v/v) penicillin/streptomycin (Invitrogen) 
for 22 hours at 28oC. The entire supernatant was then reduced to a volume 10 
μl by cryo-sublimation under vacuum. For zymography, the entire samples were 
loaded onto SDS-PAGE gels supplemented with 1mg/ml gelatin as described by 
de Vrieze et al. (2011). After staining with Coomassie blue, the gels were preserved 
between two cellophane sheets, scanned and band densities were analyzed with 
Photoshop® (Adobe).
87
5
ar
ac
hi
do
ni
c 
ac
id
 en
ha
nc
es
 tu
rn
ov
er
 o
f t
he
 d
er
M
al
 sk
el
et
on
Table 4. Composition of vitamin mix Table 5. Composition of amino acid mix
Ingredients  Content (mg/kg) Ingredients  Content (mg/kg)
Vitamin A 10  Betaine 0.5
Vitamin D3 4  Glycine 3
Vitamin E (50%) 130  Alanine 0.8
Vitamin K (50%) 10  Arginine 5
Vitamin C (35%) 350  Methionine 5
Choline 4000  Valine 3
Thiamin mononitrate 15  Taurine 0.2
Riboflavin (80%) 19  Glutamic acid 0.3
Pyridoxin.HCl 20  Aspartic acid 0.3
Niacin 200  Serine 0.3
Inositol 400  Lysine 8.1
Folic acid 5  Histidine 3
Ca-pantothenate 60  Tryptophan 4.5
Biotin 50  Isoleucine 5
B12 (0.1%) 30  Leucine 5
Casein 4697  Phenylalanine 4
 Threonine 2
In vItro scale cultures WIth arachIdonIc acId
Arachidonic acid (cat. #A355; Sigma-Aldrich) was coupled to fatty acid-free 
albumin (PAA, Pasching, Austria) by addition of 0.04 ml chloroform per mg ARA 
as described by Lie and Lambertsen (1991). The chloroform was then evaporated 
under a flow of nitrogen gas after which the ARA stock was stored in -80oC until 
use. Ontogenetic scales were picked from eight adult zebrafish. The scales were 
washed six times in 0.4 ml L-15 medium supplemented with 1% (v/v) penicillin/
streptomycin prior to incubation in treatment media. Pools of 10 scales (obtained 
from one fish) were incubated in 0.3 ml L-15 with 1% penicillin/streptomycin. 
Pooled scales from each individual fish were cultured in 48-wells plates at four 
different concentrations of (albumin-coupled) arachidonic acid: 0 (control), 5, 50 
and 150 µM ARA. The concentration of albumin was adjusted when necessary, 
to equal total protein in all treatment groups. The scales were incubated at 28oC 
under gentle agitation for 24 or 48 hours. Ten microliters of the culture 
medium from each well was used for Mmp2 and Mmp9 gelatin zymography after 
24h and 48h of incubation.
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Table 6. Primer sequences of target genes used in quantitative PCR
 Gene Accession number Sequence (‘5-’3)
tuba1l NM_001105126.2 FW: GGTGCCCTCAATGTGGATCT
RV: GCCACAGAGAGCTGCTCATG
sp7 AY380818.1 FW: CCCATTCTCCACTTTCCAGA
RV: TGGATGCCTTTGTACCATGA
rpl13a NM_212784 FW: TCTGGAGGACTGTAAGAGGTATGC
RV: AGACGCACAATCTTGAGAGCAG
cathepsin K (ctsk) NM_001017778 FW: ATGATCTGGGCATGAACCAT
RV: CCGAAGTGACGTATCCCAGT
osteocalcin (bgp) NM_001083857 FW: TGACGTGGCCTCTATCATCA
RV: TTTATAGGCGGCGATGATTC
matrix metalloproteinase 9 
(mmp9) 
NM_213123.1 FW: TCATGATCTCTGCGAAGTGG
RV: CCGAGCTTCTCGATTTTACG
Rankl (tnfsf11) ZDB-GENE-090805-2 FW: TAGTGTGGCGATTCTGTTGC
RV: ATTGGAAGGTGAGCTGATGG
gene expressIon analysIs
Scales (including their cells lining the scale surface) were homogenized in Qiazol®  
(Qiagen, Hilden, Germany) and total RNA was extracted using BioRobot® EZ1 and 
RNA Tissue Mini Kit (Qiagen) according to the manufacturer’s instruction. DNase 
treatment was included in the protocol to avoid DNA contamination. The quantity 
and purity of total RNA were assessed by NanoDrop® ND-1000 spectrophotometry 
(NanoDrop Technologies, Wilmington, Germany). All samples had 260/230 
ratios over 1.6 and 260/280 ratios over 1.8 implying a high purity of RNA. The RNA 
integrity (RIN) was measured with RNA 6000 Nano LabChip® kits and the Agilent 
2100 Bioanalyzer (Agilent Technologies, Palo Alto, USA) and was found to be over 
8.0. Copy DNA was synthesized in duplicate in a 20-µl reaction volume for each 
biological replicate using the Superscript II Reverse transcriptase kit (Invitrogen) 
and 250ng total RNA as input for each reaction. For downstream qPCR efficiency 
calculations, two-fold serial dilutions (500ng – 15.6ng) using pooled total RNA 
from all scales were prepared and reverse transcribed on each 96-wells plate. No 
amplification control (NAC) and no template control (NTC) were added to each 
plate to demonstrate absence of genomic contamination in the samples and 
absence of template contamination in the reagents. Reverse transcription was 
89
5
ar
ac
hi
do
ni
c 
ac
id
 en
ha
nc
es
 tu
rn
ov
er
 o
f t
he
 d
er
M
al
 sk
el
et
on
performed at 25°C for 10 min, followed by 42°C for 1 h in a GeneAmp PCR 9700 
machine (Applied Biosystems, Foster City, USA). Quantitative PCR analysis and 
crossing point calculations were performed as previously described by Lie and 
Moren (2012); the primers used are listed in table 6. Mean normalized expression 
(MNE), using rpl13a and tuba1 as reference genes, was calculated individually for 
ontogenetic and regenerating scales, using GeNorm software (Vandesompele et 
al., 2002). 
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Chapter 6
prednisolone induces osteoporosis-liKe 
phenotype in reGeneratinG zebrafish scales 
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Nijmegen, The Netherlands
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absTracT
purpose: To evaluate whether glucocorticoid (prednisolone) treatment of zebrafish 
induces an osteoporotic phenotype in regenerating scales. Scales, a readily acces-
sible dermal bone tissue, may provide a tool to study direct osteogenesis and its 
disturbance by glucocorticoids.  
methods: In adult zebrafish, treated with 25 μM prednisolone-phosphate via the 
water, scales were removed and allowed to regenerate. During regeneration scale 
morphology and the molar calcium:phosphorus-ratio in scales were assessed and 
osteoblast and osteoclast activities were monitored by time-profiling of cell-specific 
genes;  mineralization was visualized by Von-Kossa staining, osteoclast activity by 
TRACP histochemistry. 
results: Prednisolone (compared to controls) enhances osteoclast activity and 
matrix resorption and slows down the build-up of the calcium:phosphorus molar 
ratio indicative of altered crystal maturation. Prednisolone treatment further im-
pedes regeneration through a shift in the time-profiles of osteoblast and osteoclast 
genes that commensurates with an osteoporosis-like imbalance in bone formation.
conclusIons: A glucocorticoid-induced osteoporosis (GIOP) phenotype as seen in 
mammals was induced in regenerating scalar bone of zebrafish treated with pred-
nisolone. An unsurpassed convenience and low cost then make the zebrafish scale 
a superior model for preclinical studies in osteoporosis research.
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inTroducTion
Zebrafish (infraclass Teleostei) provide an excellent model for bone research. The 
elasmoid scale of teleosts is an easily accessible dermal bone plate that functions 
as reservoir when calcium demand is high (Mugiya and Watabe, 1977; Flik et al., 
1986). When a scale is lost or removed the fish will quickly replace it thereby offer-
ing a unique model to study bone regeneration (de Vrieze et al., 2011).
Scales can easily be harvested with minimal stress to the fish; once removed, 
formation of new scales is initiated immediately and, depending on ambient 
temperature, a new mineralized scale can be observed within a week (Sire, 1989b; 
de Vrieze et al., 2011). This process of osteogenesis, i.e. osteoblast differentiation, 
matrix deposition and mineralization can be studied on demand (Metz et al., 2012). 
The great similarity between the original (ontogenetic) and the regenerated scale 
demonstrates that (ontogenetic) scale development and regeneration follows a 
conserved program built on similar cellular and molecular controls (Bereiter-Hahn 
and Zylberberg, 1993).
Mesenchymal scale-forming osteoblasts (often called scleroblasts; osteoblasts of 
the dermal skeleton) form two disc-shaped cell layers in between which bone ma-
trix is secreted (Sire and Akimenko, 2004; Ho Lee et al., 2013). Newly deposited 
mineral is already observed in 4-day-old regenerating scales (Ohira et al., 2007; de 
Vrieze et al., 2012). As is the case with intramembranous ossification in mammals, 
scales are formed without a cartilage precursor. Calcium phosphate (hydroxy- 
apatite) is deposited in the collagenous (type-Iα) matrix (de Vrieze et al., 2012). The 
acellular matrix is deposited in a highly ordered plywood-like arrangement, and 
contains among others osteocalcin (bone gla protein) and osteopontin (secreted 
phosphoprotein 1) (Zylberberg et al., 1988; Kimura et al., 1991; Nishimoto et al., 
2003; Fonseca et al., 2007). The basal plate (the innermost half of the osteoid that 
gives flexibility to the scale) is not mineralized (de Vrieze et al., 2012). Scale growth 
involves continuous remodeling by osteoblasts and osteoclasts (de Vrieze et al., 
2010; 2011); scales keep growing peripherally by appositional bone formation as 
long as the fish grows (Ohira et al., 2007).
Rodent models for osteoporosis studies are labor-intensive and expensive; 
mammalian bone formation starts in utero, which is an experimental challenge and 
both induction of osteoporosis and fracture repair are time-consuming studies (Ris-
sanen and Halleen, 2010). Very few studies on mammals have addressed aspects 
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such as gene expression and biomineralization in vivo. Clearly, the fish scale as 
model is exempt from these limitations; scales are easily accessible, available in 
large numbers (a fish typically has hundreds of scales) and osteogenesis can be 
induced anew by scale regeneration.
Another advantage of the use of scales over mammalian bone is their in vitro appli-
cation. In a scale culture (ex vivo), associated osteoblasts and osteoclasts remain 
attached to their natural matrix and important cell-cell and cell-matrix interactions 
thus remain intact during experiments. Further, the scale matrix is transparent, 
which means that the bone cells are easily visualized by microscopy. In terms 
of complexity scales better resemble bone compared to cultured osteoblast or 
osteoclast cell-lines. Comparable mammalian in vitro models with ‘scale’ features 
are explant cultures (e.g. calvariae), which require one animal per sample obtained, 
whereas a single zebrafish can provide 50 highly similar scales drastically reducing 
the demand on experimental animals (Gomes and Fernandes, 2011; Metz et al., 
2012). Fish scales were successfully used to assess effects of (anti-)osteogenic 
compounds and hormones on osteoblast and osteoclast activities in vitro (Suzuki 
and Hattori, 2003). Scale cells respond very similar to mammalian bone cells and 
this led to the (suggested) use of scales in drug discovery (Brittijn et al., 2009; Su-
zuki et al., 2011b; Metz et al., 2012; Pasqualetti et al., 2012a). The zebrafish scale 
as model can greatly benefit from an extensive genetic toolbox, e.g. transgenic 
reporter lines and an extensive selection of mutant lines. Yet, to the best of our 
knowledge, no study so far addressed whether scales could serve as disease 
model in for instance osteoporosis.
The glucocorticoid system is highly conserved from fish to mammals; glucocorti-
coids control energy flows in an organism to cope with stressful condition and are at 
the basis of proper acclimation to a dynamically changing environment (McMahon 
et al., 1988). Long-term treatment of patients with glucocorticoids (to suppress 
inflammation) is known to induce osteoporosis (Weinstein, 2011; Moutsatsou et al., 
2012). Barrett and coworkers reported that glucocorticoids delay mineralization of 
the internal skeleton in larval zebrafish, reminiscent of an osteoporotic condition 
(Barrett et al., 2006). Unfortunately, osteoclasts are absent in early larval stages 
and the dynamics of osteoblast-osteoclast interactions alike (Witten et al., 2001; 
Barrett et al., 2006).
Glucocorticoids signal via the glucocorticoid receptor (GR) found in all tissues in-
cluding bone (Alsop and Vijayan, 2008; Seferos et al., 2010). GR signaling involves 
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genomic and non-genomic pathways and the pathophysiology of glucocorticoid- 
induced osteoporosis (GIOP) is therefore highly complex (Canalis et al., 2007). In 
general, glucocorticoids inhibit osteoblast function via decreased differentiation 
and increased apoptosis, and stimulate osteoclast formation and survival (Canalis 
et al., 2007; Moutsatsou et al., 2012). Two phases are discriminated in human GIOP: 
a rapid, early phase is characterized by decreased bone mineral density (BMD) as 
a result of increased osteoclast activity; a slower, progressive phase is ascribed to 
an additional inhibition of osteoblast activity (Weinstein, 2011).
In the present study, we investigate the effects of prednisolone on scale regenera-
tion in zebrafish. We hypothesized that prednisolone induces an osteoporosis-like 
state in zebrafish scales; i.e. increased scale resorption and decreased scale for-
mation.
resulTs
Morphometric analyses were conducted to measure size, shape and (un)mineral-
ized areas on Von Kossa stained scales (figure 1). TRACP (tartrate-resistant acid 
phosphatase), secreted by osteoclasts to degrade the scale matrix, was stained 
enzymatically in cells and matrix. Areas positive for TRACP activity were quantified 
and taken as a measure for osteoclast activity (figure 1). Regenerated scales were 
significantly smaller after 8 days, yet at the end of the regeneration experiment 
(21 days) there was no difference in size and circularity between ontogenetic and 
regenerated scales of the control group (figure 1A, B). For the control groups, the 
percentage of unmineralized surface of the regenerated scale was significantly 
larger compared to ontogenetic scales, as was the percentage of TRACP activity 
staining (figure 1C, D). Regenerating scales of prednisolone-exposed fish were 
significantly smaller after 21 days compared to both controls and their onto- 
genetic counterparts. Moreover, we observed that regenerating scales of fish 
treated with prednisolone were more irregular in shape (reflected by a significantly 
lower circularity factor); either the scales were more ellipsoid or their perimeter 
was irregular as a result of gaps along the scale edges and of fusion processes 
(examples shown in figure 2D-G). Clear interaction effects between prednisolone 
treatment and scale regeneration were found for the circularity and the percentage 
of TRACP activity-stained areas. TRACP-positive surface areas were significantly 
larger in scales of prednisolone-treated fish, as shown in figure 2.
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Representative scales of each group, stained for presence calcium phosphate 
minerals or TRACP activity, are shown in figure 2. Resorption pits were found on 
all scales, but they covered a higher percentage of the surface area of regen-
erated scales (figure 2A-G). Demineralized resorption pits (figure 2B) were more 
often found on regenerated scales and showed characteristic round boundaries as 
a result of osteoclast activity. Prednisolone treatment resulted in more irregularly 
shaped scales and even fusion of two scales was sometimes observed (figure 2D-
G; see figure 2C for a regularly shaped regenerated scale). TRACP activity stain-
ing revealed sporadic osteoclast activity on ontogenetic scales (not shown), but 
moderate TRACP activity was detected on regenerated scales (figure 2H). 
Prednisolone treatment significantly increased the TRACP activity staining after 8 
days of regeneration (figure 2I), and after 21 days TRACP activity staining was still 
intense (figure 2J). Areas of scale malformation coincide with increased TRACP 
activity staining (figure 2D, K). Resorption pits are clearly lined with TRACP activity 
staining, resulting from the presence of osteoclasts (figure 2L, M). 
Inductively coupled plasma mass spectroscopy (ICP-MS) of regenerating scales 
revealed that calcium, phosphorus and magnesium were incorporated in the newly 
formed scales and their content increased throughout the regeneration experiment 
(data not shown). Due to their small size, measurements required pooling of scales. 
Therefore, best insights in the dynamics of mineralization could be obtained by 
calculation of the calcium:phosphorus molar ratio (figure 3A, B), where each scale 
serves as its internal control for differences in size. In regenerating scales (figure 
3A), where a new mineralized matrix is formed, the Ca:P ratio increased from 1.2 
at day 4, to 1.4 on day 6 and later (P = 0.0002). Prednisolone treatment resulted in 
significantly lower Ca:P ratios in both ontogenetic and regenerated scales through-
out the experiment, with the exception of regenerating scales of 8 days old. For 
ontogenetic scales, the ratio was approximately 1.4 and was not influenced by new 
formation of scales on the opposing flank (figure 3B).
Figure 1 (left page). Morphometric analyses of scales from control and prednisolone-exposed 
fish. Data on ontogenetic and 8 and 21-days regenerating (regen (8) and regen (21) respectively) scales 
are shown for control (black dots) and prednisolone treated (open dots) fish. A Surface area of scales 
in mm2. B Circularity factor (4πA/P2; where A is the surface of the scale and P is the perimeter of the 
scale). C Percentage of the scale surface that is demineralized (anticipated to be the result of osteoclast 
activity). D Percentage of the scale surface stained enzymatically for TRACP activity, either in cells or 
secreted into the scale matrix. Each replicate is displayed; the horizontal lines represent means of the 
replicates. Interaction effect was assessed with a two-way ANOVA. Columns were compared to each 
other using the Bonferroni post test. Different letters indicate statistical differences between (logical) 
groups. 
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Figure 2. Von Kossa (A-G) and TRACP activity (H-M) staining of zebrafish scales indicative of 
presence of calcium phosphates and osteoclast activity, respectively. A Ontogenetic scale with 
demineralized resorption pits in the focus (arrowheads). Bar = 500 μm, scale circularity factor = 0.76. 
B Magnification of the focus of the scale depicted in (A), showing demineralized areas interpreted as 
resulted from resorptive activity. Bar = 100 μm. C 21 days regenerating scales of a control fish. Re-
sorption pits are depicted with arrowheads, scale circularity factor = 0.74. D-G Examples of misshaped 
regenerating scales (21 days old) resulting from prednisolone treatment. D Invagination (arrowheads) in 
the posterior part of the scale. Scale circularity factor = 0.48. E Extreme number and size of demineral-
ized areas (arrowheads). Scale circularity factor = 0.75.F Fusion of two scales, boundaries are indicated 
with arrowheads. Scale circularity factor = 0.58. G Incompletely formed scale. Scale circularity factor 
= 0.57. H 21-days regenerating scale from a control fish showing mild TRACP activity (arrowheads). 
I 8-days regenerating scale of a prednisolone treated fish showing extreme TRACP activity. J 21-days 
regenerating scale where TRACP activity appears slightly decreased compared to 8-days regenerating 
scales. K Malformation sites, such as invagination (arrowhead) coincide with excessive TRACP activity 
staining. L Magnification of 21-days regenerating scale showing TRACP activity following the edges of 
resorbed areas (arrowheads). Bar = 50 μm. m) Multinucleated osteoclasts (arrowheads) at the edges of 
resorbed areas of an 8-days regenerating scale. Bar = 10 μm.  
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To assess whether the prednisolone treatment would interfere at the very start of 
scale regeneration, treatment was started one day before scale regeneration was 
induced. The effect of this 24-h prednisolone treatment per se on zebrafish scales 
was monitored through gene profiling (figure 4). Most genes were not influenced 
in their expression by the 24-hour prednisolone treatment. Five bone-associated 
genes did respond to this short-term glucocorticoid treatment: runx2a, osteocalcin, 
tartrate resistant acid phosphatase (tracp; acp5 gene) and ectonucleotide pyrophos-
phatase/phosphodiesterase 1 (enpp1 gene) were upregulated. On the other hand, 
the amount of glucocorticoid receptor, transcript variant α mRNA (the glucocorticoid 
signaling isoform in zebrafish; Schaaf et al., 2009) had decreased. 
We then analyzed expression of the same genes in regenerating scales. Genes 
known to affect bone- and matrix formation are shown in figure 5. Osteoclast 
markers and genes encoding inhibitory proteins in bone formation are shown in 
figure 6. Osteoblast marker genes, involved in osteoblast differentiation (sp7 and 
runx2a) and production of the extracellular matrix (collagen 1a, entpd5a and oste-
opontin) significantly increased during the formation of a new scale (figure 5A-E). 
Expression peaked around day 6 and 8, after which expression gradually declined, 
yet remained elevated compared to that in ontogenetic scales. Remarkably, no 
increase in gene expression was observed for the traditional osteoblast marker 
alkaline phosphatase (alpl; figure 5F). Key osteoclast marker genes cathepsin k (ctsk)
and tartrate resistant acid phosphatase (acp5b) did not increase expression during 
scale regeneration (figure 6A, B). In fact, tartrate resistant acid phosphatase expres-
sion was suppressed. Only matrix metalloproteinase-2 and -9 (mmp2 and mmp9, 
respectively) significantly increased in expression (figure 6C, D). Some genes did 
not increase during early regeneration. Expression of sclerostin (sost) and enpp1 
increased from day 6 (figure 6G, H) whereas rankl (figure 6E), a potent osteoclast- 
inducing signal and the proton channel vatp-ase  (V1 subunit aa, atp6v1aa; figure 
6F), were only elevated in the last week of scale regeneration. 
The effect of prednisolone treatment on gene expression during scale regeneration 
is also shown in figures 5 and 6 (as white bars). Osteoblast genes are generally 
activated during scale regeneration, but in some occasions further increased due 
to prednisolone treatment. Alkaline phosphatase, which did not increase during 
normal regeneration, had significantly increased as a result of the prednisolone 
treatment at day 6 and 11 (figure 5F). Only for collagen 1a, a significant increase 
was found for more than 2 time points (figure 5C). Osteoclast marker genes such 
as mmp9 and cathepsin k had increased several times over control values, whereas 
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vatp-ase was the only gene that got down-regulated (figure 6A, D, F). Predniso-
lone also significantly increased expression of enpp1 (figure 6H), a gene involved 
in pyrophosphate generation, but which cannot yet be ascribed to a specific cell 
population in zebrafish scales (Huitema et al., 2012).
Discussion
Three major findings from which we conclude that prednisolone induces an osteo- 
porosis-like phenotype in regenerating zebrafish scales are provided here. (I) Histo-
morphometric analysis indicates that osteoclast activity and matrix resorption is 
higher in scales of prednisolone treated fish. (II) Mineralization is impaired in these 
scales. (II) Prednisolone alters the typical phased gene expression profile of scale 
regeneration, especially that of the osteoclasts.
We used adult male fish for this experiment to ensure that differences in sex steroid 
profiles did not interfere with this study. Estrogens are known to target the RANK-
RANKL-OPG pathway (Hofbauer and Schoppet, 2004) and 17β-estradiol is known 
to stimulate recruitment of calcium from scales in rainbow trout (Persson et al., 
1994; Armour et al., 1997). Indeed, vitellogenesis is induced in sexually mature 
females by elevated levels of 17β-estradiol. These females have extreme calcium 
demands to saturate hepatic vitellogenin (an abundant calcium- and phosphate- 
binding protein in the egg yolk). Sex determination upon dissection of our fish 
revealed that most groups contained a maximum two females (out of 8 fish). Gene 
expression profiles and mineral content were assessed with and without females 
included, but this did not lead to significant changes. 
Morphometric analyses revealed that, in general, regeneration of scales under 
prednisolone treatment induced malformations. Regenerating scales were smaller 
compared to their ontogenetic counterparts, which was not the case in controls. 
Moreover, prednisolone treatment significantly affected the circularity factor. Von 
Kossa mineral-staining revealed increased activity of osteoclasts i.e. increased 
demineralized scale matrix in fully regenerated scales (day 21). Prednisolone treat-
ment increased these parameters of osteoclast activity compared to controls. This 
notion was further substantiated by a stronger increase in TRACP activity-staining 
in scales from prednisolone treated fish, which resembles the increased osteoclast 
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surface found in femurs of prednisolone-treated mice (Hofbauer et al., 2009). An 
involvement of multinucleated osteoclasts in scale demineralization has been sug-
gested before (de Vrieze et al., 2010; 2011), and multinucleated cells were indeed 
found on the scale plate. The occurrence of round edges in resorption pits, lined 
with TRACP activity-staining of the matrix, substantiates that the resorption pits 
are the obvious result of cell-mediated matrix degradation. In fish, bone resorption 
involves the activity of (‘typical’) multinucleated osteoclasts, and small mono- 
nucleated cells; both are present on zebrafish scales (Sire et al., 1990; Witten et 
al., 2001). The activity of mononucleated cells could be considered comparable to 
osteocytic bone degradation in mammals (Witten and Huysseune, 2009).
Figure 3. A Mineral analysis of 
regenerating scales. B mineral 
analysis of ontogenetic scales. The 
ontogenetic scales are sampled 
from the same fish on the same 
day as regenerating scales. Scales 
from control fish are shown with 
black bars, and from prednisolone 
fish treated are shown with white 
bars. All samples are expressed as 
means ± SD of 5 to 8 fish. Statis-
tical analysis was done with 2-way 
ANOVA. Significant effects of time 
and treatment were found in both 
cases (P<0.001), while an interac-
tion effect between time and treat-
ment was found for ontogenetic 
scales (P < 0.05). Columns were 
compared to each other using the 
Bonferroni post test. (* P < 0.05, ** 
P < 0.01 and *** P<0.001). 
A
B
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Figure 4. Comparison of gene expression in ontogenetic scales of control (grey bars) and one-
day prednisolone-treated fish (open bars). A Osteoblast marker genes; B osteoclast marker genes; 
C bone-related genes that in zebrafish scales cannot (yet) be ascribed to a specific cell population. 
Bars represent means ± SD of 8 fish. Significant differences are depicted with asterisks (* = P < 0.05, 
** = P < 0.01).
A
CB
6
It is well established from X-ray radiography that glucocorticoids negatively influ-
ence bone mineral density (BMD) in rodents and humans alike (Yao et al., 2008; 
Weinstein 2011). Scales are too small to rely on the commonly used techniques to 
assess BMD. The next best options are histomorphometry of demineralized tissue 
and measurement of mineral content by inductively coupled plasma mass spec-
troscopy (ICP-MS). The calculated calcium:phosphorus ratios in this study never 
reached 1.67 (indicative of pure hydroxyapatite), as the attached scale cells can not 
be excluded from the measurement (de Vrieze et al., 2012) and cause a shift in this 
ratio. The presence of hydroxyapatite as the major mineral phase in fish scales has 
previously been verified by means of X-ray diffraction spectroscopy (Schönbörner 
et al., 1979; de Vrieze et al., 2012). In the present study, we observed calcium:phos-
phorus ratios of approximately 1.0 in the very early regenerating scales, whereas 
ontogenetic and older regenerated scales had a ratio of  approximately 1.4. Various 
calcium phosphate precursor phases (e.g. brushite; calcium phosphate ratio: 1) 
have been proposed as the primary calcium phosphate that transits to an apatite 
such as hydroxyapatite or whitlockite (Dorozhkin, 2007). Even for mammals there 
is little in vivo information on this, but in zebrafish fin rays (also dermal skeleton) 
amorphous calcium phosphate was discovered as a precursor phase (Mahamid et 
al., 2008). In this area of research, scales may provide a valuable model as miner-
alization can be induced on demand (regeneration) and further benefits from easy 
access and temperature dependence.
Prednisolone slowed down the development of the Ca:P ratio in scales compared to 
controls. Moreover, from day 5 onwards, Ca:P ratios were significantly lower com-
pared to controls for the duration of the experiment. Similar observations were made 
for the ontogenetic scales, sampled during scale regeneration on the opposing flank 
of the fish. Lowering of Ca:P ratios of biological apatites generally points towards al-
tered crystalline phase or an impurity, both of which make them less stable and more 
easy to dissolve by osteoclasts (Dorozhkin, 2007). We take our findings as addi-
tional evidence that (scale) mineralization is negatively affected by prednisolone. 
Responses of scale cells to prednisolone treatment were observed in ontogenetic 
scales already after one day. Increased expression was found for five bone related 
genes involved in osteoblast differentiation or bone resorption; clearly the high 
level of conservation in glucocorticoid signaling between fish and mammals also 
holds for bone physiology (Schaaf et al., 2009). Despite the short treatment time 
in terms of GIOP, this suggests that both osteoblasts and osteoclasts of zebrafish 
scales can elicit (quick) glucocorticoid responses.
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Prednisolone effects were more pronounced in regenerating scales. Osteoclast 
genes were well upregulated as a result of the prednisolone treatment, which was 
predicted since increased osteoclast activity is a hallmark of GIOP (Migliaccio et 
al., 2009; Moutsatsou et al., 2012). Strongest effects were found for genes encod-
ing proteins that function in matrix and mineral degradation, such as cathepsin k, 
mmp9. Highly similar up-regulations of these genes were also found in bones of 
prednisolone-treated mice (Yao et al., 2008). Note that in our study, mmp9 already 
increased during control regeneration since osteoclasts are involved in remodeling 
of the scale plate (de Vrieze et al., 2011). Based on our combined findings, this 
at least appears to take place independently of enhanced cathepsin k activity. 
In osteoporotic patients, increased serum markers of collagen degradation infer 
increased osteoclast activity (Brabnikova Maresova et al., 2013), as this cannot so 
easily be assessed on a cellular level. Zebrafish are too small to collect sufficient 
amounts of serum, but from the observed increased osteoclastic activity it may be 
anticipated that collagen degradation is increased. 
The expression pattern of phosphate/pyrophosphate homeostasis controlling 
entpd5 and enpp1 genes further substantiated the notion that mineralization in 
prednisolone-treated fish is affected. Enpp1 expression significantly increased 
in regenerating scales under prednisolone tonus, while entpd5a, in fish the only 
known osteoblast gene not expressed in dentition (Huitema et al,. 2012; personal 
communication), was not affected. The changes in balance between these two 
genes suggest increased generation of calcification-inhibiting pyrophosphates, 
which supports the notion of a hampered mineralization. In control conditions, 
enpp1 expression increased from day 6 on, when the first unmineralized osteoid of 
the basal plate appears in zebrafish and other cyprinids (unpublished observation) 
(Bereiter-Hahn and Zylberberg 1993). 
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Figure 5 (right page). Expression profiles of genes involved in bone formation during scale 
regeneration in control (grey) and prednisolone-treated fish (white). A sp7 (osterix); B runx2a 
(MASNS isoform); C collagen 1a; D entpd5a; E osteopontin (secreted phosphoprotein 1); F alkaline 
phosphatase; G osteocalcin (bgp; bone gla protein) and H glucocorticoid receptor, transcript 
variant a. Housekeeping gene-normalized results are expressed relative to the gene expression level 
found in ontogenetic scales (onto) of control fish. Data are expressed as 5-95 percentile box-plots; 
the horizontal line depicts the median of 5-8 replicates, means are indicated by the plus sign (+) 
in the box. Different letters indicate significant differences induced by scale regeneration in the 
untreated groups (compared to ontogenetic scales). Asterisks indicate significant differences as a 
result of prednisolone treatment, compared to untreated scales of the same age (* = P < 0.05, 
** = P < 0.01, *** = P < 0.001). 
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As prednisolone attenuates/inhibits osteoblast activity in mammals (Canalis et al., 
2007; Moutsatsou et al., 2012), we predicted that expression of osteoblast genes, 
such as collagen 1a, osterix, runx2a and osteocalcin, would be suppressed by pred-
nisolone. An up to 20-fold strong increase in those genes was seen in scales re-
generating under control conditions. Expression of osteocalcin, a marker of ma-
ture osteoblasts in mammals and zebrafish (Aubin et al., 1995; Knopf et al., 2011) 
increased towards the end of regeneration (not statistically significant), indicating 
that scale osteoblasts have matured. Small effects of prednisolone were found on 
the expression of osteoblastic genes, especially in the first days of regeneration 
(when their expression is highest in the control groups). In fact, at some time points 
expression of collagen 1a and runx2a increased rather than decreased. We take 
this as an indication that osteoblast activity is not directly inhibited after gluco-
corticoid treatment and attempts to keep up with the increased matrix resorption. 
Such a mechanism has been postulated before and can still result in a reduced 
bone mass (osteoporosis) as there is more bone degraded than formed (Bjarnason 
et al., 1998). Moreover, the 20-fold increase in osteoblast gene expression in our 
regeneration experiment may lower the resolution to detect inhibitory effects of 
prednisolone on osteoblasts. Although surprising, the negative effects of gluco-
corticoids on osteoblasts have mainly been described for long-term exposures. 
Indeed, increased osteoblast apoptosis is first measured in mammalian studies 
after 27 days of glucocorticoid treatment (Weinstein et al., 1998). Extensive gene 
expression profiling of long bones of prednisolone-treated mice demonstrated that 
most osteoblast genes were not significantly until 28 days of treatment (Yao et 
al., 2008). Expectedly, the observed decreases in osteoblast gene expression in 
mammals can be largely ascribed to a relative decrease in osteoblast number as 
a result of the increased apoptosis. Exposure in our experiment lasted three 
weeks, long enough for a scale to regenerate to its original size, but possibly too 
 short to observe negative effects on osteoblasts. One of the few short-term 
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Figure 6 (right page). Expression profiles of osteoclast marker and bone-inhibitory genes during 
scale regeneration in control (grey) and prednisolone-treated fish (white). A ctsk (cathepsin k); 
B tartrate resistant acid phosphatase (tracp); C mmp2; D mmp9; E rankl; F v-atpase; G sclerostin 
and H enpp1. Housekeeping gene-normalized results are expressed relative to the gene expression 
level found in ontogenetic scales (onto) of control fish. Data are expressed as 5-95 percentile box- 
plots; the horizontal line depicts the median of 5-8 replicates, means are indicated by the plus sign (+) 
in the box. Different letters indicate significant differences induced by scale regeneration in the 
untreated groups (compared to ontogenetic scales). Asterisks indicate significant differences as a 
result of prednisolone treatment, compared to untreated scales of the same age (* = P < 0.05, 
** = P < 0.01, *** = P < 0.001). 
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effects described on osteoblasts is increased RANKL secretion, which is part of 
the pivotal RANKL-RANK-OPG pathway involved in osteoclast activation (Hofbau-
er et al., 1999). A different study showed that prednisolone decreases RANKL ex-
pression in cultured osteoblasts (Humphrey et al., 2006). This was also observed in 
prednisolone-treated regenerating scales in terms of rankl gene expression, which 
coincides with the upregulation of other osteoclast markers. Unfortunately, no in-
formation could be obtained on the dominant negative soluble RANKL decoy re-
ceptor osteoprotegerin (OPG), as genomic information on its zebrafish orthologue 
is inconclusive. Overall, the typical phased gene expression profile that is charac-
teristic of scale regeneration is disturbed by prednisolone. The fine balance be-
tween bone cells has shifted towards increased and dominating osteoclast activity. 
conclusion
Our key findings of increased osteoclast activity and its reflection thereof on the 
mineralized layer of the scale follow the known mechanistics of (early) GIOP in 
mammals (Moutsatsou et al., 2012). The regeneration paradigm (rapid new forma-
tion of a bone plate) may be compared to bone repair (new formation), an aspect 
of bone physiology of which very little information exists in relation to GIOP (Cortet, 
2011). In itself, the scale regeneration process shows many similarities with bone 
formation/repair in higher vertebrates, both in chemical composition and in the 
expression of marker genes. Its response to glucocorticoid treatment is highly sim-
ilar to that seen in bone of mammals, resulting in increased osteoclast activity and 
poor bone regeneration. In addition, we show that osteoblasts are not immediately 
affected by prednisolone treatment, and can still cope with the challenge of scale 
regeneration during early GIOP. Already several papers addressed the conserved 
glucocorticoid system of zebrafish (Alsop and Vijayan, 2008; Schaaf et al., 2009) 
and now we show that glucocorticoid treatment results in a phenotype similar to 
(the early phase of) GIOP. This highlights zebrafish scale as a great model to study 
underlying mechanisms of GIOP in a bone tissue that is easily accessible. Their 
sensibility to glucocorticoids further confirms the potential application of scales in 
drug screening, for which we indeed currently have an assay in development.
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maTerials and meThods
experImental desIgn and anImal husbandry
Wildtype zebrafish (Danio rerio) were kept in groups of 8 fish in 2-L tanks at 26oC. 
Two separate recirculation systems, with a total volume of 32 L each were used 
to separately house control and prednisolone-treated fish. Each system contained 
8 tanks with predominantly males of approximately 0.4 g. Fish were fed once a 
day with flake food (Tetra, Melle, Germany). Scale sampling was done under mild 
anesthesia in 0.05% (v/v) 2-phenoxyethanol (Sigma-Aldrich). Fish were euthanized 
for final sampling in 0.1% (v/v) 2-phenoxyethanol. Experimental procedures were 
approved by the ethical committee of the Radboud University (RU-DEC 2008-099 
and RU-DEC 2011-012).
Prednisolone exposure was started one day prior to scale removal (day -1) via 
the addition of 25 μM prednisolone-21-phosphate (Fagron, Capelle a/d IJssel, The 
Netherlands, CAS nr: 125-02-0) to the water. One third of the water (with or with-
out prednisolone) volume was refreshed daily. On day 0, scale regeneration was 
induced by removal of 50 scales from the left flank of the fish. Ontogenetic scales 
were collected from two control and two prednisolone-exposed groups for analy-
sis. Subsequently, fish were sacrificed after 4, 5, 6, 8, 11, 14 and 21 days of regen-
eration. Both ontogenetic and regenerating scales were sampled for the analysis 
of mineral content and gene expression. On day 21, intact ontogenetic and regen-
erating scales were sampled for histochemical analyses. 
Our experiments showed that the mineral content of ontogenetic scales, sampled 
from fish with scales regenerating, did not differ from that of ontogenetic scales 
sampled at the start of the experiment (data not shown). This indicates that calcium 
balance of the fish was not at risk through removal of the 50 scales. Apparently the 
branchial and dietary calcium uptake compensated calcium lost by scale removal, 
which was also observed in goldfish (Yoshikubo et al., 2005). Thus, importantly, the 
experimental design did not influence calcium homeostasis. 
 
hIstochemIstry
For whole mount studies, scales were fixed in 4% paraformaldehyde in phosphate 
buffered saline (PBS) for 24 hours. Subsequently, samples were stained for activity 
of tartrate-resistant acid phosphatase (TRACP) and for presence of calcium phos-
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phates according to Von Kossa, as described in detail by de Vrieze et al. (2010). 
Morphometric analyses were done with Adobe Photoshop CS5.5®.
mIneral analyses
Ten scales were freeze-dried, subsequently dissolved in 200 μl nitric acid (65%); 
this solution was diluted 100x with MilliQ water. Total calcium, phosphorus and 
magnesium contents were measured with ICP-MS (inductively coupled plasma 
mass spectrometry; Thermo Fisher Scientific) after which the Ca:P molar ratio was 
calculated.
gene expressIon
The remaining scales were pooled per fish and used to determine gene expression 
profiles. Total RNA was isolated with Trizol (Invitrogen) according to manufacturer’s 
instruction. RNA preparations were treated with DNase I (Invitrogen). An output of 
500 ng was used for cDNA synthesis with Superscript Reverse Transcriptase II (In-
vitrogen) according to manufacturer’s instructions. The obtained cDNA was diluted 
20x in ultrapure water and used for quantitative PCR.
Quantitative PCR mix (25 µl) contained 1x Power SYBR® Green Mix (Applied Bio-
systems), 5 µl diluted cDNA and 5 µM of each primer, except for mmp-2 (2.5 µM 
forward and reverse primer). The primers used in this experiment are listed in sup-
plementary table 1. Before data analysis, dissociation curves were checked for 
specificity and primer efficiency was confirmed to be 2 ± 0.05. The Genorm algo-
rithm was used to select the three most stable housekeeping genes, viz. 40s, β-actin 
and elf1a and calculate the mean normalized expression of target genes (MNE) 
(Vandesompele et al., 2002). 
statIstIcal analysIs
Normal distribution of data was assessed by the D’Agostino & Pearson omnibus 
normality test. Normally distributed data were tested for significant differences 
using the Student’s t-test with Welch’s correction when variances were unequal. 
Not-normally distributed data were tested for significance of differences between 
means with the non-parametric Mann-Whitney test. Results from analysis of scale 
morphometry and mineral content were tested for interaction between pred- 
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nisolone treatment and scale regeneration by means of two-way ANOVA. Columns 
were compared to each other using the Bonferroni post-test. Statistical analysis 
of gene expression data was conducted on the mean normalized expression data 
also when set relative to control conditions. 
Table 1: Primer sequences of target genes used in quantitative PCR
 Gene Accession number Sequence (‘5-’3)
40s AY648802 FW: GTGTGGTGACCAAGATGAAGATG
RV:  ACGGTTGTACTTGCGGATGTAA
β-actin AF057040 FW: CAACAGGGAAAAGATGACACAGAT
RV:  CAGCCTGGATGGCAACGT
collagen 1a2 AJ318213 FW: GGAAACCTGAAGAAGGCTGTGT
RV:  TGAAAGTGAAGCGGCTGTTG
alkaline phosphatase (alp) NM_201007.1 FW: CAGTGGGAATCGTCACAACAA
RV:  CCACACAGTGGGCATAAGCA
sp7 (osterix) AY380818.1 FW: AAGAAACCTGTCCACAGCTG
RV:  GAGGCTTTACCGTACACCTT
runx2a MANSN-isoform AY508964.1 FW: CTCCCGCTTTAGGACTTCGA
RV:  GGAGTCACCGAGCTGAAAAGACT
cathepsin k (ctsk) BC092901 FW: CTATAAAGAGATTCCTCAGGGTAACGA
RV:  ACACGGGTCCCACATTGG
tartrate resistant acid phos-
phatase 5b (acp5b)
NM_001002452 FW: CGTCCACTGACCACAGGAAGA
RV:  AAGGATCCTGACGTCTGATTGA
v-ATPase (atp6v1aa) NM_201135 FW: CCCTACTGACTGGACAACGTGTAC
RV:  CTGGAATGGCAGTGGTTCCT
matrix metalloproteinase 9 
(mmp9)
NM_213123.1 FW: AAATCTGTGTTCGTGACGTTTCCT
RV:  GCCGTAACGCTTCAGATACTCAT
matrix metalloproteinase 2 
(mmp2)
NM_198067.1 FW: TTGCTTCCCTGCAAACTTTTG
RV:  GAGCCACTTCTTTGTCTGTGTGA
glucocorticoid receptor, 
transcript variant a
EF436284 FW: AACTGGCACGGTTCTATCAGCTCA
RV:  TTCTGGTGAAAGCAGCGG
rankl (tnfsf11) ZDB-GENE-090805-2 FW: CCAATCAAGACGCCCATAGACT
RV:  TCATGCCATCCCAGGCTATC
sclerostin (sost) ZDB-
GENE-110411-139
FW: CACAAACCCGAGGAGCAGATAC
RV:  CGTTCTTCGCCCGATTCA
osteocalcin NM_001083857.3 FW: TGGCCTCTATCATCATGAGACAGA
RV: CTCTCGAGCTGAAATGGAGTCA
osteopontin NM_001002308.1 FW: CGCTCAGCAAGCAGTTCAGA
RV: AGAATAGGAGGTGGCCGTTGA
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Chapter 7
a new tool in preclinical screeninG for 
osteoGenic compounds based on scales of 
sp7:luciferase zebrafish
Erik de Vrieze1
Jan Zethof1
Stefan Schulte-Merker2
Gert Flik1
Juriaan Metz1 
1 Department of Organismal Animal Physiology, Institute for Water and Wetland 
Research, Faculty of Science, Radboud University Nijmegen, Heyendaalseweg 135, 6525AJ, 
Nijmegen, The Netherlands
2 Hubrecht Institute, KNAW & UMC, Utrecht 3584 CT, The Netherlands 
EU patent filed: 28.11.2012, patent nr. EP12075131: A method to measure therapeutic effects 
of a compound on bone formation or degradation
absTracT
Interactions between all populations of bone cells and their extracellular matrix are 
of key importance in the maintenance of bone homeostasis. As a consequence, 
in drug design current models for bone diseases are limiting either in complexity 
(cell-based assays), or in compound throughput (animal-based experiments). We 
have developed and validated a model to screen large numbers of compounds 
combined with a high predictive value, based on scales of Sp7:luciferase zebrafish. 
Zebrafish are attractive model species in bone research as physiology and 
responses to (anti)osteogenic signals of their bone and scales are highly similar 
to mammalian bone. Our approach provides the assay with a quick and sensi-
tive readout, integrating the effects of various signaling pathways (e.g. WNT- and 
BMP-signalling) to expression of the transcription factor SP7, pivotal in osteo-
blast differentiation and activity. Sp7 is highly expressed in active osteoblasts of 
regenerating scales in vivo and expression can be initiated de novo within 36 
hours. Further validation was done with zebrafish Bmp-2a, which induced a dose- 
dependent increase in Sp7-driven luciferase activity ex vivo, and the screening of 
a small library of WNT-signaling modulators. We identified three compounds that 
stimulate luciferase activity: riluzole, genistein and niclosamide, the latter never 
associated before with bone formation. This underlines the ex vivo Sp7:luciferase 
zebrafish scale assay as a unique, powerful and efficient new tool that can sat-
isfy the needs for intermediate models, improve efficiency and reduce costs and 
experimental animals. 
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The initial step in the search for novel candidate drugs against bone diseases relies 
mainly on high-throughput screening (HTS). It aims to uncover new interactions of 
the compounds with carefully selected targets, either in protein-protein interaction 
assays or in cell culture systems (Auld et al., 2004; Roth et al., 2011; Calamini et al., 
2012). In the next step, positively identified, promising compounds are tested in 
models with increasing complexity such as bone explant cultures or in vivo animal 
studies. Despite the high-throughput pipeline, where a virtually unlimited number 
of molecules can be tested, the actual number of major new drugs that have ap-
peared on the market has declined over the years, while development costs have 
increased (DiMasi et al., 2003; Kaitin, 2010). To be competitive in today’s challeng- 
ing economic environment, it is paramount to reduce development time and cost 
by e.g. faster termination of unpromising candidates (Kaitin, 2010).
Particularly for skeletal pathologies (e.g. osteoporosis), receptor-based high- 
throughput screenings are considered limited models, as the interactions 
between bone-forming cells (osteoblasts) and bone-degrading cells (osteoclasts) 
are of vital importance, yet difficult to include (Rissanen and Halleen, 2010). The 
best-known example is the RANKL (receptor activator of nuclear factor κB ligand) 
signaling pathway, that includes a membrane-bound receptor on osteoclasts 
(RANK) and a soluble decoy receptor (OPG; osteoprotegerin) secreted by osteo-
blasts (Eriksen, 2010). Via this pathway, compounds proven to stimulate osteoblast 
activity in vitro may still end up having catabolic effects bone in vivo. 
Available models for bone diseases that do include cell-cell and cell-matrix inter-
actions are mainly rodent-based in vivo models or explant cultures. In vivo models 
include the drill-hole method where bone repair is induced in mice, or ovariectomy 
of rats to cause osteoporosis (Uusitalo et al., 2001); most widely applied ex vivo 
(explant) model is the fetal mice calvarial organ system (Wu et al., 2010). Both 
methods are commonly used, are certainly of great scientific value and supplement 
each other, not in the least since from both models strengths and weaknesses 
are widely recognized. Obviously, such studies are expensive and time-consuming 
and fall short when larger amounts of substances need to be tested. An inter- 
mediate model, which includes the vital osteoblast-osteoclast interactions, and 
at the same time can be combined with reasonable throughput, would drastically 
improve efficiency. 
117
The degree of conservation between mammalian and teleost bone is high in terms 
of development and control of major signaling pathways, which make (zebra)fish 
attractive in bone research (Renn et al., 2006; Apschner et al., 2011; To et al., 2012; 
Mitchell et al., 2013). In osteoporosis research, larval models may be less optimal as 
their skeleton is still under development and osteoporosis generally comes with age 
(and thus affects mature bone). Moreover, the presence of osteoclasts during the 
first stages of skeletal development that are generally investigated in larval studies 
is still under debate (Witten et al., 2001; Fleming et al., 2005). We have previously 
demonstrated that zebrafish scales can be useful models in bone physiology; 
they are abundantly available on a single species and highly similar to mam- 
malian bone in terms of matrix composition, associated cell types and underlying 
gene expression (de Vrieze et al., 2011; 2012; Metz et al., 2012; de Vrieze et al., 
2013). Although elasmoid scales are formed via intramembranous ossification and 
the long evolutionary distance between fish scales and the human endoskeleton 
is evident, various in vivo an ex vivo studies have illustrated that fish scales re-
spond to hormones and other substances as one would predict from literature on 
mammalian bone (e.g. Flik et al., 1986; Persson et al., 1994; Redruello et al., 2005; 
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n Human_SP7        1 MASSLLEEEVHYGSSPLAMLTAACSKFGGSSPLRDSTTLGKAG----TKKPYSVGSDLSA
Zebrafish_Sp7    1 MAASILEEETRYGSSPLAMLTATCNKFGSTSPVRDSATPGKPGSTIPIKKAYSMTSELQS
Human_SP7       57 SK-----TMGDAYPAPFTSTNGLLSPAGSPP-APTSGYANDYPPFSHSFPGPTGTQDPGL
Zebrafish_Sp7   61 AKNGRNESVADSYTGSFSSSGGLLTPTGSPPPAPTGAYGSEYNPFS-TFQTSSVSQDPSL
Human_SP7      111 LVPKGHSSSDCLPSVYTSLDMTHPYGSWYKAGIHAGISPGPGNTPTPWWDMHPGGNWLGG
Zebrafish_ p7  120 LGSK--ATADCLTSVNTYLDMTHPYGSWYKG-IHPGITASPANATSSWWDVHTNANWLSP
Human_SP7      171 GQGQGDGLQGTLPTGPAQPPLNPQLPTYPSDFAPLNPAPYP------APHLLQPGPQHVL
Zebrafish_Sp7  177 GQAQPDSLQAPLQPVAPQASLNPQMPSYTPDFTPLNPAPYPSVGLSSSSHLLQS-SQHML
Human_SP7      225 PQDVYKPKAVGNSGQLEGSGGAKPPRGASTGGSGGYGGSGAGRSSCDCPNCQELERLGAA
Zebrafish_Sp7  236 PQDMYKPKPVPTSGILDNSMGLKSAR-----GSGYAAGSTTGRSSCDCPNCQELERLGAS
Human_SP7      285 AAGLRKKPIHSCHIPGCGKVYGKASHLKAHLRWHTGERPFVCNWLFCGKRFTRSDELERH
Zebrafish_Sp7  291 AASLRKKPVHSCHIPGCGKVYGKASHLKAHLRWHTGERPFVCNWLFCGKRFTRSDELERH
Human_SP7      345 VRTHTREKKFTCLLCSKRFTRSDHLSKHQRTHGEP---GPGPPPSGPKELGEGRSTGEEE
Zebrafish_Sp7  351 VRTHTREKKFTCLLCNKRFTRSDHLSKHQKTHSEASLQGKEEPETRAEESSADKVAPAGS
Human_SP7      402 ASQTPRPSASPATPEKAPGGSPEQSNLLEI
Zebrafish_Sp7  411 EIGIQEPAVGGEEKSSTGNGVDSGSGLLEI
S
transactivation domain
transactivation domain
zincfinger domain
zincfinger domain
Figure 1. Amino acid sequence alignment of human and zebrafish SP7. Conserved amino 
acids are indicated in black and amino acids with conserved characteristics are indicated in grey. The 
transactivation domain is highlighted in blue and has a sequence conservation of 52%. The zincfinger 
domain is highlighted in red and has a sequence conservation of 92%. The alignment was calculated 
with ClustalW2 and the image was generated with BoxShade 3.21. Domains are based on the human 
SP7 (Hatta et al., 2006).
7
Yoshikubo et al., 2005; Rotllant et al., 2005; Suzuki et al., 2011a). The use of cul-
tured scales (with associated osteoblasts and osteoclasts) is highly advantageous 
since scales are small, independent pieces of dermal bone, by far more natural 
than any other assay based on (co-)cultured cell lines (Metz et al., 2012). Moreover, 
an ex vivo assay based on scales would benefit from having both osteoblasts and 
osteoclasts on their original matrix, which warrants interactions between these cell 
types and the matrix. 
In the present study, we have developed and validated the zebrafish scale model 
for quick and sensitive ex vivo testing of large numbers of compounds. Genera-
tion of Sp7:luciferase transgenic fish provided us a readout that is highly sensitive 
and more suitable to analyze large number of samples than previously described 
assays. SP7 (previously known as Osterix) is a transcription factor that plays a 
pivotal role in the differentiation and activity of osteoblasts (Nakashima et al., 2002; 
Matsubara et al., 2008). Conservation of the zebrafish and human SP7 protein 
sequence is high, especially in the zincfinger domain (92%), which targets the 
DNA regions for transcriptional regulation (figure 1). SP7 functions downstream of 
Runx2-regulated transcription of e.g. osteocalcin and collagen1a, two vital compo-
nents of bone matrix, and alkaline phosphatase activity (Nakashima et al., 2002; 
Matsubara et al., 2008). Given the role of SP7 in osteoblasts, we hypothesize that 
effects can be measured shortly after compound treatment. Moreover, use of Sp7 
promoter activity allows us to integrate various regulatory mechanisms in bone 
physiology, such as BMP- and WNT-signaling, of which the latter is now regarded 
as the most promising target for therapeutics (Baron and Hesse, 2012). 
resulTs
Fluorescence microscopy through the skin of intact Sp7:NLS-GFP zebrafish re-
vealed expression of the Sp7 transcription factor in osteoblasts that reside on 
the inner, hyposquamal side of the zebrafish scales (figure 2). Newly formed, 2- 
to 7-days-old regenerating scales had a considerably higher fluorescent intensity 
than ontogenetic (original) scales (figure 2). Some scales appeared to have lost 
unintentionally (possibly a result of handling). In ontogenetic scales, the growing 
edges showed increased fluorescence (figure 2B). Expression of GFP was low in 
osteoblasts of ontogenetic scales and GFP proteins were mainly localized in the 
nucleus (as a results of the nuclear localization signal; NLS) (figure 2C). Thirty six 
hours after scale removal, the first appearance of fluorescence, indicative of newly 
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Figure 2. Whole mount (A, B, D and E) and ex vivo (C and F) fluorescent images of scales of 
Sp7:NLS-GFP zebrafish of approximately 4 cm standard length. A Seven days after removal of 
8 scales from the right flank of the fish, newly-formed scales show intense fluorescence (in dashed 
box). Note that there are more scales with high intensity, which had not been experimentally removed. 
B Detail of (partly overlapping) ontogenetic scales embedded in the skin. Fluorescence is more intense 
around the edges of the scale (arrows) where growth occurs by appositional bone formation. Bar = 800 
μm. C Detailed image of scale osteoblasts on the hyposquamal side of an isolated ontogenetic scale. 
Nuclear GFP concentrates in the nucleus, but also found along cytoskeletal structures. Image was taken 
with an exposure time of 6 seconds. Gaps between cells are artifacts resulting from scale handling 
and mounting on microscope slides. Bar = 15 μm. D First appearance of Sp7 positive osteoblasts in 
regenerating scales in vivo (indicated by arrows) at 36 hours after scale removal. Bar = 800 μm. E Image 
of 48 hours regenerating scales showing the substantial rate at which the scale grows.  Bar = 800 μm. 
F Detailed image of scale osteoblasts on an isolated 6-day-old regenerating scale. Cells are more cubic 
in shape. Intense expression of GFP in these cells is evident from similar fluorescent intensity between 
nuclei and cytoplasm, and from the exposure time of 200 milliseconds (vs. 6s for ontogenetic scales). 
Gaps between cells are artifacts resulting from scale handling and mounting on microscope slides. Bar 
= 15 μm.
A
B C D
E F7
differentiated (Sp7-positive) osteoblasts was seen in the scale pocket (figure 2D). 
Earlier time points did not reveal GFP-positive cells in the (emptied) scale pocket 
(data not shown). The growth and shaping of the new scale could clearly be ob-
served in 48 hours-regenerating scales (figure 2E). GFP fluorescence in osteo-
blasts of 6-day-old regenerating scales was more intense compared to osteoblasts 
of ontogenetic scales and was equally distributed between nucleus and cytoplasm 
(figure 2F). Shorter exposure time was required to obtain images of regenerating 
scales; only 200 milliseconds compared to 6 seconds for ontogenetic scales.
Luciferase activity was measured in ontogenetic and regenerated scales taken 
from Sp7:luciferase fish. Luciferase activity in ontogenetic scales well exceeded 
background noise (figure 3A). Luciferase activity in regenerating scales increased 
significantly; approximately 100-fold. A similar increase was found in sp7 gene 
expression (figure 3B), which establishes the readout of luciferase as measure of 
Sp7 promoter activity. 
First step in setting up the ex vivo scale assay for compound screening was the op-
timization of the culture conditions. Comparison of different culture media, based 
on previous reports on cultured fish scales and osteoblasts (Koumans and Sire, 
1996; Suzuki et al., 2000; Pombinho et al., 2004), revealed the highest luciferase 
activity in scales cultured in osteogenic DMEM, which apparently best sustains 
scale-cultures (figure 4A). This was verified by microscopic observations of cell 
morphology, apoptosis and necrosis, using scales of Sp7:NLS-GFP zebrafish (data 
not shown). The formulation of osteogenic DMEM was further optimized by varying 
concentrations of calcium, ascorbic acid and serum (figure 4B-D). The concentra-
tion of calcium in the culture medium did not affect luciferase activity (figure 4B), 
while omission of ascorbic acid increased luciferase activity (figure 4C). Addition 
of 2% - 10% serum to the scale culture greatly improved cell viability (figure 4D). 
Based on the results obtained, all further experiments were conducted with the 
formulation described in the Materials and Methods section. 
Exposure of scales taken from Sp7:luciferase fish to recombinant zebrafish BMP-
2a resulted in a dose-dependent and significant increase in luciferase activity after 
72 hours, but not after 48 hours of culture (figure 4E, F). For proof-of-principle, we 
screened a small library of compounds known to interact in WNT-signaling. We 
applied only a single concentration of each compound (10 μM) for an exposure of 
48 hours. Table 1 shows the average induction or inhibition of luciferase activity 
relative to DMSO controls. Subjectively, we only accepted compounds to have an 
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effect if increased (> 1.25) or decreased (< 0.75) luciferase activity was consistently 
found (i.e. in at least 3 instances out of a total of 4 replicates). This yielded us three 
compounds to stimulate luciferase activity: riluzole, niclosamide and genistein. 
Compounds leading to an increase in one scale, but no response or a decrease in 
another in some cases stimulated luciferase activity on average. Apigenin, sulindac 
and celecoxib are examples of this. Fifteen compounds consistently decreased 
luciferase activity; the other compounds had no effect at the concentration and 
exposure time tested.
To further establish specificity and reproducibility of the ex vivo scale assay, we 
selected the three positively identified compounds, two compounds without effect 
and one inhibitory compound and retested them at three different concentrations 
(figure 5). Riluzole and niclosamide induced a dose-dependent increase in lucifer-
ase activity (figure 5A, B), while genistein decreased luciferase activity at the lowest 
concentration tested (figure 5C). Pyrvinium pamoate and GW9662, non-responsive 
in the first compound screening, had no effect at any of the concentrations tested 
(figure 5D, E). BML285 was initially identified as an inhibitor and this effect was only 
found in the retrial at 100 μM, albeit statistically not significant (figure 5F).
discussion
We here present a new and easily applicable ex vivo model, based on scales of 
Sp7:luciferase transgenic zebrafish to quickly screen the osteogenic potential of 
compounds on complete bone samples. Our major findings include validation of 
the assay and high degree of similarity with mammalian bone in terms of osteoblast 
(luciferase) activity to known substances. The proposed scale assay combines 
complexity of explant culture (cell-cell and cell-matrix interactions are preserved) 
with potential of medium throughput (i.e. hundreds of compounds per week). As 
such we envisage the current assay between cell-based assays and rodent-based 
explant cultures to preselect only the most promising compounds for further test-
ing. Not only can this approach speed up current drug discovery procedures, also 
it may reduce the use and discomfort of laboratory animals.
The idea to use of (zebra)fish scales to investigate osteoblast and/or osteoclast 
biology is not new per se and indeed brings many advantages (e.g. Suzuki and 
Hattori, 2003; Redruello et al., 2005; Suzuki et al., 2011a; Pasqualetti et al., 2012a). 
Cultured scales are in fact complete bone units, and include endogenous osteo-
blast-osteoclast interactions and cell-matrix interactions, which is the foremost 
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advantage when compared to cell culture-based assays. The here presented 
Sp7:luciferase transgenic zebrafish allows for highly sensitive measurement of 
osteoblast activity on living, isolated scales. The Sp7 promoter driving luciferase 
expression was selected to yield integrative information on osteoblast signaling 
pathways; in mammalian osteoblasts SP7 has been shown to play a central role 
in regulation of osteoblast activity and differentiation (Nakashima et al., 2002). SP7 
has been shown to stimulate gene expression of e.g. alkaline phosphatase, bone 
sialoprotein, osteocalcin, and collagen 1a in osteoblast cell-lines and in primary 
cultures (Matsubara et al., 2008; Peng et al., 2013; Ortuño et al., 2013; Okamura et 
al., 2013). Furthermore, Sp7-null mice have dramatically decreased bone mineral 
density (BMD), bone formation rate and decreased expression of osteocalcin (Baek 
et al., 2009). Indeed in zebrafish, sp7 expression is exclusively found in bone- 
forming cells (Spoorendonk et al., 2008). 
We further demonstrated that sp7 expression is highly increased during regen- 
eration of a new scale. The increase in sp7 expression was indeed detected with 
luciferase measurements of scales from sp7:luciferase fish, which shows that 
123
sc
re
en
in
G 
fo
r 
os
te
oG
en
ic
 c
oM
po
un
ds
 w
it
h 
sp
7:
lu
ci
fe
ra
se
 sc
al
es
Figure 3. A Enzymatic luciferase activity measured in individual ontogenetic and regenerating scales of 
Sp7:luciferase transgenic zebrafish.  Luciferase was measured directly after scales were sampled from 
the skin was approximately 100-fold increased in regenerating scales compared to ontogenetic scales. 
b) Expression of the sp7 gene, assessed by real-time quantitative PCR. Comparable to the luciferase 
measurement, sp7 expression was increased in regenerating scales compared to ontogenetic scales. 
Lines represent means of the individually plotted values (n=8-12; *** P < 0.001, Student’s t-test).
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enzymatic activity luciferase correlates to the actual expression of the sp7 gene. 
Sp7-positive cells can already be observed 36 hours after induction of scale re-
generation, from which we conclude that the Sp7 promoter can respond quickly to 
stimuli that induce bone formation. Once the regenerating scale has grown to its 
original size, and further growth occurs only at the edges when the fish grows, sp7 
expression is attenuated (de Vrieze et al., 2013). Thus the scale model offers the 
opportunity to study both highly active bone (e.g. to resemble ontogeny or bone 
repair) and existing bone with moderate activity. 
We carefully optimized culture conditions and assay procedures and obtained the 
best results with the addition of luciferin directly to the culture medium; this allows 
for measurement before and after exposure to the compound(s) of choice and in 
this way each scale serves as its own control. Pasqualetti and coworkers (2012b) 
described that zebrafish scale cells gradually lose morphology and organization, 
and have shown increased apoptosis after 72 hours of culture. However, since Sp7 
promoter activity can be activated within 36 hours (as during scale regeneration), 
the assay proposed here aims at identifying osteogenic effects between 36 and 72 
hours of culture. 
For assay validation we tested Bmp-2a, the biologically active ortholog of mam-
malian BMP-2, a potent inducer of osteoblast differentiation and SP7 signaling 
(Matsubara et al., 2008). In the ex vivo scale assay Bmp-2a significantly stimulated 
luciferase activity after 72 hours, a  time frame similar to that of mammalian osteo- 
blasts and mesenchymal stem cell cultures (Rawadi et al., 2003; Matsubara et al., 
2008). PTH(1-34) (teriparatide; brandname Forteo®) is the only FDA-approved ana-
bolic drug therapeutically used tot treat osteoporosis (Kaback et al., 2008; Mazziot-
ti et al., 2012). The N-terminal region is well conserved from fish to mammals 
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Figure 4. A Comparison of luciferase activities of scales cultured for 48 hours in different media com-
monly used for fish scales and osteoblasts. Nine different compositions were tested (L15 in combina-
tion with a low or high dose of dexamethasone; dex low, 10 nM; dex high, 100 nM; L15 prep, a special 
preparation of L15 for fish scale culture (Koumans and Sire, 1996). N.D., not detectable. B No differenc-
es in luciferase activity were found between the three calcium concentrations tested. C Ascorbic acid is 
one of the supplements of oDMEM, yet luciferase activity was found to be higher without ascorbic acid 
supplementation. D Effects of different concentrations of fetal calf serum on luciferase activity. Omission 
of serum, or addition of only 1%, results in significantly lower luciferase activity compared to 2%, 5% 
and 10% supplementation. E, F Effects of known the osteogenic peptides Bmp-2a on luciferase activity 
in ex vivo cultured scales of sp7:luciferase transgenic zebrafish. Zebrafish Bmp-2a was applied contin-
uously for 48 hours (E) and 72 hours (F). Clearly, a concentration-dependent stimulating response was 
found in the 72-hours treated scales. Data are expressed as mean ± SD of 8 replicates. Scales where 
luciferase could not be measured were omitted from the analysis in (A). Top letters indicate groups 
between which a significant difference exists (One-way ANOVA). 
7
and it has previously been shown that human and fugu PTH can elicit similar anabolic 
responses of the fish skeleton (Fleming et al., 2005; Suzuki et al., 2011a). Remarkably, 
PTH(1-34) downregulates SP7 expression when administered to cultured osteo-
blasts and calvaria (Hong et al., 2009; Barbuto and Mitchell, 2013), suggesting that 
SP7 mediates the catabolic effects of PTH to maintain calcium homeostasis. The 
therapeutic effects of PTH(1-34) are ascribed to a RUNX2 mediated increase of 
osteoblast lifespan and is likely independent of PTH (Kaback et al., 2008; Yamane 
et al., 2009). Nevertheless, human PTH(1-34) was administered to cultured scales in 
a pilot experiment, and only appeared to stimulate luciferase activity after a single 
pulse (data not shown). Even though PTH is a negative regulator of SP7 expression, 
future experiments may provide better insight in the effects of PTH on zebrafish 
scales and their similarities with mammalian bone. From the stimulatory effect of 
zebrafish Bmp-2a we conclude that the proposed zebrafish Sp7:luciferase scale 
model has predictive value to evaluate osteogenic actions of compounds.  
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Table 1. Average induction or inhibition of luciferase activity relative to DMSO controls. Positive effects are 
indicated with green arrows, negative effects are indicated with red arrows. Effects were subjectively ac-
cepted when an increased (> 1.25) or decreased (< 0.75) luciferase activity was consistently found (i.e. in 3 
either 4 instances out of a total of 4 replicates). 
7
Compound name effect Compound name effect Compound name effect
Sulindac 1,62 Retinoic acid 0,95 kenpaullone 0,77
Celecoxib 1,58 BML286 0,95 Deoxycholic acid 0,76
Niclosamide 1,56 Carnosol 0,94 Val-Val-Val 0,75
Thalidomide 1,51 QS-11 0,93 NCI16221 0,75
Riluzole 1,42 BIO 0,93 EGCG 0,73
Genistein 1,39 GW9662 0,92 Busutinib 0,72
Apigenin 1,38 Rosiglitazone maleate 0,92 SB-216763 0,71
PP2 1,35 WAY-262611 0,92 FH-535 0,71
Ellagic acid dihydrate 1,29 Pyrvinium pamoate 0,91 Quercetin 0,68
Sulindac Sulfide 1,28 Reservatrol 0,91 ICG-001 0,66
3253-5986 1,25 IWP-2 0,90 Gallic acid 0,65
Diclofenac.Na 1,20 XAV939 0,88 NO-ASA 0,64
5-Aza-2-deoxycytidine 1,20 PGE2 0,87 Troglitazone 0,64
AR-A014418 1,17 TNP-470 0,86 TWS-119 0,62
IQ1 1,17 Purpurogallin 0,85 DHA 0,61
IWR-1 1,15 Curcumin 0,85 D4476 0,60
JS-K 1,13 Cardamomin 0,83 sodium valprolate 0,58
CHIR99021 1,08 Hexachlorophene 0,82 LY456236.HCL 0,53
Box5 1,07 Pterostilbene 0,81 BML285 0,52
foxy-5 1,04 Bafilomycin A1 0,81 Harmine.HCl 0,44
imatinib mesylate 1,01 (-)-Terreic acid 0,80 Trichostatin A 0,31
IM-12 1,00 PNU-74654 0,80 Doxorubicin.HCL 0,25
Usnic Acid 0,99 Exifone 0,79 diarylsulfonesulfonamide 0,19
EPA 0,99 anandamide 0,78
CCT036477 0,96 BML-284 0,77
Favanone 0,96 Forskolin 0,77
Table 1. Osteogenic effect f substances involved in th  WNT-signaling pathway. Red arrows indicates a negative ffect 
(4 decreases or 3 de reases and one neut al ffect). Green arrows indicate a positive effect (4 i creases or 3 i creases 
and one neutral effect).
BMP-2 (and PTH(1-34)) can modulate osteoblast activity via the WNT-signaling 
pathway (Rawadi et al., 2003; Jilka, 2007; Crockett et al., 2011) which is currently 
regarded as the most promising target in the search for therapeutics, yet due to 
its ubiquitous role preferably targeted indirectly (Enders, 2009; Baron and Hesse, 
2012). A small, commercially obtained library of compounds that regulate WNT- 
signaling was screened in the scale assay for potential osteogenic effects. With 
the subjective criteria adopted to designate positive, neutral or negative effects 
in the initial compound library screening, the amount of false positives was low. 
Stimulatory effects of the three positive hits from the screening could be replicated. 
Numerous inhibitory compounds were identified from the library, which comes as 
no surprise since the majority of compounds in the library are known as inhibitors 
of Wnt-signaling. For instance, sodium valproate, a compound previously reported 
to decrease bone mineral density (Kafali et al., 1999), decreased luciferase activity 
in scales. 
The three osteogenic compounds identified initially from the Wnt-signaling library 
(retested dose-dependently) genistein, riluzole and niclosamide, have been poorly 
addressed in relation to bone physiology or disease. Genistein is a phytoestrogen 
that can activate estrogen receptors (ERα and ERβ) and has been previously 
suggested as a possible (natural) therapeutic (Kuiper et al., 1998; Yamaguchi 
and Weitzmann, 2009; Banu et al., 2012). In previous studies, genistein has been 
demonstrated to stimulate osteoblast differentiation in bone marrow cultures and 
to change the RANKL/OPG balance that subsequently lead to attenuated osteo-
clast activity (Chen et al., 2003; Liao et al., 2007). Riluzole is a known inhibitor 
of glutamate release at central synapses, used to slow the progression of amyo- 
trophic lateral sclerosis (ALS) (Bellingham, 2011; Lacomis and El-Dokla, 2013). 
Inhibitory effects on both osteoblast and osteoclast activity have been previously 
ascribed to riluzole, but experiments were only done on monocultures of osteo-
blasts and osteoclasts (Chenu et al., 1998; Genever and Skerry, 2001). The positive 
identification of riluzole by our ex vivo scale assay (which includes osteoblasts and 
osteoclasts attached to their original matrix) highlights the need for such complex 
models to identify the net effect of compounds on bone. No effects on bone have 
so far been described for niclosamide, and antihelmithic drug that was here iden-
tified as a stimulator of luciferase activity (and thus scale sp7 expression). Future 
studies will provide more insight in the osteogenic potential of this compound.  
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Niclosamide
conclusion
The newly established zebrafish Sp7:luciferase scale model appears promising in 
evaluating osteogenic potential of compounds. Since scales are complete bone 
units, the obtained results will have high predictive value of their in vivo effect when 
compared to those obtained from bone cell (mono)cultures. Testing can be per-
formed within 2 days and combined with automated scale and liquid handling; as 
such a throughput of hundreds of compounds per week can easily be achieved. 
The ex vivo Sp7:luciferase zebrafish scale assay is a unique, powerful and efficient 
addition to existing assays available for drug screening. It can satisfy the need for 
intermediate models to improve efficiency and reduce both costs and experimental 
animals. 
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maTerials and meThods 
fIsh husbandry
Zebrafish were kept at 27oC in a recirculation system (Aqua Schwarz, Göttingen, 
Germany) at a maximum density of 20 fish per 2-liter tank. Fish were fed twice a 
day brine shrimp nauplii and commercial flake food (Tetra, Melle, Germany). Larvae 
were raised according to general procedures (Westerfield, 2010). Fish were sub-
sequently introduced in the recirculation system and fed protozoans (Tetrahymena 
sp.) until old enough for brine shrimp nauplii. All experimental procedures were 
approved by the animal ethics committee of the Radboud University Nijmegen 
(RUDEC2010-105; 2012-105). 
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Figure 5 (left page). Concentration-response analyses of selected compounds after 48 hours of 
culture. Positively identified compounds in the first trial A Riluzole and B Niclosamide concentration- 
dependently stimulated luciferase activity, while C genistein, decreased luciferase activity at 1 μM. 
Compounds without effect in the initial screen D Pyrvinium pamoate, E GW9662 and F BML-285 also 
had no effect when retested at three different concentrations. Bars represent the means ± SD of 8 repli-
cate measurements, expressed to their respective DMSO controls. Top letters indicate groups between 
which a significant difference exists (One-way ANOVA).
7
mIcroscopy
Scales of Tg(Ola.Sp7:NLS-GFP)zf132 fish were cultured in clear 48-well micro-
plates to asses effects of culture time and medium composition on cell health. 
Apoptosis and necrosis were visualized on cultured scales with a GFP-certified 
apoptosis/necrosis detection kit for microscopy (Enzo Life Sciences). Fluorescent 
imaging was done with a Leica TCS SP2 AOBS confocal laser-scanning micro-
scope (Leica-microsystems, Mannheim, Germany). 
Whole mount imaging of (regenerating) scales in the skin was done on a sedated 
fish (0.1% 2-phenoxyethanol via the water), with a Leica MZFLIII fluorescent stereo- 
scope. Twelve separate pictures were taken to cover the full body size of the fish, 
and stitched to one figure with Adobe Photoshop® CS5.1. 
gene expressIon analysIs
To determine gene expression levels of sp7, a total of 20-40 scales were pooled 
per fish. Total RNA was isolated from the scales using Trizol (Invitrogen, Carls-
bad, USA) according to manufacturer’s instruction, and subsequently treated with 
DNase I (Invitrogen). An output of 500 ng was used for cDNA synthesis with Super- 
script Reverse Transcriptase II enzyme (Invitrogen) according to manufacturer’s 
instructions. Thus obtained cDNA was diluted 20x in ultrapure water and used for 
quantitative PCR. Quantitative PCR mix (25 µl) contained 1x Power SYBR® Green 
Mix (Applied Biosystems, Foster City, USA), 5 µl diluted cDNA and 5 µM of forward 
(5’-AAG AAA CCT GTC CAC AGC TG-3’) and reverse (5’- GAG GCT TTA CCG TAC 
ACC TT-3’) primer. For downstream RT-PCR efficiency calculations, two-fold serial 
dilution (1000ng – 62.5ng) was prepared from pooled total RNA. No amplification 
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Figure 6. Map of the Tol2 Sp7:luciferase construct for transgenesis. Restriction sites between 
which the luciferase gene was cloned are highlighted in red. The construct was based on the Sp7:NLS- 
GFP in pDB739 mini Tol2. Note that the sizes of elements are arbitrary.
7
control (NAC) and no template control (NTC) were included in each plate to ensure 
absence of genomic contaminations in samples and/or reagents. Expression levels 
were calculated with the GeNorm algorithm (Vandesompele et al., 2002), relative to 
an index of the housekeeping genes 40s (5’- GTG TGG TGA CCA AGA TGA AGA 
TG-3’ and 5’- ACG GTT GTA CTT GCG GAT GTA A-3’) and β-actin (5’- CAA CAG 
GGA AAA GAT GAC ACA GAT-3’ and 5’-  CAG CCT GGA TGG CAA CGT-3’). 
generatIon of stable transgenIc sp7:lucIferase zebrafIsh 
The Tg(Ola.Sp7:luciferase) construct (figure 6) for transgenesis was based on that 
of Tg(Ola.Sp7:NLS-GFP) fish (Spoorendonk et al., 2008), generated by Renn and 
colleagues (Renn and Winkler, 2009). The NLS-GFP gene was first removed from 
the vector with restriction enzymes BamHI and NotI. The vector was subsequently 
purified by agarose gel electrophoresis and gel extraction (QIAEXII, Qiagen, Hilden, 
Germany). The luciferase gene was amplified from a pGL3 basic vector (Promega, 
Madison, USA) with the primers 5’-ATA GTT TAG CGG CCG CCG GAT CCT TAT 
CGA TTT TAC CAC-3’ (containing a NotI recognition sequence) and 5’-CGT GCT 
AGC CCG GG-3’. The obtained fragment was purified, digested with restriction 
enzymes BglII and NotI, and subsequently ligated in the BamHI and NotI sites of 
the digested Sp7 transgenesis vector with T4-DNA ligase (Promega).
The obtained vector was amplified in competent E. coli (TOP10; Invitrogen, Carls-
bad, USA) and purified according to standard procedures supplied by the manu-
facturer. A volume of 1 nanoliter containing 25 picogram Sp7:luciferase construct 
and 25 picogram transposase mRNA was micro-injected according to standard 
procedures (Suster et al., 2009). Fish were reared to adulthood, genotyped and 
tested for germline transmission of the construct. Two rounds of outcrossing were 
performed to obtain a stable transgenic F2 generation, which were used for to 
perform the experiments. 
scale culture
Adult transgenic fish were mildly anesthetized in 0.05% 2-phenoxyethanol (Sigma 
Aldrich, St. Louis, USA). Scales were removed with a watchmaker’s forceps under 
a dissection microscope and immediately distributed over 96-wells luminometer 
plates with culture medium. Scales were cultured individually in medium pur-
posely selected to maintain bone cells of fish (Pombinho et al., 2004), consisting 
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of standard Dulbecco’s Modified Eagle Medium without phenol red (DMEM; Invitro- 
gen), containing 2% penicillin/streptomycin, 10% bovine calf serum (BCS; Hyclone, 
Thermo Fischer Scientific, Waltham, USA), 10 mM beta-glycerophosphate and 4 
mM calciumchloride. Zebrafish recombinant BMP-2a was obtained from R&D Sys-
tems (cat. #111-BM-010; R&D Systems, Minneapolis, USA). 
compound screenIng protocol
Baseline luciferase activity was measured in each individual scale by addition D- 
luciferin (Biosynth, Staad, Switserland) in culture medium to a final concentration 
of 2 mM. Plates were incubated for 5 minutes with luciferin after which the acti- 
vity was measured in a Wallac Victor multilabel counter (PerkinElmer, Waltham, 
USA) for 5 seconds per well, measuring each plate 3 times. Ninety (90) minutes 
after luciferin was added, luciferin-containing medium was removed and scales 
were washed carefully with 200 μl culture medium. After 5 minutes, medium was 
replaced again with fresh medium to which compounds of interest were added. 
Scales were cultured at 28.5oC, depending on the experiment up to 72 hours. 
Culture medium was refreshed daily in experiments with peptides or hormones, 
and left undisturbed for small molecules. End-point luciferase activity measure-
ment was done accordingly to the initial measurement. For each individual sample 
background (no scale control) was subtracted and end-point measurement was 
calculated relative to initial activity.
Compounds from a commercial WNT-signaling pathway library (Enzo Life Sciences, 
Antwerp, Belgium) were supplied in DMSO and tested after 48 hours of incubation, 
at a concentration of 10 μM on 4 replicate scales taken from 2 different fish, in 
separate experiments with no-compound and DMSO controls. 
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Chapter 8
synthesis
The fish scale, widely believed to primarily protect the fish (nl.wikipedia.org 2013), 
has in fact more physiological relevance than generally appreciated. In this thesis, 
elasmoid scales of bony fish1 (Osteichthyes) are studied in the context of their dy-
namic contribution to the physiology of the fish skeleton. In bone research, model 
systems that can (partly) replace existing rodent models are highly desirable. The 
use of (zebra)fish scales as an alternative model is explored in this thesis, leading 
to the presentation of a directly applicable model for drug discovery in chapter 7. 
The long evolutionary distance between fish scales and the human endoskeleton2 
is however evident. Although scientifically the term “bone” includes all intentionally 
calcified connective tissues of the vertebrate skeleton (Lawrence, 2008), and thus 
also fish scales, it is used in popular language to refer to endoskeletal bone (e.g. 
long bones). Scales are part of the dermal skeleton, which becomes strongly 
reduced in mammals. Here, we discuss ample evidence supporting a niche for the 
scale model in bone research. To fully appreciate the zebrafish scale as such, it 
is essential to first review the evolution of the mineralized skeleton, where dermal 
scales appeared before a mineralized endoskeleton (Donoghue et al., 2006). 
8
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1 Bony fish:  taxonomic superclass of fish with a skeleton made of bone, as opposed to cartilaginous 
skeletons of e.g. sharks and rays. The majority of species within this superclass (ca. 27.000), including 
popular fish species in bone biology, belong to the infraclass teleostei (teleosts or teleost fish).
2 Endoskeleton: vertebrate skeletal system that forms merely from mesenchyme (Hall, 2005). This 
includes the vertebral column (axial skeleton) and the bones of extremities (appendicular skeleton). The 
endoskeleton can be formed via all ossification modes.
on The origin of bone and scales 
Mineralization of biological tissues has arisen independently in a great number of 
invertebrate and vertebrate lineages during the Cambrian explosion (Ascenzi et 
al., 1983; Donoghue and Sansom, 2002; Killian and Wilt, 2008; Falini and Fermani, 
2004). It is clear that biomineralization triggered the evolution of the skeleton, but 
many different theories exist on its exact origin. These theories can be divided in 
two categories reviewed by Donoghue and Sansom (2002). Physiology-based hy-
potheses argue that the skeleton arose from a physiological role in ion regulation 
(e.g. a storage site for calcium and phosphate ions or scarce trace elements (Pau-
tard, 1961; Northcutt and Gans, 1983). Functionality-based hypotheses suggest 
that the skeleton evolved to protect the fish from predators, to house (and en-
hance) electroreceptive organs or a combination of both (Romer, 1933; Thomson, 
1977; Northcutt and Gans, 1983). 
The earliest appearance in phylogeny of a mineralized structure in the extinct cono-
dont lineage rejects all these hypotheses, including the commonly believed protec-
tive function. Conodonts possessed a complex set of mineralized teeth, skeletal 
elements that point towards an adaptation for feeding and predation (Donoghue 
and Sansom, 2002). However, the homology of conodont and vertebrate skeletal 
tissues has long been the subject of controversy (Blieck et al., 2010; Turner et al., 
2010; Murdock et al., 2013). Recent insights regard the mineralized conodont teeth 
as a remarkable instance of evolutionary convergence (Murdock et al., 2013). For 
this reason, the origin of the mineralized vertebrate skeleton may remain obscure 
forever. It is however evident that it resulted in a cellular program to synthesize 
mineralized tissues. With further vertebrate evolution, the ability of skeletal cells 
(scleroblasts) to modulate their synthetic activity and ectopic activation of skeleto-
genic pathways allowed the skeleton to evolve new structures in response to new 
and local environmental demands (Sire, 2001; Hall, 2005). Functions that the skele-
ton has today, such as protection, support and storage of calcium phosphate ions, 
were only made possible through generation of strong, calcified tissues, and are, 
as such, regarded exaptations of the first skeletal elements (Gould and Vrba, 1982). 
phylogeny of scales
First evidence of scale-like structures was found in the polyphyletic group of os-
tracoderms, that possessed an exoskeletal armor covering the head and trunk 
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(Sire et al., 2009; Shimada et al., 2013). This exoskeleton3  is retained in teleost fish 
in the form of dermal scales and fin rays, the postcranial part of the dermal skele-
ton (Sire and Huysseune, 2003). With the colonization of the land, the exoskeleton 
was drastically reduced or even lost in the trunk region and the mesoderm-derived 
endoskeleton became the major support structure (figure 1; Shimada et al., 2013). 
The oldest ostracoderm fossils with a mineralized exoskeleton that contains actual 
bone4, are pteraspidomorphi, jawless vertebrates that lived from the early Ordovi-
cian to the late Devonian (~460–375 Mya). Their typical exoskeleton comprised two 
or more large skeletal plates (shields) covering the head and thorax, while small 
overlapping scales covered the rest of their body. Shields and scales consisted 
of thick acellular bone plates ornamented with tooth-like tubercles (Sansom et 
al., 2005). The central region of these bone plates (aspidin) resembles cancellous 
bone, the basal region (isopedin) is similar to the organization of lamellar bone 
(Donoghue and Sansom, 2002; Donoghue et al., 2006). The tubercles are com-
prised of an acellular mineralized collagen matrix (dentin) covered with a layer of 
hypermineralized and collagen-free enamel (Donoghue et al., 2006). 
After the mineralized skeleton appeared, primitive vertebrates developed a broad 
range of skeletal elements that are all variations to the four main skeletal tissues, 
viz. bone, dentin, enamel and cartilage (Hall, 2005; Donoghue et al., 2006). Except 
for cartilage, the other three skeletal tissues were present in so-called rhombic 
scales of the earliest bony fish (Sire et al., 2009). The superclass of bony fishes 
contains two classes: the lobe-finned fish (Sarcopterygii) and the ray-finned fish 
(Actinopterygii), to which among others zebrafish and medaka belong. Rhombic 
scales of early ray-finned fish, so-called ganoid scales, typically possess an enam-
eloid external layer (Sire et al., 2009). They further have layers of dentin, elasmodin 
and cellular bone from their external to internal face (Sire et al., 2009). 
138
3 Exoskeleton: vertebrate skeletal system that forms in contact with the ectoderm or endoderm; e.g. 
dermal bone, scales, fin rays, teeth. The exoskeleton is formed via intramembranous ossification (Hall, 
2005). Although “exo” implies an exterior location, exoskeletal elements can also be superficially em-
bedded in the dermis (e.g. scales)
4 Bone: Supportive skeletal tissue that consists of cells and a mineralized extracellular matrix of pre-
dominantly type 1 collagen in a lamellar orientation (Hall, 2005). Two different types of bone can be 
distinguished based on structural organisation: trabecular or cancellous bone which contains red bone 
marrow (where hematopoesis takes place) and compact or cortical bone, a stronger and harder bone, 
which lines trabecular bone. Bone of fish scales can be roughly divided in isopedine (cellular lamelar 
bone) or aspidin (acellular lamellar bone) (Sire et al., 2009).
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The most common type of scale found in extant teleosts is the elasmoid scale, 
a highly reduced scale compared to its rhombic and polypteroid ancestors (Sire 
et al., 2009). As reviewed in chapter 1, the elasmoid scale is composed of three 
acellular layers; the elasmodin layer or basal plate on the inside; the (mineralized) 
external layer and the outer limiting layer (enamel; only found where the epidermis 
covers the scale; Schönbörner et al., 1979). The basal plate consists of elasmodin, 
a collagenous matrix in a twisted plywood orientation (figure 2) that is also found 
in lamellar bone of higher vertebrates (Giraud-Guille, 1988; Zylberberg et al., 1988). 
It is generally accepted that (zebra)fish scales underwent two modifications that 
make them different from the ganoid scale: the superficial layers of dentin and gan-
oine are lost and the deep lamellar bone is reduced or modified (Sire et al., 2009).
The elasmodin layer, which provides the elasmoid scale with flexibility, was long 
considered to be a specific type of bone, homologous to the lamellar bone found 
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Figure 1. Evolution of the vertebrate skeleton. Two distinct skeletons are found in vertebrates; exo-
skeleton (e.g. dermal skull roofs, teeth, scales and fin rays) and endoskeleton (e.g. neurocranium, verte-
bra and appendicular skeleton). While the endoskeleton (endochondral bones) is formed via a cartilage 
precursor that is replaced by bone, the majority of exoskeletal tissues are formed by membranous (di-
rect) ossification. The mineralized skeleton is believed to have emerged initially as an exoskeleton, likely 
advantageous in feeding. While bony fish (Osteichthyes) retain the exoskeleton in the form of dermal 
scales and fin rays, it has been drastically reduced during the water-land transition; it remains only in 
the head region in the form of the dermal skull roofs. Schematic bodies in light grey depict absence of 
an endoskeleton; dark grey bodies indicate the presence of an endoskeleton. Outer blue circles show 
the presence of exoskeletal elements. From Shimada et al. (2013), reprinted with permission of Nature 
publishing group.
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in rhombic scales. The presence of elasmodin was long overlooked in scales of 
basal ray-finned fish and its discovery in developing lungfish (Polypterus senegalus) 
scales shed new light on the origin of the components of scales. From its formation 
together with the dentin layer of ganoid scales, elasmodin was interpreted as a 
dental tissue, more specifically as a form of lamellar dentin, and led Sire to con-
clude that the teleost elasmoid scale is a paedomorphic ganoid scale (Sire, 1989a). 
The functionality of elasmoid scales is not reduced, although the structural reduc-
tion may suggest otherwise. Elasmoid scales retain their protective strength, but 
gained in flexibility, an adaptation to reduce drag when swimming (Marino Cugno 
Garrano et al., 2012; Browning et al., 2013). In addition, the mineralized external 
layers underlie a function as calcium buffer and reservoir (Mugiya and Watabe, 
1977; Flik et al., 1985; Persson et al., 1994). The quick regeneration that occurs 
upon the (naturally occurring) loss of a scale, not only emphasizes its importance 
for the fish, but also highlights fast regenerative pathways that are obviously lost in 
mammals (Sire, 1989b; Brittijn et al., 2009). 
ontogeny of scales
One theory regards the basal plate (dermal bone) and the superficial part of the 
scale as separate tissues, derived from osteogenic and odontogenic condensates, 
respectively (reviewed by Sire et al., 2009). Polypteroid scales develop elasmodin 
and bone successively from an odontogenic condensate, but this is regarded an 
exception (Francillon-Vieillot et al., 1990; Sire and Huysseune, 2003; Sire et al., 
2009). Based on the high level of similarity in early development of scales and 
teeth, Sire and colleagues further argue that an odontogenic condensate is solely 
responsible for the elasmoid scale, and that the osteogenic program responsible 
for ganoid scales is not activated (Sire and Huysseune, 2003). 
In contrast to the previous theory, Donoghue proposes a more dynamic theory 
where the odontode not only gives rise to odontogenic components of the dermal 
skeleton, e.g. teeth and dentine, but also to osteogenic components responsible 
for the bone of the jaw, fin rays and probably the bony base of scales and dermal 
plates (Donoghue et al., 2006). Both theories concur that the evolutionary origin of 
elasmoid scales can be interpreted as modifications or inhibitions of mechanisms 
controlling initiation of osteogenic and odontogenic programs (Sire, 1989a; Dono-
ghue et al., 2006). In fact, Donoghue’s view, where a single cell population can 
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initiate an odontogenic and osteogenic program, is in line with polypteroid scale 
development (regarded as an exception by Sire); the difference lies in the involve-
ment of either one or two different cell types. 
cellular orIgIn
It remains difficult to distinguish between osteoblasts (mesenchymal origin) and 
odontoblasts (neural crest-derived, i.e. ectoderm), even at the level of the tran-
scriptome, since virtually all osteoblast marker genes are also expressed in odon-
toblasts. The only exception seems to be entpd5a (ectonucleoside triphosphate 
diphosphohydrolase 5a), a regulator of bone mineralization in zebrafish (Huitema 
et al., 2012), which has been found only in skeletal osteoblasts (and scales!) but 
not in odontoblasts (teeth; Huitema, personal communication). This suggests that 
scale-forming cells may be closer to osteoblasts than previously recognized.
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Figure 2. Sirius red staining of an EDTA-decalcified tilapia (Oreochromis mossambicus) scale, 
showing the plywood like arrangement of the collagen layers. The upper part is photographed 
through a polarization filter. The elasmodin layer of the scale is indicated with e, the skin (dermis) with 
d. The arrow indicates the external layer. Scale bar = 100 μm
8
Given the developmental similarity with teeth, it has been hypothesized that scales 
form through interaction of ectoderm and mesenchymal cells of neural crest or-
igin, so-called ectomesenchyme (Sire and Akimenko, 2004; Sire et al., 2009). 
Neural crest cells, derived from the developing neural tube, are responsible for 
many unique vertebrate features including teeth and dermal skull elements (Be-
reiter-Hahn and Zylberberg, 1993). This would imply that scales either also have 
a neural crest origin, or a fundamental embryological distinction exists between 
scales and teeth (Donoghue et al., 2006; Fraser et al., 2010). Techniques to verify 
this hypothesis have only recently become available. Shimada and coworkers re-
cently elucidated the embryonic origin of both scales and fin rays with a series of 
transplantation studies in medaka (Shimada et al., 2013). Cells from double trans-
genic β-actin:DsRed/Sp7:EGFP medaka embryos were transplanted in wildtype 
host embryos to trace them during ontogeny. Transplanted cells of dorsal neural 
tubes (including neural crest cells) reappeared in scales and fin rays, but did not 
differentiate into Sp7-positive osteoblasts. When, however, somites (mesoderm) 
were transplanted, DsRed positive cells were again found in scales and fin rays of 
host fish, yet these cells did express GFP; this proves that osteoblasts of scales 
and fin rays originate from the mesoderm and not from the neural crest (Shimada 
et al., 2013). Similar experiments conducted with zebrafish were published only a 
few months later, and led to the same conclusion (Ho Lee et al., 2013; Mongera and 
Nüsslein-Volhard, 2013). 
These observations show that neither bone matrix composition, nor anatomical 
topology (exo- versus endoskeletons) is coupled to developmental cell lineages. 
Likely, developmental pathways that underlie formation of the skeleton are shared 
between neural crest-derived and mesoderm-derived cells. Therefore, it may be 
better to distinguish the diversity in skeletal tissues based on their pathways of 
bone formation (ossification) and physiology.
scale biology
ossIfIcatIon
Though all bone in principle is calcified extracellular collagen matrix, there is not 
just a single pathway that leads to bone formation. Two distinct modes of bone 
formation are known that give rise to most of the vertebrate skeleton, namely 
endochondral and intramembranous ossification. In fish, there is an exceptional 
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variety of ossification programs that give rise to so-called intermediate skeletal 
tissues (Hall, 2005; Apschner et al., 2011). 
It is textbook knowledge that the majority of the vertebrate endoskeleton (axial 
as well as appendicular) is formed via a cartilage precursor that is secondarily re-
placed with bone (endochondral ossification). On the other hand, flat bones of the 
skull, but also scales and fin rays of bony fish are formed via direct (intramembra-
nous) ossification, where mesenchymal cells differentiate into osteoblasts that di-
rectly secrete bone matrix and grow via appositional bone formation (Schönbörner 
et al., 1979; Hall, 2005; Shimada et al., 2013). It was long believed and predicted 
that bones formed via intramembranous ossification and endochondral ossifica-
tion would be metabolically distinct at the cellular level, but evidence supporting 
such notion in mammals is poor and mainly based on the kinetics of mineralization 
(Yamada, 1961; Bird and Mabee, 2003; Mackie et al., 2011). 
Both the proteins and the minerals that characterize bone matrix are shared be-
tween endochondral and intramembranous bone and are also found in zebrafish 
scales. Scales are mineralized with hydroxyapatite crystals, the most stable bio-
mineral that is typically found in bone and teeth (chapter 2). Major bone matrix 
proteins, viz. collagen 1a, osteocalcin, osteopontin and osteonectin, have been pre-
viously reported in elasmoid scales of a variety of fish species (Kimura et al., 1991; 
Le Guellec and Zylberberg, 1998; Nishimoto et al., 2003; Fonseca et al., 2007). 
Results presented in chapter 6 show that orthologs of those genes are indeed 
expressed in zebrafish scale cells. It comes as no surprise that murine osteoclasts 
(RAW264.7 cells) can resorb the mineralized matrix of elasmoid scales (chapter 1; 
Metz et al., 2012). The combination of all these findings underlines the high degree 
of structural similarity between bone and scale matrix.
Even in intramembranous bone distinctions can be made based on the contribu-
tion of ectoderm or endoderm, found in dermal elements but not in mammalian 
membranous bone (Hall, 2005). Elasmoid scales are formed close to the epidermis 
(ectoderm) and direct contacts are observed in the posterior region, where the 
enameloid outer limiting layer is formed (Sire et al., 1997b). Although actual con-
tributions are not yet described, the resulting enameloid layer is often regarded as 
evidence that scales are closely related to teeth (Sire and Huysseune, 2003). The 
outer limiting layer is absent from the anterior part of the scale that is covered by 
an overlapping scale (and thus not by ectoderm). Apparently, it is more likely that it 
is the ectoderm, and not so much the osteogenic program of scale cells, dictates 
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the formation of the outer limiting layer. In conclusion, there is not a firm ground to 
argue that the osteogenic program of scale formation is substantially different from 
bone formation.
cells and physIology
Three cell populations orchestrate bone homeostasis in teleost fish and mammals: 
osteoblasts, osteocytes and osteoclasts. Notable exception is the acellular bone 
of fish, where osteocytes (cells encapsulated in the matrix) are by definition absent 
(Meunier and Huysseune, 1992; Franz-Odendaal et al., 2006). Important osteocytic 
functions are however conserved in acellular bone (Shahar and Dean, 2013). Pres-
ence of osteoblasts and osteoclasts on elasmoid scales is well established in liter-
ature and throughout this thesis (reviewed by Metz et al., 2012). 
Although the skeleton of early freshwater teleosts, such as carp and zebrafish, 
are predominantly made of cellular bone, scales and fin rays are acellular and do 
not possess the typical encapsulated osteocytes (Meunier and Huysseune, 1992). 
Expression of sclerostin (sost gene) in zebrafish scale cells (chapter 6) may be in-
dicative of osteocyte-like cells on scales, as expression of SOST in humans is re-
stricted to osteocytes (Dijke et al., 2008). Although expression of sclerostin cannot 
(yet) be ascribed to a specific population of scale cells, we take this as evidence 
that scales do possess a population of cells that exert osteocyte functions. 
Bone remodeling, known as the continuous process of bone degradation and new 
formation, is conserved between endochondral and intramembranous bone (Hall, 
2005). Maintenance of the fine balance between formation and resorption is piv-
otal and even subtle disturbances in this balance are associated with many bone 
diseases (Deckelbaum et al., 2006). Osteoblasts and osteoclasts communicate 
with each other in order to maintain a healthy balance in bone turnover. Osteo-
clasts, for example, can initiate new bone formation via growth factors that are 
liberated from the bone matrix they degrade. Well known, and central in the cause 
of postmenopausal osteoporosis, is the RANK-RANKL-OPG signaling pathway. 
Osteoblasts produce RANKL (receptor activator of nuclear factor ΚB ligand), a sig-
naling molecule that activates its receptor (RANK) on osteoclast progenitor cells, 
inducing their differentiation and activation (Boyle et al., 2003). Simultaneously, 
osteoblasts produce a decoy receptor (OPG; osteoprotegerin) that negatively 
regulates the RANKL signal (Yasuda et al., 1998). The RANKL-signaling pathway 
appears to be conserved in teleost fish; expression of rankl is demonstrated in (scale) 
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osteoclasts, and also rank and opg are annotated in a variety of fish genomes (Su-
zuki et al., 2011a; To et al., 2012; Yano et al., 2013). Surprisingly, there is not yet a 
conclusive annotation of the opg gene in zebrafish5. With rank and rankl genes ex-
pressed by scale cells (chapter 6 and unpublished observations), there seems no 
question whether this signaling pathway exists in zebrafish (scales). Unfortunately, 
without knowledge on osteoprotegerin, it is as yet impossible to assess the status 
of this important signaling pathway. 
Bone remodeling is essential in normal calcium and phosphorus homeostasis (Bja-
rnason et al., 1998; Boyle et al., 2003; Hadley and Levine, 2006). The notion that 
the calcium and phosphorus6 pool of fish scales can be recruited on demand, 
supports the idea of remodeling of the scale (Mugiya and Watabe, 1977; Flik et al., 
1986; Carragher and Sumpter, 1991; Persson et al., 1995). The small number of 
osteoclasts on an ontogenetic scale suggests a low turnover, but clear evidence 
of matrix degradation has been found during scale regeneration, in principle an 
anabolic process (chapter 4). 
Additional evidence of a comparable bone physiology is found in the homologous 
responses to internally and externally administered stimuli. Calcium recruitment 
not only occurs when calcium is scarce, but also during oogenesis and vitello-
genesis, highly calcium-dependent processes (Flik et al., 1986; Persson et al., 
1995; 1998). In vivo administration of fugu parathyroid hormone stimulated scale 
resorption and osteoclast activity via activation of type 1 Pth receptor, in line with 
the hypercalceamic function of PTH in mammals, first described by James Ber-
tram Collip (Collip, 1925; Rotllant et al., 2005; Suzuki et al., 2011b). The effects of 
PTH have also been demonstrated in vitro to stimulate osteoblast and osteoclast 
activity (Suzuki et al., 2011b). Effects of dietary arachidonic acid (ARA), well known 
modulators of vertebrate bone physiology (Gil Martens et al., 2010; Kruger et al., 
2010), further underline the comparable physiology of zebrafish scales and en-
doskeletal bone. High levels of dietary ARA increase matrix metalloproteinase 
(Mmp)-mediated bone turnover (chapter 5). Arachidonic acid is metabolized to 
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5 Although zebrafish opg (tnfrsf11b) can be found in public databases, the same sequence is also anno-
tated as tnfrsf6b. It is possible that human OPG and TNFRSF6B are two paralogs of a single zebrafish 
ortholog. There is as of yet no functional data to establish that zebrafish tnfrsf11b/tnfrsf6b encodes a 
decor receptor of Rankl.
6 Since fish rarely experience calcium limitations under normal conditions, scale resorption more com-
monly occurs in circumstances of phosphorus limitation (Lall and Lewis-McCrea, 2007; Witten and 
Huysseune, 2009).
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prostaglandin E2 (PGE2), a signal to increase bone turnover under mechanical 
stress (Klein-Nulend et al., 1997; Poulsen et al., 2007). Both ARA and PGE2 stim-
ulate osteoclast activity in ex vivo cultured scales (chapter 5; Omori et al., 2012). 
Over the last decade, scales were treated with a panel of compounds (e.g. calci-
tonin, prolactin, estrogen and Bmp2) that generally yielded responses anticipated 
from mammalian bone physiology (chapter 7; Suzuki et al., 2000; Redruello et al., 
2005; Yoshikubo et al., 2005; Rotllant et al., 2005; Takahashi et al., 2008; Omori et 
al., 2012). From all these results combined we suggest that the mechanisms and 
signaling pathways mammals use to store and recruit skeletal calcium and phos-
phorus were already present in scales. 
pathology
To the best of our knowledge, zebrafish scales so far have not been investigated 
in relation to human bone diseases. Glucocorticoid drugs are one of the major 
causes of osteoporosis in humans; prolonged administration stimulates bone re-
sorption and inhibits formation (Weinstein, 2011; Moutsatsou et al., 2012). Since 
glucocorticoid signaling is highly conserved from teleosts to mammals (Alsop and 
Vijayan, 2008; Schaaf et al., 2009), we treated zebrafish with prednisolone. Indeed, 
this resulted in an osteoporosis-like phenotype in their (regenerating) scales, e.g. 
characterized by significantly increased osteoclast activity (see chapter 6). Reflect-
ing on the progress in our understanding of scale physiology, we argue that there 
is a more than sufficient scientific foundation to propose zebrafish scales as an al-
ternative and versatile model for studies on bone physiology and in drug discovery.
model sysTems in skeleTal biology
In the search for new drugs against bone diseases, discovery generally starts 
with high throughput screening (HTS) assays to identify which compounds inter-
act with carefully chosen targets, either in protein-protein interaction assays or 
in cell culture systems (Auld et al., 2004; Roth et al., 2011; Calamini et al., 2012). 
Although a virtually unlimited number of compounds can be tested, HTS assays 
can only demonstrate whether a potential drug can bind and/or (in)activate a spe-
cific target. Especially for skeletal pathologies (e.g. osteoporosis), receptor-based 
high-throughput screenings are considered limited models as the interaction be-
tween bone-forming cells (osteoblasts) and bone-degrading cells (osteoclasts) is 
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of vital importance, but difficult to include (Rissanen and Halleen, 2010). Available 
in vivo models for bone diseases that do allow these cell-cell interactions include 
the drill-hole method, where bone repair is induced in mice, and ovariectomy in 
rats to cause osteoporosis (Uusitalo et al., 2001). Also ex vivo models, such as test-
ing compounds on cultured calvaria of fetal mice, heavily rely on use of rodents. 
Existing models have their strengths and weaknesses (and for that reason one 
assay often not suffices), but they do fall short when large amounts of substanc-
es need to be tested (Eriksen, 2010, Gomes and Fernandes, 2011, Rissanen and 
Halleen, 2010). There are options to enhance complexity of cell culture assays, 
such as 3D cultures of layered osteoblast and osteoclasts or with osteoclast-con-
ditioned media. However, cell cultures still depend on artificial matrices that do not 
contain bone matrix proteins, which can act as signaling molecules or facilitate cell 
adherence (Marquis et al., 2009; Crockett et al., 2011).
zebrafIsh models
Zebrafish may offer the solution to this lack of satisfactory (mammalian) models in 
bone research that combine complexity of in vivo or explant models with a com-
pound screening strategy. During the last decade, the zebrafish has been rec-
ognized as a valuable model in biomedical research (Lieschke and Currie, 2007; 
Perry et al., 2010). In fact, phase II clinical trials recently started for the first drug 
discovered in using zebrafish model recently (Cutler et al., 2013; Fatetherapeutics.
com, 2013; Eurekalert.org, 2013). Among the key advantages are transparency of 
the embryos, which allows real time imaging of (bone) development; the extensive 
genetic toolbox, including a wide variety of mutants and transgenes; and their 
extensive regenerative capacity (de Bruijn et al., 2009; Suster et al., 2009; Spooren-
donk et al., 2010; Bradford et al., 2011; Gonzalez-Rosa et al., 2012). Until 5 dpf, 
larvae are exempt of regulations on animal experiments which further speeds up 
the experiments (Zon and Peterson, 2005; Barrett et al., 2006). But also adult fish 
can provide unique new insights in physiology (Metz et al., 2012; To et al., 2012; 
Gonzalez-Rosa et al., 2012). In many research fields, including research on cancer, 
cardiovascular diseases, infectious diseases and bone physiology, zebrafish mod-
els make now substantial contributions to our understanding of (patho)physiology 
(Peterson et al., 2004; Fleming et al., 2005; Perry et al., 2010; Veneman et al., 2013).
Larval stages of zebrafish have become popular models in bone research (Flem-
ing et al., 2005; Spoorendonk et al., 2010; Vanoevelen et al., 2011; Huitema et al., 
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2012). Forward genetic screens have identified new genes in bone physiology that 
could be new targets for therapeutics (Spoorendonk et al., 2010; Huitema et al., 
2012). On the other hand, larvae are used in compound screens to identify new 
(osteogenic) lead compounds that can be followed up in the drug discovery pipeline 
(Fleming et al., 2005). Both models can be adapted to high throughput approaches 
and benefit from the use of the whole animal. However, in early developmental 
stages (up to hatching at 48-72 hpf), embryos reside in their chorion, protected by 
perivitelline medium. The chorion impedes passive diffusion of compounds into 
the zebrafish larvae (Ali et al., 2011). Amongst the limitations of larval models is 
the very rapidly developing skeleton, which predominantly involves osteoblasts. 
In fact, first evidence of osteoclasts is described not earlier than nine days post 
fertilization (Witten et al., 2001; Fleming et al., 2005). 
Bone of juvenile and adult fish is, amongst others, studied by the group of Winkler 
and colleagues. They have generated different transgenic medaka (Oryzias latipes) 
lines to visualize bone cells and especially osteoblast-osteoclast interactions in 
vivo (Renn and Winkler, 2009; To et al., 2012). Medaka with inducible rankl expres-
sion make a literally spectacular osteoporosis model; activation of rankl expression 
induces a dramatic increase in bone resorption (To et al., 2012). Such an in vivo 
model is highly advantageous to unravel complex fundamental physiological pro-
cesses in bone physiology, e.g. signaling. They are however less suitable to adapt 
for medium- or high throughput screenings. 
Fin rays of (adult) fish have also gained significant attention, mostly for their ability 
to regenerate following amputation. The fin ray is not only a model for bone forma-
tion, but also for tissue regeneration in general. One of the key features studied in 
the fin regeneration model is cellular (de)differentiation of osteoblasts (Marí-Beffa 
et al., 2007; Knopf et al., 2011; Singh et al., 2012). This model is also used to in-
vestigate pathways involved in bone formation and patterning, including BMP-, 
FGF- and hedgehog signaling (Poss et al., 2000; Quint et al., 2002; Smith et al., 
2006). While fin rays are a more generally accepted bone model than scales, they 
are thought to have evolved from scales of early vertebrates (Smith and Hall, 1990; 
Marí-Beffa et al., 2007). Fin osteoblasts indeed develop from the same cell lineage 
as cells on zebrafish scales (Ho Lee et al., 2013; Mongera and Nüsslein-Volhard, 
2013; Shimada et al., 2013).
All of the zebrafish models discussed above highlight different aspects of bone 
physiology. However, none of those including osteoblast-osteoclast interactions 
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are suitable for medium or high-throughput compounds screening. Combining 
the predictive power of a bone explant culture with the low cost of zebrafish as 
model, we envisioned a zebrafish scale-based assay that can be used for in vitro 
compound screening. In contrast with zebrafish larvae, which are increasingly used 
for HTS but have as yet no or very few osteoclasts, scale explant cultures include 
both osteoblast and osteoclasts and represent the adult bone that is mainly affect-
ed in bone disease. Scales can be removed virtually without harming the fish and 
their presence on a single fish is numerous. Since manual harvest and distribution 
of single scales over microwell plates will be the time-limiting step of the assay, we 
propose to implement the scale assay between HTS and preclinical rodent studies, 
to subsequently test only the most promising compounds in existing validated, yet 
expensive, rodent models. 
design and validaTion of The Zebrafish scale assay
In previous studies, including our own, enzymatic activities of alkaline phospha-
tase (ALP) and tartrate-resistant acid phosphatase (TRACP) have commonly been 
used to determine the activity of osteoblasts and osteoclasts, respectively (Suzuki 
and Hattori, 2002; Yoshikubo et al., 2005; Takahashi et al., 2008; Suzuki et al., 
2011a; de Vrieze, Lock and Metz, unpublished results). Although apparently ap-
plied with success in goldfish scales (group of Suzuki and colleagues), phospha-
tase assays appeared not sensitive enough for zebrafish scales. Moreover, ALP nor 
TRACP is exclusively expressed in bone cells; the epidermis that covers the scale 
also stains positive for ALP activity and it is known from mammalian studies that 
TRACP is also expressed by a subset of macrophages and dendritic cells (Walsh 
et al., 2003). Zymographic analyses of matrix metalloproteinases and cathepsin K 
(chapters 4 and 5; Metz, unpublished observations) provide sensitive information 
on osteoclast activity, but this gel-electrophoresis based technique is laborious 
and semi-quantitative. Likewise, gene expression analysis is labor-intensive and 
expensive. Thus, these approaches are applicable in proof of principle studies, but 
have limitations and are not suitable to analyze large numbers of samples.
When we considered design of the current assay, we opted for a luciferase reporter 
line. Luciferase, an enzyme from firefly Photinus pyralis, produces light from lucif-
erin and adenosine triphosphate (ATP) (Gould and Subramani, 1988). The emitted 
light is easily measured and as such, luciferase activity is widely used in many cell 
culture assays. Generation of a luciferase reporter zebrafish is not novel per se and 
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was done for larvae in endocrine disruption studies (Damdimopoulou and Treuter, 
2011). Using scales from a zebrafish with a luciferase gene driven by a promoter 
that is activated upon osteoblast activity, we now can measure the osteogenic 
potential of compounds leaving intact all vital cell-cell and cell-matrix interactions. 
The Sp7 promoter was selected for its early role in pathways regulating osteo-
blast differentiation and function, both in mammals and zebrafish (Nakashima et 
al., 2002; Matsubara et al., 2008; Spoorendonk et al., 2008; Knopf et al., 2011). 
SP7 is activated by osteogenic signals such as BMP-2 and PTH1-34 (teriparati-
de, Forteo®), and regulates expression of e.g. osteocalcin, collagen 1a and alkaline 
phosphatase (Kaback et al., 2008; Matsubara et al., 2008; Yamane et al., 2009). The 
resultant is an assay based on the same principle as receptor-reporter assays used 
in high throughput screening (Calamini et al., 2012), but for use with ex vivo cultured 
tissues. This assay does not focus on the activation of a single target (e.g. recep-
tor, enzyme, etc.), but integrates signals from all pathways leading to osteoblast 
activation (i.e. sp7 expression) and includes all communication pathways between 
bone cells and matrix. 
valIdatIon and valorIzatIon
Dozens of zebrafish-based models have been proposed to use in drug discovery 
over the last decade (Fleming et al., 2005; Schiffer et al., 2007; Ali et al., 2011; 
Carvalho et al., 2011). For all assays, including our own, a thorough validation 
is required before it may be implemented in the drug discovery pipeline. A high 
predictive value (based on both sensitivity and specificity) is essential and can be 
assessed with known stimulators of bone formation and sp7 expression. False 
positive hits would result in useless follow-up experiments, while false negatives 
could account for the escape of potentially promising candidates. It seems obvi-
ous that specificity of the assay can best be assessed with compounds from phar-
maceutical companies, including not only promising drugs but also compounds 
that did not make it to (pre)clinical trials. Without cooperation from pharmaceutical 
companies, fundamental scientists have access to only a small number of drugs 
that are on the market to test the predictive value of a new assay. Especially for 
degenerative bone diseases (e.g. osteoporosis) options are limited, since most 
drugs slow progression of the disease; the ultimate goal is to identify a drug that 
rescues the low bone mass (Banu et al., 2012; Baron and Hesse, 2012). The N-ter-
minus of the human parathyroid hormone (PTH1-34) is the only FDA-approved an-
abolic drug against osteoporosis, but the success of treatment strongly depends 
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on timing, dosage and interval of administration (Bellido et al., 2003; Jilka, 2007; 
Kim et al., 2012). Teleost PTH and the closely related PTHrP both signal via the 
ortholog of the mammalian PTH receptor (PTH1R) to control calcium homeostasis 
(Redruello et al., 2005; Rotllant et al., 2005; Guerreiro et al., 2007; Abbink and 
Flik, 2007; Suzuki et al., 2011a). Pilot experiments revealed osteogenic effects of 
PTH1-34 when administered to scales of Sp7:luciferase zebrafish with a dependency of 
administration interval similar to mammals (unpublished observation). Being lim-
ited to commercially available compounds, validation of the assay was further 
done with the osteogenic BMP-2 (both human and zebrafish) and a small library of 
compounds modulating WNT-signaling, a pathway known to regulate osteoblast 
differentiation and proliferation (Bennett et al., 2005; Mak et al., 2006). In agreement 
with literature, many negative regulators of sp7 were identified from the library 
(chapter 7). However, also three novel stimulators of osteoblasts in were identified 
using the Sp7:luciferase scale assay.
perspecTives
The here presented zebrafish scale model centers around a regulator of osteoblast 
differentiation and activity viz. Sp7. With extension of the transgenic fish repertoire, 
virtually all aspects of bone physiology can be covered. For instance, such lines 
can include luciferase driven by promoters of bone matrix genes, or GFP-labeled 
osteoclasts of which migration (and bone resorption) can be traced in real-time. 
Combining scales of different transgenic lines can further increase the benefits of 
using this model between HTS en preclinical trials.
Diseases with pronounced bone phenotypes are growing to pandemic proportions. 
Osteoporosis and obesity are diseases that both find their origin in mesenchyme: 
osteoblasts and adipocytes, respectively. There is increasing evidence that links 
these diseases: e.g. osteoporosis caused by replacement of osteoblasts by adi-
pocytes and the hypothalamic modulation of bone mass via anorexigenic signals 
such as hepatic and fat-derived leptin and brain-derived CART. Severe obesity 
is often associated with hypogonadism; estrogen deficiency in post-menopausal 
women causes osteoporosis. As a result of increasing prevalence, combined with 
the complex and often unexpected interactions between both diseases, demand 
for models to study bone (patho)physiology is higher than ever. Zebrafish and their 
scales provide excellent models to gain more insight in the interdependence be-
tween both diseases. 
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Summary
Samenvatting
summary
Bone diseases such as osteoporosis have already a large societal impact today 
and their prevalence is predicted to increase substantially the coming 50 years 
(Harvey et al., 2010). A treatment adequate in all aspects is lacking and develop-
ment of new therapeutics and treatment strategies are now more important than 
ever. This thesis introduces the zebrafish scale as a promising new model in bone 
biology and drug discovery. Scales are among the first mineralized tissues that 
evolved in vertebrates and have since attained functions in protection, hydrody-
namics of swimming behavior and calcium homeostasis.  
Between single cell type culture studies on the one hand and rodent experiments 
on the other, the small and easily obtainable dermal scales, which come by the 
hundreds in a single fish, can fulfill the need for more complex models to test 
potential drugs (figure 1). In this thesis, three key issues were addressed: (I) the 
level of compositional similarity between zebrafish scales and mammalian bone, 
(II) physiological analogy between scales and bone, and (III) design and validation 
of a directly applicable assay for compound screening based on scales. The major 
findings include:
I) The mineral phase of adult carp and zebrafish scales consists predominant-
ly of calcium phosphate in a hydroxyapatite form and is restricted to the 
external layer (chapter 2). The calcium:phosphorus molar ratio increases 
during early scale regeneration from approximately 1.0 to approximately 1.6 
and this provides evidence that calcium phosphates are first deposited in 
an amorphous precursor phase. The acellular, collagenous scale matrix is 
lined on both sides with scale cells (scleroblasts). Cells on the inner surface 
(hyposquamal scleroblasts; osteoblasts) produce the classical osteoblast 
marker alkaline phosphatase. Mono- and multinucleated osteoclasts reside 
on the mineralized outer surface (episquamal side) and secrete proteolytic 
enzymes (chapter 3). The analogy with mammalian bone cells is further es-
tablished by the expression of typical osteoblast and osteoclast genes, such 
as sp7, osteocalcin, mmp9 and rankl in scale cells (chapters 4, 5, and 6).
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II) Bone remodeling, the process of continuous breakdown and formation, 
is seen in scales and becomes particularly evident during scale regenera-
tion, an overall anabolic process. Secretion of proteolytic enzymes (Mmp2 
and Mmp9) and collagen degradation both increase during regeneration, 
demonstrating matrix degradation during the formation process of new ma-
trix, hence remodeling (chapter 4). Fish fed high levels of arachidonic acid, 
show increased osteoclastic activity and bone turnover compared to fish 
fed low levels of arachidonic acid, underlining the value of scales in research 
on general aspects of bone physiology (chapter 5). We further show that 
scalar bone is not only similar to mammalian bone in terms of physiology, 
but also in pathology: when exposed to a prednisolone, scales develop a 
phenotype that resembles glucocorticoid-induced osteoporosis of human 
patients. Mineralization and morphology of the (regenerating) scale are se-
verely affected, as is the phased gene expression profile, which is strongly 
reminiscent of increased osteoclast activity (chapter 6). All the above-men-
tioned experimental data substantiate strong (patho)physiological similari-
ties between scales and mammalian bone.
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Figure 1. Proposed drug development pipeline that includes the newly described zebrafish 
scale model. Zebrafish can either be applied in target discovery (e.g. forward genetic approach), or 
between high throughput, cell-based screening assays and mammalian models (e.g. scale model; in 
red box). Figure adapted and reprinted with permission from Brittijn et al., 2009.
S
III) This thesis further presents an ex vivo screening assay based on scales of 
Sp7:luciferase transgenic zebrafish that is ready to be implemented in the 
drug-discovery pipeline (figure 1). Key advantage of the scale model over 
existing models are the original cell-cell and cell-matrix interactions. Several 
approaches known to stimulate osteoblast activity (more specifically, sp7 
expression), including scale regeneration and treatment with Bmp-2, a bone 
anabolic protein, were used to validate the assay. A recent pilot with the 
anti-osteoporotic PTH(1-34) yielded similar results. More excitingly, three 
novel osteogenic molecules were identified in a first small screening of a 
compound library (chapter 7), showing the potential of the zebrafish scale 
assay in drug discovery.
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samenvaTTing in heT nederlands (summary in duTch)
Osteoporose (botontkalking) en aanverwante botziekten hebben een grote impact 
op onze samenleving. De meest voorkomende oorzaken van osteoporose zijn de 
afname van oestrogenen na de menopauze en het gebruik van glucocorticoïden 
(o.a. voorgeschreven als ontstekingsremmer). Het aantal patiënten dat aan osteo- 
porose lijdt is de laatste jaren sterk toegenomen en de verwachting is dat dit aantal 
ook de komende 50 jaar nog verder gaat stijgen. 
Momenteel zijn er geen medicijnen beschikbaar om osteoporose te behandelen, 
enkel om de progressie te vertragen. Logischerwijs is de ontwikkeling van nieuwe 
medicijnen en therapieën voor osteoporose van groot belang. Dit proefschrft intro-
duceert de zebravis schub als een veelbelovend nieuw model in het botonderzoek. 
Schubben behoren tot de eerste verharde (gemineraliseerde) weefsels die in de 
evolutie van gewervelde dieren zijn ontstaan en hebben net als het humane skelet 
functies verworven in calcium homeostase en bescherming. 
In het huidige onderzoek naar nieuwe medicijnen worden miljoenen chemische 
verbindingen (zogenaamde compounds) gescreend op biologische activiteit die 
het verloop van een ziekte kan beïnvloeden. Hiervoor wordt gezocht naar com-
pounds die kunnen binden aan belangrijke eiwitten binnen het ziekteproces of een 
therapeutisch effect hebben op gekweekte cellen. Een groot nadeel van veel po-
tentiële medicijnen tegen osteoporose is het feit dat ze vaak zowel de cellen die 
het bot opbouwen (osteoblasten) als de cellen die het bot afbreken (osteoclasten) 
beïnvloeden. Hierdoor is het netto effect moeilijk te voorspellen. Vooralsnog zijn 
dierproeven (vaak ratten of muizen) de beste manier om het netto effect op de 
botbalans te voorspellen. Dergelijke proeven zijn zeer kostbaar en arbeidsintensief. 
Hier bieden de schubben van (zebra)vissen uitkomst. Een vis heeft enkele honder-
den schubben, die verzameld kunnen worden voor experimenten zonder de vis te 
moeten offeren. Sterker nog, wanneer een schub verwijderd wordt, groeit deze in 
een paar weken tijd weer terug (regeneratie). De schub is een soort van botplaatje 
dat als geheel, met bijbehorende osteoblasten en osteoclasten, in kweek gehou-
den kan worden om potentiële medicijnen te testen. Dit maakt schubben uitermate 
geschikt om de netto effecten van compounds op botcellen beter te voorspellen. 
Op deze manier kunnen enkele honderden compounds per dag worden getest. Dit 
maakt het schub-model een ideale tussenstap tussen de screenings van miljoenen 
compounds en de experimenten op knaagdieren (zie figuur 1 op pagina 155). 
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Tijdens het onderzoek beschreven in dit proefschrift, is gekeken naar de mate van 
overeenkomst in opbouw en functie tussen schubben en bot. Daarnaast is het 
schub-model voor het screenen van compounds ontwikkeld en gevalideerd. De 
belangrijkste bevindingen staan hieronder samengevat:
Net als bij het bot van mensen, bestaat de gemineraliseerde laag van de schub uit 
hydroxyapatiet kristallen (hoofdstuk 2). Deze kristallen bevatten calcium en fosfaat, 
zijn zeer moeilijk oplosbaar en geven botten en schubben hun stevigheid. Deze 
kristallen slaan neer op een matrix van eiwitten (voornamelijk collageen), die voor 
zover nu bekend hetzelfde zijn voor schubben en bot. In tegenstelling tot bot be-
vatten schubben alleen cellen aan de buitenkant. Deze cellen lijken in hun functie 
sterk op de cellen die bot opbouwen en afbreken (hoofdstuk 3). In deze cellen 
komen genen tot expressie die ook in cellen van humaan bot tot expressie komen 
(hoofdstukken 4, 5 en 6).
De vorming van een nieuwe schub is een proces van opbouw en afbraak, waardoor 
de schub haar vorm krijgt. Humaan bot wordt ook continu afgebroken en opnieuw 
opgebouwd, om zo calcium vrij te maken wanneer het lichaam daar om vraagt. 
Bij zowel schubben als bot zijn hier dezelfde enzymen bij betrokken (hoofdstuk 4). 
Daarnaast is het bekend dat botcellen  kunnen reageren op externe factoren zoals 
vetzuren in het dieet, of medicijnen als prednisolone. In hoofdstuk 5 en hoofdstuk 
6 staat beschreven dat de reactie van schub-cellen op deze stimuli sterk over-
eenkomt met die op humaan bot. Hiermee is aangetoond dat schubben in functie 
vergelijkbaar zijn met bot en dus geschikt zijn om de effecten van compounds 
(potentiële medicijnen) te testen.
In hoofdstuk 7 staat het schub-model beschreven dat is ontwikkeld om com-
pounds te screenen op een positief effect op bot. Hiervoor wordt gebruik gemaakt 
van schubben van een speciale, genetisch gemodificeerde zebravis. De vis is zo 
gemaakt dat er een enzym aangemaakt wordt wanneer intracellulaire routes wor-
den geactiveerd die voor botopbouw zorgen. Dit enzym (luciferase) geeft licht tij-
dens de omzetting van een substraat. Tijdens de validatie van dit schub-model 
is aangetoond dat Bmp2, een stimulator van botvorming, ook de intracellulaire 
routes van botvorming stimuleert in schubcellen. Daarnaast is ook een kleine serie 
compounds gescreend, waaruit drie nieuwe stoffen zijn geïdentificeerd als poten-
tiële stimulatoren van de botvorming. Deze stoffen zijn nog niet eerder beschreven 
in het kader van botonderzoek en laten zien dat het schub-model een waardevolle 
toevoeging aan de huidige modellen kan zijn. 
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